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Summary 
 
Bacterial meningitis remains one of the major health problems in Sub-Saharan Africa and 
contributes significantly to childhood morbidity and mortality. The three most important 
agents are Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus 
influenzae. All three pathogens are common colonizers of the human nasopharynx, 
invasive disease is usually a rare event. While meningitis caused by Haemophilus 
influenzae (Hib) and Streptococcus pneumoniae (pneumococcus) is mostly endemic and 
affects certain risk groups, Neisseria meningitidis (meningococcus) is known for its 
potential to cause meningitis epidemics especially in Sub-Saharan Africa. In the so called 
African Meningitis Belt, epidemics of meningococcal meningitis reccur every 8-12 years 
with incidence rates of up to 1% in the affected population, typically caused by serogroup 
A. Recently, outbreaks of serogroup W135 have raised general concern. The dynamics of 
these epidemic cycles is uncompletely understood. As meningitis cases in the early phase 
of epidemics usually fulminantly shoot up, outbreaks are often only detected when the 
epidemic is already on course. Also a lack of functional infrastructure in the respective 
countries, contributes to the delayed initiation of intervention measures, to prevent the 
majority of cases such as emergency immunization of the affected population with 
meningococcal polysaccharide vaccine .  
After a major meningitis epidemic in Northern Ghana in 1998 a long-term colonisation 
and disease study was initiated in the Kassena Nankana District (KND), by a joined 
collaboration of the Navrongo Health Research Center and the Swiss Tropical Institute. 
The study aims to enhance the understanding of the dynamics of meningococcal 
meningitis epidemics in the African Meningitis Belt for early outbreak detection and 
improved intervention. This thesis as part of the long term study, concentrates on 
epidemiological characteristics of colonisation and disease and the association of the 
population of meningococcal carriage- and patient-isolates. Furthermore, the impact of 
emerging clones (e.g. serogroup W135) and other bacterial species (in particular S. 
pneumoniae) causing acute bacterial meningitis in Northern Ghana was investigated. 
 
During eight years study period completed so far, we observed sequential waves of 
colonisation with pathogenic and apathogenic meningococcal genoclouds that typically 
lasted for three to four years. Epidemiological trends were profoundly different from those 
observed in industrialized countries. The carried populations of meningococci were i) less 
vi Summary 
stable in genotype composition, ii) less diverse during the peaks of colonization waves, iii) 
non-groupable (NG) strains were comparatively rare and iv) the hyperinvasive genoclouds 
responsible for all culture-reconfirmed meningococcal meningitis cases were not a 
minority, but dominated, representing 71% of the colonisation isolates.  
Serogroup A meningococci caused two outbreaks during the study period. Sequence 
Type (ST) 5 bacteria were detected during a post-epidemic outbreak in 1998 and 
colonisation persisted until 1999. While A ST5 meningococci have never been isolated 
again in the KND, closely related A ST7 meningococci emerged in 2001, causing 
substantial outbreaks between 2002 to 2004 before disappearing from the district in late 
2005. In between, an outbreak of serogroup X bacteria occured in 2000 and 2001, with 
colonisation rates of up to 20%, but only a limited number of cases. Even though the 
meningococcal population observed in the KND over eight years exhibited a low genetic 
diversity, constant microevolution was observed in the different genoclouds.  
W135 meningococci, exhibiting epidemic potential in neighbouring Burkina Faso only 
caused sporadic meningitis cases in Ghana and no major wave of colonisation and 
disease. However, W135 strains isolated from single meningitis patients were 
indistinguishable from Burkinian epidemic isolates by PFGE analysis and in certain patient 
communities efficient clonal colonisation with carriage rates of up to 20% was observed. 
Hib meningitis was recorded only infrequently in the KND since routine vaccination with 
the Hib polysaccharide-protein conjugate vaccine had been implemented in Ghana in 
2000. In contrast, S. pneumoniae caused an outbreak of pneumococcal meningitis in the 
KND between 2000 and 2003, that revealed features characteristic for meningococcoal 
meningitis such as seasonality, clonality and a broad age spectrum of the patients. 
Serotyping and MLST analysis showed the dominance of a serotype 1 clonal complex, 
which has repeatedly been isolated in various African countries. PFGE analysis and pspA-
sequencing of the outbreak strains in comparison with reference strains representing three 
serotype 1 lineages, confirmed the clonal relationship of the Ghanaian isolates and 
indicated a phylogenetic association of the three serotype 1 lineages.  
 
The observed lack of a temporally stable and genetically diverse resident pharyngeal 
flora of meningococci might contribute to the susceptibility of the population in the African 
meningitis belt to meningococcal disease epidemics. Because capsular conjugate 
vaccines are known to impact meningococcal carriage, effects on herd immunity and 
potential serogroup replacement should be monitored following the introduction of such 
vaccines. Furthermore the emergence of new genoclouds of non-vaccine serogroups with 
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epidemic potential or other species such as S. pneumoniae needs to be carefully 
examined to evaluate the need for other vaccines or a change of the intervention 
strategies.  
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Zusammenfassung 
 
Bakterielle Meningitis stellt eines der grossen Gesundheitsprobleme in Sub-Sahara 
Afrika dar und trägt dort nach wie vor erheblich zu Kindermorbidität und -mortalität bei. Die 
drei wichtigsten Erreger sind Neisseria meningitidis, Streptococcus pneumoniae, und 
Haemophilus influenzae. Alle drei Pathogene sind Bestandteil der normalen bakteriellen 
Flora des menschlichen Nasen-Rachenraums, invasive Krankheiten bilden die Ausnahme. 
Während durch Haemophilus influenzae (Hib) und Streptococcus pneumoniae 
(Pneumokokkus) verursachte Meningitis üblicherweise endemisch auftritt und zumeist 
bestimmte Risikogruppen betrifft, ist Neisseria meningitidis (Meningokokkus) bekannt für 
sein Potential, Meningitis-Epidemien in Afrika südlich der Sahara auszulösen. Mit 
Inzidenzraten von bis zu 1% der betroffenen Bevölkerung treten Meningokokken-
Epidemien im sogenannten Afrikanischen Meningitis Gürtel alle 8-12 Jahre auf. Epidemien 
werden primär durch Erreger der Serogruppe A verursacht. Seit einigen Jahren erregen 
jedoch Ausbrüche der bislang als relativ apathogen angesehenen Serogruppe W135 
Besorgnis. Die Dynamik der epidemischen Zyklen ist noch nicht aufgeklärt. Da die Zahl 
der Meningitisfälle zu Beginn eines Ausbruchs explosionsartig ansteigen, werden 
Epidemien oft erst in fortgeschrittenem Stadium erkannt. Mangelhafte Infrastruktur in den 
Ländern des Meningitis Gürtels trägt dazu bei, dass nötige Interventionen, insbesondere 
Massenimpfungen der betroffenen Bevölkerung zu spät initiiert werden, um die Mehrzahl 
der Fälle zu verhindern.  
Nach einer Meningitis Epidemie im Norden Ghanas wurde 1998 mit einer Langzeit-
Studie der Meningokokkenkolonisation und Erkrankungen im Kassena Nankana Distrikt 
(KND) begonnen- ein gemeinsames Projekt des Navrongo Health Research Center und 
des Schweizerischen Tropeninstituts. Die Studie hat sich zum Ziel gesetzt, zu einem 
tieferen Verständnis der Dynamik der Meningokokken-Epidemien im Afrikanischen 
Meningitis Gürtel beizutragen, um Früherkennung und Interventionen zu verbessern. Als 
ein Teil dieser Langzeitstudie befasst sich die vorliegende Arbeit mit der Epidemiologie 
von Kolonisation und Krankheit und dem Verhältnis der von Trägern und Patienten 
isolierten Meningokokken-Populationen. Ausserdem wurde die Bedeutung von 
aufkommenden neuen Klonen, z.B. der Serogruppe W135, und anderer bakteriellen 
Meningitiserregern (insb. S. pneumoniae) untersucht.  
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Während der acht Studienjahre wurden aufeinanderfolgende Wellen der Koloniation mit 
pathogenen und apathogenen Meningokokken-„Genoclouds“ beobachtet, die etwa drei bis 
vier Jahre lang andauerten. Hierbei zeigten sich deutliche Unterschiede zur Epidemiologie 
der Kolonisation mit Meningokokken in Industrieländern. Die Population der Trägerisolate 
war i) weniger konstant in ihrer Zusammensetzung, ii) weniger divers während der 
Kolonisationswellen, iii) nicht-serogruppisierbare Stämme wurden vergleichsweise selten 
isoliert und iv) die hyperinvasiven „Genoclouds“, die für alle kultur-rückbestätigten 
Meningokokken-Meningitis Fälle verantwortlich waren, dominierten mit 71% unter den 
Trägerisolaten.  
Meningokokken der Serogruppe A verursachten im Verlauf der Studie zwei Meningitis 
Ausbrüche im KND. Erreger des Sequenz Typ (ST) 5 wurden während des Ausbruchs von 
1998 isoliert, die Kolonisation mit diesen Erregern dauerte bis 1999 an. Danach jedoch 
wurden sie nie wieder im KND nachgewiesen. Meningokokken der Serogruppe A, ST7, 
kamen 2001 auf und verursachten Ausbrüche von 2002 bis 2004, bevor sie Ende 2005 
wieder aus dem Distrikt verschwanden. In der Zwischenzeit sorgte eine Welle von 
Serogruppe X Meningokokken für Kolonisationraten bis zu 20%, aber nur für eine 
begrenzte Zahl von Fällen. Obwohl die Meningokokken Populationen im KND über acht 
Jahre hinweg nur eine begrenzte genetische Diversität aufwiesen, wurde mittels Pulsed 
Field Gel Electrophorese (PFGE) eine fortwährende Mikroevolution der „Genoclouds“ 
beobachtet.  
W135 Meningokokken, die in Burkina Faso ein Potential zu Meningokokken Ausbrüchen 
gezeigt hatten, verursachten in Ghana nur vereinzelte Meningitis Fälle. Es kam weder zu 
einer Epidemie noch zu einer grösseren Kolonisationswelle. Die vereinzelten W135-Isolate 
von ghanaischen Meningitis Patienten waren mittels PFGE von den epidemischen Isolaten 
aus Burkina Faso nicht zu unterscheiden. Im Heimatdorf eines Patienten beobachteten wir 
klonale W135 Kolonisation mit Trägerraten von bis zu 20% beobachtet.  
Haemophilus-Meningitis wurde im KND nur sehr selten festgestellt, da seit dem Jahre 
2000 in Ghana der Hib Konjugat-Impfstoff in das Standard-Impfschema für Kleinkinder 
eingegliedert ist. Hingegen haben wir im KND zwischen 2000 und 2003 einen Ausbruch an 
Pneumokokken-Meningitis beobachtet. Dieser Ausbruch wies typische Charakteristika der 
Meningokokken-Meningitis, wie Saisonalität, Klonalität und ein breites Altersspektrum der 
Patienten, auf. Serotyp-Bestimmung und Multi Locus Sequence Typing (MLST) zeigten die 
Dominanz eines Serotyp 1 klonalen Komplexes, der schon wiederholt in verschiedenen 
afrikanischen Ländern isoliert wurde. PFGE und Sequenzierung des Pneumokokken 
Oberflächen Protein A Gens (pspA) im Vergleich zu weiteren Serotyp 1 Linien bestätigte 
x Zusammenfassung 
die klonale Verwandtschaft der ghanaischen Isolate und wiesen weiterhin auf eine enge 
phylogenetische Beziehung der drei Serotyp 1 Linien hin.  
 
Das Fehlen einer stabilen und mannigfaltigen Meningokokken-Flora könnte zur erhöhten 
Empfänglichkeit für Meningokokken-Epidemien im Meningitis Gürtel beitragen. Da 
Imfpungen mit Kapsel-Konjugat Impfstoffen sich auf die Kolonisation mit Meningkokokken 
auswirken können, sollten mögliche Effekte auf Herd-Immunität und ein potentieller 
Austausch der Serogruppe bei einer Einführung dieser Impfstoffe im Meningitis Gürtel 
genauestens überwacht werden. Weiterhin sollte das Aufkommen neuer „Genoclouds“ von 
Serogruppen, die nicht in den aktuellen Imfpungen enthalten sind oder anderer 
Bakterienspezies wie S. pneumoniae sorgfältig untersucht werden, um so den Bedarf für 
neue Impfstoffe oder neue Interventionen zu evaluieren. 
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2 Chapter 1. Introduction 
  
Bacterial meningitis is a medical emergency and remains a major cause of mortality and 
morbidity throughout sub-Saharan Africa (Hart C.A. & Cuevas L.E. 2003;Greenwood 
2004). From post-mortem interviews it has been estimated that about 2 percent of deaths 
in children under 5 years of age are due to meningitis, thus an overall 200’000 cases of 
bacterial meningitis cases have been extrapolated to occur in African children each year, 
70’000 of these with fatal outcome (Greenwood 2004). The most important causative 
agents of bacterial menigitis are Neisseria meningitidis (the meningococcus), 
Streptococcus pneumoniae (the pneumococcus) and Haemophilus influenzae type b (Hib) 
(Cadoz et al. 1981;Campagne et al. 1999;Palmer et al. 1999;Peltola 2001). Haemophilus 
influenzae is well known for causing childhood meningitis, and S. pneumoniae mostly 
affects elderly, infants, and immunocompromised patients. Epidemics of bacterial 
meningitis are usually associated with Neisseria meningitidis (Mar et al. 1979;Moore 
1992;Makela et al. 1992). All three species are common colonizers of the human 
nasopharynx; colonisation only occasionally causes disease. These bacteria spread from 
person to person predominantly via aerosol droplets. In most instances, meningitis results 
from colonisation and subsequent invasion of the bloodstream; it may also develop due to 
a bacterial spread from a focus of infection such as otitis media (Hart C.A. & Cuevas L.E. 
2003;Greenwood 2004).  
Symptoms may set off suddenly with fever, the disease ususally progresses fast. Typical 
signs for the involvment of the meninges include headache, irritability, nausea, vomiting, 
and neck stiffness. Convulsions may occur especially in children. Clinical diagnosis of 
acute bacterial meningitis might be difficult when characteristic symptoms are absent, e.g. 
in the old and the very young patients. Cerebral malaria is an important differential 
diagnosis in areas with high malaria endemicity (Hart C.A. & Cuevas L.E. 2003). Fatality 
rates are highly dependant on timely treatment and therefore varies substantially in 
different reports. In a meta-analysis of various African studies, fatalitiy rates of 8% for 
meningococcal meningitis, 29% for Hib meningitis and 45% for pneumococcal meningitis 
have been cumulatively calculated (Peltola 2001). 
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Neisseria meningitidis 
Neisseria meningitidis, a gram negative diplococcus initially called Diplococcus 
intracellularis, was isolated for the first time in 1887 (Weichselbaum A. 1887). Currently, 
meningococci are classified into 13 serogroups according to the chemical structure of their 
polysaccharide capsule (Yazdankhah & Caugant 2004). Being an obligat human 
pathogen, it usually colonizes the nasopharynx and only occasionally causes invasive 
disease. Only a few serogroups are associated with invasive disease, namely the 
serogroups B,C,Y and W135, with sialic acid containing polysaccharide capsules, and the 
serogroup A, with a capsule composed of mannosaminephosphate (Poolman et al. 1995). 
The polysaccharide capsule can confer resistance to host complement mediated attack 
mechanisms leading to the survival and spread of the bacteria in the bloodstream. 
The annual incidence of meningococcal disease in industrialized countries is about 1-5 
cases per 100’000. Highest incidence rates are usually recorded during early childhood 
and in teenagers and young adults. Limited outbreaks of disease are often associated with 
overcrowding and resulting high transmission of meningococci, such as in schools, student 
dormitories or military campls. Apart from contact with a case and overcrowding, exposure 
to smoke has been identified as a possible risk factor. In Europe and Northern America a 
seasonal increase of meningococcal cases is usually recorded during winter months 
(Cartwright 1995;Tikhomirov et al. 1997). 
 
Serogroup specific epidemiology 
Historically, serogroup A meningococci have caused most large epidemics of 
meningococcal meningitis (Greenwood 1999). Before the second world war, large 
meningitis epidemics were also recorded from Europe and North America, but since then 
serogroup A meningococcal meningitis have only rarely been reported from these regions. 
Exceptions are an outbreak in Finland in the late 1960s (Achtman 1995b) and sporadic 
cases as a result of serogroup A pandemics (Zhu et al. 2001). In 1998/99, only 0.7% of the 
meningococcal meningitis cases registered in Europe were attributed to serogroup A 
(Cartwright et al. 2001).  
However, serogroup A bacteria have been responsible for three pandemic waves ov 
meningococcal meningitis outbreaks since the mid 1960’s. The first wave detected in 
China in the mid 1960’s, spread to northern Europe (Russia and the Scandinavian 
countries; 1969-mid 1970’s), and Brazil (mid 1970’s). A second pandemic wave began in 
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the early 1980s in China and Nepal. It caused a meningitis outbreak in Mecca during the 
annual hajj in 1987, and was distributed with returning pilgrims to most countries of the 
globe, triggering a series of severe epidemics throughout Africa. In 1996, these bacteria 
were predominantly responsible for more than 150’000 cases of meningococcal disease 
reported from Africa (Tikhomirov, Santamaria, & Esteves 1997). A third pandemic began in 
China in 1993. Since 1994 these subgroup III bacteria have caused outbreaks in Mongolia, 
Moscow and Africa. Details of these pandemic waves will be discussed later. 
Serogroup B, only sporadically isolated in Africa, is currently the most common cause of 
meningococcal meningitis in Europe, with approximately two third of the reported cases 
(Cartwright, Noah, & Peltola 2001). Serogroup C is increasingly causing localized 
outbreaks in Europe and North America, which promoted the efforts towards the 
development of a serogroup C polysaccharide-conjugate vaccine (see below). Some of the 
larger outbreaks in Africa have also been attributed to serogroup C (Broome et al. 
1983;Whittle et al. 1975). Serogroup X meningococcal meningitis cases have been 
reported occasionally from North-America (Ryan & Hogan 1980), Europe (Grahlow et al. 
1986;Pastor et al. 1985), and Australia (Hansman 1983). Outbreaks of serogroup X have 
been reported increasingly from Niger since the early 1990 (Etienne et al. 1990;Djibo et al. 
2003;Boisier et al. 2005) and from Northern Ghana in 2000/01 (Gagneux et al. 2002b). 
Only 1.5% of the meningococcal cases reported in Europe have been attributed to 
serogroup Y (Cartwright, Noah, & Peltola 2001). However, in the US the proportion of 
meningococcal cases caused by serogroup Y increased from 2% during 1989-1991 to 
37% during 1997-2002 (Bilukha & Rosenstein 2005). W135 meningococci have been 
associated with ~1-8% of all cases of sporadic meningococcal disease worldwide (Mayer 
et al. 2002) and in Africa only isolated cases have been described initially (Denis et al. 
1982;Kwara et al. 1998). In 2000, serogroup W135 meningococci caused an outbreak with 
several hundred cases during the annual Hajj in Mecca. Thereafter isolated W135 cases 
were seen in several countries due to bacterial spread with returning pilgrims (Taha et al. 
2000;Aguilera et al. 2002;Hahne et al. 2002b). Between 2002 and 2004, these W135 
bacteria were partly responsible for large outbreaks in Burkina Faso and Niger and have 
been isolated in several countries all over the Meningitis Belt.  
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The African Meningitis Belt 
The first documented outbreak of bacterial meningitis in sub-saharan Africa has been 
recorded in Northern Nigeria in 1905 and was confirmed by the detection of diplococci in 
the cerebrospinal fluid (CSF) (McGahey K 1905). The first epidemic in Ghana (Gold Cost) 
between 1906-08 started only one year later. Evidence that epidemic cerebrospinal 
meningitis (CSM) was not prevalent before that time comes from early African literature, 
reports from the first European explorers to West Africa and accounts obtained from the 
local populations at the time of the first major epidemics. It has been suggested that the 
bacteria causing the 1906/08 outbreak may have been introduced by pilgrims returning 
from Mecca. At that time, they travelled with caravans through the Sahara via Sudan, 
where an epidemic occurred a few years previously (Greenwood 1999). 
Lapeysonnie, in his comprehensive report “La méningite cérébro-spinale en Afrique” 
published in 1963, defined the African Meningitis Belt, south of the Sahara and north of the 
tropical rain forest, within the 300-1100mm mean annual rainfall isohytes, stretching from 
Upper Volta (today Burkina Faso) to Sudan, with overall 28 Mio inhabitants. Based on 
numerous records collected from the first half of the 20th century, he described the typical 
epidemiology of bacterial meningitis in this region. He characterized the periodicity of 
outbreaks, disease causing agents, clinical aspects, general morbidity, treatment, carriage 
and climatic factors, in detail for five of the countries and in general for the entire region 
(Lapeyssonnie 1963). Still today, most of the features described by Lapeysonnie are valid, 
when analysing the pattern of meningococcal meningitis in Africa.  
Both, endemic and epidemic meningococcal meningitis is seasonal, peaking during the 
dry and hot season of the year (December - May) and rapidly declining with the onset of 
the rains (Moore 1992). Large epidemics occur in 8-14 year-cycles, with incidence rates of 
up to 1% in the general population. While in endemic settings highest rates of 
meningococcal meningitis are recorded in young children, a shift in the age distribution has 
been observed during major epidemics, where often teenagers and young adults 
experience the highest attack rates (Moore 1992;Lapeyssonnie 1963).  
The determinants of meningococcal meningitis epidemics have not been completely 
understood. Yet, a combination of factors related to the host, the pathogen and 
environmental conditions might contribute to this phenomenon. The loss of herd immunity 
in the interepidemic period or the emergence of new meningococcal clones that may 
escape the immune system of the host might increase the susceptibility of a population. 
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But the appearence of a new clone does not always cause an epidemic outbreak. Certain 
communities in close vicinity to outbreak villages have escaped the epidemic and it has 
been hypothized, that exposure and transmission of the clone during the rainy season 
might induce sufficient levels of immunity to prevent invasive disease in most individuals in 
the following dry season. The “2nd hit” theory suggests, that invasive disease might be 
favored in combination with a predisposing factor, such as levels of circulating monomeric 
IgA elicited by cross reactive bacteria colonizing the gut (Moore 1992;Greenwood 
1999;Tikhomirov, Santamaria, & Esteves 1997;Griffiss 1982;Greenwood et al. 1987). High 
titers of IgA may block the triggering of the complement mediated serom bactericidal 
activity by IgG and IgM. 
In the last 50 years, the affected region of the Meningitis Belt has extended further from 
Ethiopia in the East to as far as Senegal in the West, probably due to climate changes 
(Moore 1992). Over 300 Mio people live in this region, and outbreaks happen more often 
and irregularly than initially described by Lapeysonnie. Furthermore, in Eastern and 
Southern Africa meningococcal meningitis outbreaks are increasingly reported (Figure 
1.1). These observations are in a high level of agreement with the current updated maps of 
the 300-1100mm mean annual rainfall isohytes (Savory et al. 2006;Molesworth et al. 
2002). 
 
 
 
Figure 1.1 The Extension of the African Meningitis Belt A Countries included in the epidemic meningitis 
Belt (WHO); B Maximum rates (cases per 100’000 population reported in routine WHO surveillance data 
between 1981 and 1999; C Area of 300-1100 mm annual rainfall (based on 1920-1980 climatology). (source: 
Molesworth et al. 2002) 
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The largest recent outbreak of meningococcal meningitis occurred in 1996, with more 
than 150’000 cases all over Africa. Almost 80’000 of these occurred in Nigeria, and more 
than 40’000 in Burkina Faso (Tikhomirov, Santamaria, & Esteves 1997). After frequent 
outbreaks between 1994 and 2003, with altogether more than 700’000 cases throughout 
the Meningitis Belt, fewer outbreak have been recorded since then in the countries 
belonging to the WHO surveillance system (WHO 2005).  
 
Management of epidemics 
In the pre-antibiotic era, the mortality of meningococcal meningitis was around 80%. The 
introduction of sulphonamids in 1938 reduced the mortality to 10% and less. However, 
emerging resistance against sulphonamids in several African countries led to the 
replacement of these drugs in the early 1970s (Greenwood 1999). Currently, a single 
intramuscular injection of oily chloramphenicol is the recommended standard treatment in 
countries with meningococcal meningitis outbreaks. The recommendations of WHO also 
suggest Penicillin G (intravenous) and third generation cephalosporines (WHO 1998). As 
these intravenously administered drugs need to be applied several times over a period of 
several days, the one-shot-therapy with chloramphenicol is usually preferred during 
meninigits epidemics. A recent non-inferiority study proved the effivacy of a single dose 
treatment of cetriaxone during an outbreak in Niger (Nathan et al. 2005). However, third 
generation cephalosporines have so far not been considered as standard regimens 
because of cost considerations.  
 
To date, the most important intervention strategy to control meningococcal meningitis 
epidemics are mass vaccinations with antimeningococcal vaccines based on the 
polysaccharide capsule as soon as the epidemic is detected. The available vaccines 
include a quadrivalent formulation, comprising serogroups A, C, Y, W135, and bivalent-  
and trivalent serogroup formulations primarily used in the African Meningits Belt. Due to 
the explosive increase in cases at the beginning of major outbreaks, epidemics have often 
been detected too late to prevent most of the cases by emergency vaccination 
(Greenwood 1999). To standardise response to emerging epidemics at the district level, 
WHO has developed emergency response recommendations using a threshold principle. 
The alert threshold with 5 meningitis cases per 100’000 population per week is used to 
sound an early warning and to check for epidemic preparedness. The epidemic threshold 
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is used to confirm the emergence of an epidemic and launch mass vaccinations. The 
epidemic threshold in high risk situations is 10 cases, in non-high risk situations 15 cases 
per 100’000 per week (WHO 2000).  
 
Streptococcus pneumoniae 
As surveillance on bacterial meningitis in Africa is dominated by the interest in 
meningococcal disease, comprehensive information about other pathogens is rare. A 
meta-analysis of 50 studies from different african regions between 1960 and the 1990s 
reviewed incidence rates of bacterial meningitis and the causative agents. The 
pneumococcus was the leading causative agent of non-epidemic meningitis and other 
bacterial diseases, followed by H. influenzae (Peltola 2001). Between 2003 and 2005, 
WHO reported that 25% of positive CSF samples contained S. pneumoniae.  
 
Streptococcus pneumoniae belongs to the large heterogeneous group of the 
streptococci. The pneumococcus is an alpha-hemolytic, gram positive and facultative 
anaerobe oval diplococcus, often found in short chains. It is surrounded by a thick 
polysaccharide capsule and can be divided into 90 serotypes. Serotypes that exhibit close 
serological cross-reactivity are grouped into serogroups. Thus, of the 90 serotypes,  58 
belong to 20 serogroups containing 2 to 4 serotypes (Dowson 2004)  
Due to their narrow host specificity, humans are virtually the only natural reservoir for 
pneumococci. As part of the normal commensal flora, they usually colonize their host 
without causing severe pathology. Transmission of S. pneumoniae occurs via respiratory 
droplets from person to person. Although disease occurs in only a small proportion of 
individuals colonized by pneumococci, the ubiquity of the organism in human populations 
results in a large burden of disease and yearly 700.000 to 1 Million deaths are currently 
attributed to pneumococcal disease (www.who.int) The most commonly identified 
pneumococcal infections are community acquired pneumonia, bacterial meningitis, acute 
otitis media and acute bacterial sinusitis (Butler 2004;Bogaert et al. 2004a). In temperate 
regions, cases of pneumococcal disease are most common during the cold months. Even 
though this phenomenon is not yet completely understood, low humidity, crowding of the 
susceptible hosts and associated viral infections have been attributed to it (Dowell et al. 
2003;Talbot et al. 2005). Most pneumococcal infections occur sporadically, but outbreaks 
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of pneumonia, meningitis, and conjunctivitis are occasionally reported, usually from closed 
or semi-closed communities (Butler 2004). 
The incidence rates of pneumococcal disease are highest in the very young and the 
elderly individuals. The increased risk of infants is likely related to an immature 
immunological response, to the polysaccharide capsule, and a high prevalence of 
colonisation. Factors contributing to the higher rates of pneumococcal disease and case 
fatality among the elderly include higher rates of underlying medical conditions and age-
related immune dysfunction (Castle 2000). Certain ethnic groups appear to be at higher 
risk for pneumococcal infections. In the US, rates of invasive pneumococcal disease are 
higher for blacks and native Americans than for whites and persons of other ethnic 
background (Cortese et al. 1992;Pastor et al. 1998;Robinson et al. 2001). Similarly, rates 
of invasive pneumococcal disease among Aborigines in central Australia are some 20 to 
30 times higher than those reported for non-Aborigines living in Australia (Torzillo et al. 
1995;Trotman et al. 1995). Factors contributing to these disparities in disease rates are 
poorly understood and may include differences in living conditions and higher prevalence 
of immunocompromising conditions (Dworkin et al. 2001). Finally, the risk and severity of 
pneumococal infection is increased for persons with certain chronic medical conditions, 
including functional or anatomic asplenia, HIV infection, chronic obstructive pulmonary 
disease, asthma, cirrhosis, diabetes, and conditions with impaired immune system (Butler 
2004). 
 
The pneumococcal polysaccharide capsule is essential for virulence as it acts as 
protection against phagocytosis. Anticapsular antibodies are the major defence 
mechanism against infection. Non-encapsulated variants are avirulent in experimental 
infections and the amount of polysaccharide expressed correlates with the degree of 
virulence (Kim & Weiser 1998) Out of the known 90 serotypes a relatively small number 
causes most invasive infections. The number of serotypes responsible for a given 
percentage of invasive disease is remarkably constant within each age group and 
geographical region. Only 2-3 serotypes and 4-5 serotypes account for ~50% of the cases 
in infants and children/adults, respectively. In contrast, the relative importance of a specific 
serotype to cause invasive disease varies in the different age groups and by geographic 
locations (Table 1.1) (Hausdorff et al. 2000). However, a meta-analysis comparing 
carriage- and disease isolate collections from seven studies in distinct geographical 
settings indicated differences in invasiveness between pneumococcal serotypes. 
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Commonly carried serotypes were less likely isolated from invasive disease and “invasive” 
serotypes (such as 1, 5, 7), were only seldomly obtained from healthy carriers 
(Brueggemann et al. 2004). From these “invasive” serotypes, small outbreaks with a 
limited genetic diversity of disease isolates have been reported (Porat et al. 2001;Gratten 
et al. 1993;Henriques et al. 2001). However, it is not clear, whether the polysaccharide 
capsule alone determines this virulence or whether other genotype-associated properties 
also determine the nature of the host-pathogen relationship. 
 
Table 1.1 Contribution of individual serogroups to invasive disease, by region and age group 
(relative ranking is in decreasing order of importance) source: Haussdorff et al. 2000 (part I) 
 
 
Dynamics of nasopharyngeal colonisation 
The upper respiratory tract represents the natural habitat for many bacterial species. In 
children, the nasopharyngeal flora becomes established soon after birth (Sulikowska et al. 
2004). A broad variety of microorganisms, including S. pneumoniae, H. influenzae and N. 
meningitidis, can colonise the nasopharynx. Attendance to day care centers, schools, 
military camps often promotes transmission, resulting in higher carriage rates. Bacterial 
colonisation of healthy individuals and person to person transmission are therefore 
important mechamisms for dissemination of the pathogen within the community (Bogaert 
et al. 2004c). 
 Nasopharyngeal colonisation is a dynamic process both in terms of turnover of 
colonising species and genotypes. Interspecies competition is thought to affect the 
composition of the nasopharyngeal flora. The resident flora, including  alpha-hemolytic 
streptococci, may inhibit colonisation by transient invading species (Faden et al. 1990). 
Furthermore, the different pathogenic species may influence each other (Bogaert, van 
Belkum, Sluijter, Luijendijk, De Groot, Rumke, Verbrugh, & Hermans 2004c). During in 
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vitro experiments, the growth of H. influenzae, M. catarrhalis and N. meningitidis was 
inhibited in the presence of and during coculture with S. pneumoniae which has been 
attributed to its production of hydrogene peroxide (Pericone et al. 2000). In contrast, in 
vivo mice experiments have recently shown, that components of H. influenzae stimulate 
complement dependant killing of S. pneumoniae by recruitment of neutrophils, thus 
indicating a role of the innate immune response in the interspecies competition for 
colonisation of mucosal surfaces (Lysenko et al. 2005). 
 
Colonisation with meningococci is low in infancy, and has its peak in the 5-15 year old 
children. Rates of transmission and carriage increase in closed and semi-closed 
communities, such as military recruits, university students, and in the household contacts 
of patients with meningococcal disease (Yazdankhah & Caugant 2004). In non-epidemic 
settings, in industrialized countries approximately 10% of healthy individuals carry N. 
meningitdis at any time (Cartwright et al. 1987;Caugant et al. 1994). About 50% of carrier 
isolates lack the capsule and are therefore serologically not serogroupable (Claus et al. 
2002;Caugant et al. 1988;Jolley et al. 2000). There is evidence that loss of capsule 
enhances the capability of meningococci to colonize the human nasopharynx 
(Hammerschmidt et al. 1996). The population of carried meningococci is usually highly 
diverse. Carriage of the disease causing lineages is infrequent (Caugant, Kristiansen, 
Froholm, Bovre, & Selander 1988;Yazdankhah et al. 2004). During African meningitis 
epidemics colonisation rates up to 33 % with the epidemic strain have been reported 
(Greenwood et al. 1987). It has been observed that after the end of epidemics carriage 
declines quickly and that endemic carriage rates are low (Hassan-King et al. 1988). While 
disease is highly seasonal in the African Meningitis Belt,  transmission does not appear to 
be associated with season (Greenwood et al. 1984;Blakebrough 1979)   
 
Pneumococcal colonisation is highest in young children, reaching up to 100% in the 
under five year olds, before it decreases again in older children and adults. One of the 
strongest risk factors for pneumococcal carriage in infants is the presence of colonized 
siblings. This has been observed in both high-income (Gray et al. 1980;Leino et al. 2001) 
and low-income countries (Coles et al. 2002). Children at their peak age of pneumococcal 
carriage (i.e. 2-5 years) seem to be a main source of pneumococcal transmission (Givon-
Lavi et al 2002, Leino et al 2001). Overall, pneumococcal carriage is markedly greater  in 
low-income countries than in high-incomce countries (Feikin et al. 2003;Lloyd-Evans et al. 
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1996;Montgomery et al. 1990). However, no robust comparative investigations have 
analysed the risk factors associated with this difference.  
 
Serological and Molecular Typing of N. meningitidis and S. pneumoniae 
Agglutination of bacteria with antisera targeting the polysaccharide capsules specifically 
differentiates meningococci into 13 serogroups and pneumococci (using the “Quellung 
reaction”) into over 90 serotypes. For meningococci, an additional classification into 
serotypes based on differences in the class 2 and 3 outer membrane proteins (OMP, 
PorB) and sero-subtypes depending on variation in the class 1 OMP (PorA) using 
monoclonal antibodies has been commonly applied (Poolman, van der Ley P.A., & 
Tommassen J. 1995). However, these classical serological methods have their limitation 
because adequate typing reagents are not available for all serotypes or serogroups. 
Furthermore, many strains isolated from the nasopharynx do not react serologically due to 
down-regulation or modification of capsule expression or loss of genes involved in capsule 
production (Claus et al. 2005).  
 
Several molecular typing methods have been developed for a more comprehensive 
differentiation of isolates for epidemiological surveillance and analysis of bacterial 
evolution. Herein, problems with different demands on the typing method may be 
adressed. Short-term epidemiological questions, for example aiming to understand the 
microevolution of a pathogen during an outbreak, require a typing method based on rapidly 
accumulating genetic variation using for example genes that are under immune selection. 
Typing methods based on conservative genes, that accumulate (nearly) neutral variation 
(e.g. housekeeping genes) exhibit phylogenetically more reliable information on the global 
spread and evolution of the organism. As these genes are usually very conserved several 
loci are usually included in a multilocus typing approach for as sufficient resolution. 
 
Multi Locus Enzyme Electrophoresis, MLEE, uses the natural variation in electrophoretic 
mobility of proteins such as cytoplasmatic allozymes (enzyme variants) or outer membrane 
proteins as markers for different genetic alleles on the bacterial chromosome. Bacterial 
strains with indistinguishable electrophoretic patterns are assigned a common 
Electrophoretic Type, ET. Depending on the different laboratories, by cluster analysis of 
meningococcal strain collections, groups of related ETs have been designated subgroups 
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(for serogroup A), clusters or complexes (for serogroup B and C). Because of the difficulty 
in interlaboratory comparability, a DNA sequence based approach, Multi Locus Sequence 
Typing (MLST), was developed in 1998 (Maiden et al. 1998) to replace MLEE. 400 to 500 
bp long fragments of seven housekeeping genes are sequenced and the sequences 
compared. Each unique sequence is assigned a unique allele number, the set of alleles 
results in the sequence type (ST). Strain collections are compared on the basis of shared 
alleles. Clusters of closely related isolates, where each strains shares the majority of 
alleles (usually six of seven alleles) with at least one other isolate of the cluster are 
designated clonal complexes (Feil et al. 2004). Using the e-BURST software, recent 
evolutionary developments are modelled using a simple algorithm. BURST (based upon 
related sequence types), focuses on the identification of clonal complexes, which are 
assumed to share a recent common ancestor, within a bacterial population. The assumed 
founding genotype has increased in frequency and diversified by the accumulation of 
mutations and/or recombinational replacements resulting in the emergence of closely 
related variants. Furthermore, the founding genotype should be identifiable according to its 
highest number of single locus variants (SLV) (Figure 1.2). 
 
A different approach, pulsed field gel electrophoresis (PFGE) is based on restriction 
digestion of genomic DNA. Genomic DNA is carfully prepared by lysing bacteria 
embedded in agarose blocs and subsequent digest of DNA with rare cutting restriction 
enzymes. The separation of the DNA fragments on the gel is performed by electric pulses 
coming from the different angels of a hexagonal electrode. The large DNA pieces are 
separated according to the velocity of reorientation within the electric field towards the 
anode. The result is a fingerprint of the DNA pieces generated by the restriction digest. 
Closely related strains will share all or at least most of the band pattern (Tenover et al. 
1995). This method is suitable to compare strain collection within one lab. It usually has a 
high resolution and short term evolutionary changes can be detected. However, results are 
difficult to digitalize and inter-laboratory comparison is problematic. 
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Population structure and bacterial evolution 
During asexual reproduction in bacterial populations, chromosomal variation occurs by 
de novo mutations, which can spread only by being passed on to the descendants of the 
cells in which they arose (“vertical transmission”), and new lineages emerge by the 
accumulation of such mutations over successive generation. However, bacteria also 
possess a number of parasexual mechanisms for the horizontal genetic exchange of 
chromosomal DNA. The three most important mechanisms, conjugation, transduction, and 
transformation do not involve the exchange of complete chromosomal genetic material, but 
rather small genome segments (Smith et al. 1991;Spratt & Maiden 1999).  
 
The first studies on bacterial population dynamics using MLEE, indicated that in the 
populations examined, most isolates belong to a limited number of closely related 
genotype clusters Thus, a clonal structure of bacterial populations was concluded 
suggesting that uniform groups of pathogens in diverse species arose from a common 
ancestor (Musser et al. 1988;Selander et al. 1985;Musser et al. 1987;Achtman 2004). 
Consequently, the distribution of chromosomal polymorphisms within an asexual (clonal) 
bacterial population would be non-random, or in linkage disequilibrium (Spratt & Maiden 
1999). 
The clonal paradigm of bacteria was challenged in 1993 by MLEE studies of Neisseria 
gonorrhoeae and Bacillus subtilis populations (O'Rourke & Stevens 1993). Maynard Smith 
and collegues then postulated that recombination is so frequent in some species, that 
clonal complexes might exist only temporarily and epidemic spread might therefore result 
in transient apparent clonality (Smith et al. 1993a). Furthermore, they stated that in case of 
an emerging lineage with increased invasive capacity, the analysis of isolates obtained 
exclusively from disease can result in an overestimate of the significance of the epidemic 
clone as a consequence of sampling bias. As recombination seemed so frequent, it was 
found impossible or difficult to reconstruct the phylogenetic framework of evolution of many 
pathogenic species (Feil et al. 2001).  
 
The large databases collected since the introduction of MLST in 1998 indicate that a 
spectrum of population structures exists. It reaches from the extremes of strictly clonal, 
e.g. Salmonella enterica (Boyd et al. 1996), where apparently no recombination has 
occurred in the evolutionary history of the species, to ‘panmictic’, e.g. Helicobacter pylori 
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(Go et al. 1996), where recombinational exchanges are sufficiently frequent to randomize 
the alleles in the population and to prevent the emergence of stable clones. The term 
‘epidemic clonal’ has been used to describe a situation, where a particularly effective 
lineage within a basically non-clonal bacterial population arises and rapidly spreads, so 
that, in the short term, a large number of related organisms come to predominate the 
population (Smith et al. 1993a;Smith et al. 2000). All three types of structure, clonal, 
panmictic and epidemic clonal, can be present in a single bacterial species (Spratt & 
Maiden 1999). 
 
However, it is now more and more accepted, that the distinction between clonality and 
frequent recombination is too simplistic to reflect the variety of population structures that 
are found in diverse bacterial species (Achtman 2004), and new tools and algorithms are 
needed to classify and understand the diversity (Feil & Enright 2004). It has been recently 
recognized that a number of species are of recent decent and possess little sequence 
diversity. Yersinia pestis, according to MLST results, is a clone of Y. pseudotuberculosis 
that has evolved in the last few millenia (Achtman et al. 1999). Also Mycobacterium 
tuberculosis, M. ulcerans, Bacillus anthracis and some other pathogens are highly uniform 
and may be of recent decent. These various groups of pathogens define a novel 
population structure, possibly best designated as “Young”, which does not fall into the 
clonal versus recombination debate (Achtman 2004). 
 
The population structure of N. meningitidis and S. pneumoniae 
Both, the meningococcus and the pneumococcus are antigenically and genetically highly 
diverse. MLEE- and MLST data have shown a high level of recombination in the house 
keeping genes of both species. Most recent analysis of these data has quantified the 
relative contribution of recombination vs. mutation and shown that the generation of novel 
alleles of these housekeeping loci in pneumocooci is driven predominantly by 
recombination rather than point mutation. The number of alleles that arise by 
recombination in contrast to mutation is estimated to 10:1 for pneumococci and 4:1 for 
meningococci (Feil et al. 2000).  
 
Pneumococci as well as meningococci colonizing the nasopharynx live alongside closely 
related bacterial species, such as viridans Streptococci and other Neisseria species 
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respectively. For both pathogens, interspecies recombination with closely related bacteria 
occupying the same ecological niche has been described, further enhancing the diversity 
of the species. For example penicillin-resistant pneumococci have acquired altered 
penicillin-binding proteins by interspecies recombination (Coffey et al 1995). Acquisition of 
foreign genes or gene-segments during epidemic spread of Neisseria meningitidis has 
been reported for the iga gene, the opc gene, the porA gene (Maiden et al. 1996),  and the 
tbp-gene (Linz et al. 2000).  
 
For both pathogens the bacterial capsule is essential for causing invasive disease and is 
considered as one of the major virulence factors. However, comparisons of the disease-
associated and carried populations have shown that most invasive disease is caused by a 
minority of serological grouping and genotypes. 
 
The major invasive meningococcal serogroups are B and C for Europe and Northern 
America and serogroup A (and C) for developing countries. The MLST database of 
Neisseria species comprises up to date more than 5000 STs and over 7000 bacterial 
isolates (http://pubmlst.org/neisseria/) isolated from diseased patients and healthy carriers 
since 1917. Analysing isolates from meningococcal carriage vs. disease  has revealed, 
that certain STs, especially those belonging to the ST-1, ST-4, ST-5, ST-8, ST-11, ST-32, 
and ST-41/44 clonal complexes are overrepresented in collections of disease-associated 
isolates relative to their frequency in collections of asymptomatically carried isolates. 
However, the analysis of three meningococcal isolate collections (I. carriage population in 
the Czech Republic, II. a temporally and geographically equivalent set of disease isolates, 
III. the global diversity of meningococcal isolates in the second part of the 20th century) 
indicated that overall patterns of diversity, as measured by absolute levels of 
polymorphism, allele frequency spectra, and linkage disequilibrium, were similar in 
collections of disease-associated and carried meningococci, despite the dominance of 
hyperinvasive lineages among the disease associated isolates (Jolley et al. 2005). 
 
The existence of invasive clones in the presence of frequent recombination seems to be 
a contradiction. Clonal expansion is usually associated with epidemic spread, where a 
large number of similar strains emerge in a very short time. Meningococcal meningitis 
epidemics in any one country only last for about 2-3 years and not only disease, but also 
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carriage returns to endemic levels very quickly (Hassan-King, Wall, & Greenwood 1988). It 
has been suggested that towards the end of an epidemic the frequency of both genetic 
escape variants and and serological variants increases dramatically, presumably due to 
immune pressure. But most of these variants seem to be less fit than their parents and are 
lost by bottlenecks during the spread from country to country (clonal reduction) (Achtman 
2004). As a result, isolates from a pandemic spanning multiple countries and continents 
can be indistinguishable, even by very sensitive methods, whereas multiple unique 
variants can be isolated in each country. The resulting population type, describing a 
genotype plus its closely related descendants, was designated “genocloud” (Zhu et al. 
2001). The three pandemic waves of serogroup A, subgroup III meningococci since the 
mid 1960’s were by analysis of six polymorphic loci associated with the sucsessive 
replacement of individual dominant genoclouds by others. These genoclouds exhibited 
very close relationship with each other, the strains causing the second and third pandemic 
wave by MLST were identified as ST5 and ST7 bacteria respectively, differing only in one 
of seven alleles. However, this genetic evolution is non-reversible; genoclouds only exist 
transiently before they are continously eliminated during spread from country to country. In 
addition they disappear from individual countries and areas after several years, even in the 
absence of vaccination (Zhu et al. 2001). Capsule switch of pathogenic meningococci as a 
mechanism to escape serogroup specific immunity has been reported (Swartley et al. 
1997), but it is not known, to which extent this occurs in natural populations. 
 
Also the epidemiology of S. pneumoniae shows, that usually at any time and place only a 
small group of serotypes is responsible for the majority of invasive disease (in contrast to a 
highly diverse carriage population) (Enright & Spratt 1998). The MLST database of S. 
pneumoniae comprises to date almost 3600 isolates that constitute 2180 ST, and 184 
clonal complexes. The extend of clustering among all genotypes within the current 
pneumococcal MLST database can be displayed by a “population snapshot”, an e-Burst 
diagram, comprising the complete MLST database (Figure 1.3). A high diversity within 
serotypes has been described. For many serotypes only one or two clonal complexes are 
recovered from invasive disease in different countries. For serotype 14, two unrelated 
clones (ST9 and ST124) have been found in various studies (Enright & Spratt 
1998;Brueggemann et al. 2003). In other cases, such as serotypes 6A and 19A, the 
population seems to be more heterogeneous and no single ST has been identified as the 
predominant cause of invasive disease in different countries (Spratt et al. 2004). In many 
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cases, global spread of pneumococcal clones has been associated with emergence and 
manifistation of drug resistance in commonly carried serotypes (Klugman 2002). These 
clones, which have appeared within the last 30 to 50 years have been well monitored and 
they have been shown to quickly diversify. Good evidence has been found for frequent 
recombinational exchange of the pneumococcal capsular locus, reported repeatedly from 
major antibiotic resistant clones, that have been extensively studied (Figure 1.2) (Coffey et 
al. 1998;Ramirez & Tomasz 1999;Jefferies et al. 2004).  
 
 
 
 
 
 
 
Figure 1.2 E-Burst diagram of the ST81 clonal complex. The MLST database comprises a large number 
of isolates sharing the ST81 and a number of closely related isolated, most of them are Single Locus 
Variants (SLV) of ST81. The E-Burst diagram strongly predicts that ST81 is the founding genotype (blue). All 
isolates of the clonal complex are all multiple antibiotic resistant. The clone is known as Spain23F-1. Isolates 
showing ST81 are of different seotypes: 23F, 19F, 19A, 14, 9V indicating a history of serotype switching. 
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Figure 1.3  Population snapshot by e-Burst of the S. pneumoniae MLST database according to its 
status in June 2006. Each ST is represented by one dot. Single locus variants are connected by lines, blue 
dots represent predicted founders of a clonal comples, yellow dots show predicted subgroup founders.  
 
 
While the population structure of meningococci and pneumcocci is well studied and 
genomes of several isolates have been sequenced, it is still unclear, which factors make 
the individual genoclouds more virulent than others. Also the mechanisms responsible for 
the emegence and dissapearence of patricular clones are not understood. 
Systembiological approaches will be required to give deeper insight into the underlying 
host-pathogen interaction at the population level. Molecular epidemiological studies will 
help to identify groups of isolates that should be selected for high-throughput genomic and 
proteomic analysis with the aim to identify genetic constellations responsible for successful 
competition at the colonisation level and for higher virulence in particular host populations. 
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Rationale and research frame work 
The work presented here is part of a long-term collaboration between the Swiss Tropical 
Institute, Basel, and the Navrongo Health Research Centre in Ghana that attempts to 
better understand the dynamics of bacterial meningitis in the African Meningitis Belt. Even 
though the meningitis epidemics of the last decades have been studied in detail in the 
various countries, the factors precipitating these epidemics are still largely unknown, and 
outbreaks remain unpredictable. The collaboration started after a major epidemic that 
occurred in the dry season of 1997 in Northern Ghana with the establishment of a 
meningitis surveillance system in the Kassena Nankana District and a longitudinal 
colonisation survey. In the first phase of this collaboration (reported in the PhD theses of 
A. Hodgson and S. Gagneux), the epidemiological features of the outbreak of 1997 were 
closely analysed, and the risk factors and sequelae were studied. Furthermore, the 
molecular epidemiological characteristics of a serogroup A post-epidemic outbreak in 1998 
and of a serogroup X colonisation wave were analysed in detail.  
 
This thesis presents part of the second phase of this collaboration, focussing on long-
term analysis of the relationship between colonisation and disease during a 8-year period, 
and determining the role of newly emerging pathogenic clonal complexes of N. 
meningitidis and S. pneumoniae.  
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Goal and Objectives 
 
Goal 
The goal of the long-term colonisation and case study in Northern Ghana is to contribute 
to a better understanding of the epidemiology of bacterial meningitis in the Meningitis Belt 
of Sub-Saharan Africa. In particular we were interested in the association of 
meningococcal colonisation and disease. Furthermore we aimed to examine the 
significance of other emerging meningococcal clones such as W135 meningococci, and 
other bacterial pathogens causing cerebrospinal meningitis in particular S. pneumoniae 
and H. influenzae B in the Kassena Nankana District of Northern Ghana.  
 
Objectives 
1. To analyse continuously collected CSF samples from the KND and health facilities 
from neighbouring districts in Northern Ghana, to isolate the respective causative agents 
and to characterize meningococcal and pneumococcal strains by serological and 
molecular methods.  
 
2. To monitor the colonisation with N. meningitidis and N. lactamica in the KND by twice 
yearly carriage surveys. To analyse the population structure of the colonizing 
meningococcal population, to relate this to the disease causing strains and to examine 
long term trends of colonisation and disease. 
 
3. To investigate the threat of W135 meningococcal meningitis epidemics in Ghana by 
molecular epidemiological analysis of ghanaian W135 case isolates and investigation of 
their spread in the healthy population by located colonisation surveys. 
 
4. To analyse the epidemiological and microbiological characteristics of pneumococcal 
meningitis in Northern Ghana 
 
5. To examine the population structure of S. pneumoniae isolates dominating in Northern 
Ghana in comparison with reprtesantative strain of a global collection of isolates. 
 
Chapter 3. Pneumococcal Meningitis in Northern Ghana 23 
 
 
 
 
Chapter 3  
 
An outbreak of serotype 1 Streptococcus pneumoniae meningitis  
in Northern Ghana with features  
characteristic of epidemic meningococcal meningitis 
 
 
Julia Leimkugel1, Abudulai Adams Forgor2, Sébastien Gagneux1*, Valentin Pflüger1, 
Christian Flierl1, Elizabeth Awine2, Martin Naegeli1, Jean-Pierre Dangy1, Tom Smith1, 
Abraham Hodgson2 and Gerd Pluschke1 
 
 
1
 Swiss Tropical Institute, Basel, Switzerland 
2
 Navrongo Health Research Centre, Ministry of Health, Navrongo, Ghana 
 
*present address: Division of Infectious Diseases and Geographic Medicine, Stanford 
University Medical Centre, Stanford, USA 
 
 
 
 
This article has been published in: 
Journal of Infectious Diseases (2005),195: 192-199 
24 Chapter 3. Pneumococcal Meningitis in Northern Ghana 
Abstract 
 
Background The Kassena-Nankana District (KND) of northern Ghana lies in the 
African meningitis belt where epidemics of bacterial meningitis have been re-occurring 
every 8-12 years. These epidemics are generally caused by Neisseria meningitidis, an 
organism considered uniquely capable of causing meningitis epidemics. 
 
Methods We recruited all suspected meningitis cases in the KND between 1998 and 
2003. Cerebrospinal fluid samples were collected and analysed by standard 
microbiological techniques. Bacterial isolates were subjected to serotyping, multi-locus 
sequence typing (MLST) and antibiotic resistance testing. 
 
Results A continual increase in the incidence of pneumococcal meningitis was 
observed from 2000 to 2003. This outbreak exhibited strong seasonality, a broad host age 
spectrum, and clonal dominance, all of which are characteristic of meningococcal 
meningitis epidemics in the African meningitis belt. The case fatality rate for pneumococcal 
meningitis was 44.4%, the majority of pneumococcal isolates were antibiotic sensitive and 
expressed the serotype 1 capsule. MLST revealed that these isolates belonged to a clonal 
complex dominated by sequence type (ST) 217 and its two single-locus variants ST303 
and ST612.  
 
Conclusions The ST217 clonal complex of S. pneumoniae represents a 
hypervirulent lineage with a high propensity to cause meningitis. In addition, our results 
suggest that this lineage might have epidemic potential. Serotype 1 is not included in the 
currently licensed paediatric heptavalent pneumococcal vaccine. Mass vaccination 
targeting hypervirulent serotypes with a less complex conjugate vaccine should therefore 
be considered.  
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Introduction 
 
Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae type b 
(Hib) are the most common causes of acute bacterial meningitis (Hart C.A. & Cuevas L.E. 
2003). Meningitis caused by N. meningitidis has been considered unique with respect to its 
epidemic occurrence. A region of sub-Saharan Africa extending from Ethiopia to Senegal, 
designated the ‘meningitis belt’, has been particularly vulnerable to meningococcal disease 
epidemics. In addition to sporadic disease, which occurs mainly during the annual dry 
season, epidemics have occurred in the meningitis belt every 8-12 years over the past 100 
years (Greenwood 1999;Achtman 1995a). 
 
Information about the epidemiology of pneumococcal meningitis in the African meningitis 
belt is fragmentary, but some studies have found S. pneumoniae to be the most important 
causative agent of bacterial meningitis in certain areas (Mar, Denis, & Cadoz 1979). The 
incidence in these areas is 10-20 cases per 100,000 and year, which is about ten times 
higher than in Western Europe and the United States (Greenwood 1987;Hausdorff, Bryant, 
Paradiso, & Siber 2000). Cases of S. pneumoniae meningitis occur throughout the year, 
and most studies report the youngest (<2) and the oldest (> 60) age groups to be at 
greatest risk (Mar, Denis, & Cadoz 1979;Greenwood 1987). For unknown reasons, the 
case fatality rate for pneumococcal meningitis (about 50%) is five to ten times higher than 
for meningococcal meningitis.  
 
Although there are about 90 pneumococcal serotypes known, only a limited number 
account for most of the invasive infections. The serotype distribution varies with time, 
location and age group (Hausdorff, Bryant, Paradiso, & Siber 2000). Clonal dominance 
and global spread has been described for a small number of highly successful, (often 
multi-) drug resistant pneumococcal clones (Klugman 2002). Serotype 1 is one of the most 
common serotypes causing invasive disease worldwide, particularly in Africa (Greenwood 
et al. 1980;Hausdorff, Bryant, Paradiso, & Siber 2000;Brueggemann & Spratt 2003). It has 
a high attack rate but is rarely isolated from healthy carriers or mild occult bacteraemia. 
Outbreaks of invasive serotype 1 pneumococcal disease have occurred in several 
communities (Dagan et al. 2000;Gratten, Morey, Dixon, Manning, Torzillo, Matters, Erlich, 
Hanna, Asche, & Riley 1993;Hausdorff, Bryant, Paradiso, & Siber 2000;Mar, Denis, & 
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Cadoz 1979;Porat, Trefler, & Dagan 2001;Henriques, Kalin, Ortqvist, Akerlund, Liljequist, 
Hedlund, Svenson, Zhou, Spratt, Normark, & Kallenius 2001;Tugwell et al. 1976). 
 
The present study was conducted between 1998 and 2003 in the Kassena-Nankana 
District (KND) in northern Ghana. Following a large meningococcal meningitis epidemic in 
the dry season of 1997, all suspected meningitis patients were recruited prospectively. 
Cerebrospinal fluid (CSF) samples were taken and analysed by standard microbiological 
techniques. Between 2000 and 2003, a continuous increase in incidence of pneumococcal 
meningitis was observed. We demonstrate that the epidemiological and bacteriological 
features of this outbreak closely resemble the ones usually associated with meningococcal 
disease epidemics. The implications of these observations for the control of bacterial 
meningitis in the African meningitis belt are discussed. 
 
Methods 
Study area 
The KND has a population of 140,000 and lies within the Guinea Savannah woodland 
area of northern Ghana. Two major seasons exist, a short wet season from May to 
October and a long dry season for the rest of the year. The general population is rural 
except for those living in the town of Navrongo, which has a population of 20,000. People 
live in compounds with an average of 10 inhabitants. 
 
Patients 
CSF samples were collected from January 1998 to December 2003 from suspected 
meningitis patients reporting to the War Memorial Hospital, Navrongo, or to one of four 
Health Centres in the KND. In line with the standard diagnostic procedures in Ghana, 
samples were analysed at the laboratory of the War Memorial Hospital for confirmation of 
the clinical diagnosis. Additional samples were obtained from the Regional Hospital of the 
Upper East Region in Bolgatanga, and from health facilities in the Bongo and Bulsa 
Districts. In 1998 and 1999, only samples collected during the dry season were analysed. 
Thereafter, samples obtained from the few suspected meningitis cases presenting during 
the wet season were also included. Ethical clearance for the study was obtained from the 
responsible institutional review boards and the Ghanaian Ministry of Health. Clinical and 
demographic information was recorded from all patients. Personal data were linked with 
the database of the Navrongo Demographic Surveillance System (NDSS). The 
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denominators used for calculation of incidence rates represent the average annual district 
population between 1995 and 1999 (Nyarko et al. 2002). 
 
Analysis of CSF 
CSF samples were analysed by direct Gram staining. Boiled CSF-supernatants were 
tested serologically for capsular polysaccharide antigens of N. meningitidis (serogroups A, 
B, C and W135), S. pneumoniae and Hib (Slidex meningite-Kit, Bio Merieux, Pasteurex-
Kit, BIO RAD #61718). CSF specimens were inoculated on blood-, chocolate-, and Thayer 
Martin Agar and incubated in candle jars for 24 hours at 37˚C. S. pneumoniae colonies 
were identified based on colony morphology, Gram staining behaviour and resistance to 
Optochin (Taxo P discs, BD #231046). All pneumococcal isolates were serotyped with the 
Quellung Reaction using antisera from the Statens Serum Institute, Copenhagen.  
 
Antibiotic resistance testing 
All isolates from the KND were tested for resistance to penicillin G, chloramphenicol (the 
two antibiotics commonly used for standard therapy of bacterial meningitis in Ghana), 
cefotaxime, and ciprofloxacin using E-test strips (Isenberg Henry D.(ed.) 1998). 
Breakpoints of the NCCLS protocol have been applied. For ciprofloxacin 4µg/ml has been 
taken as breakpoint for resistance (Brueggemann et al. 2002). The ATCC 49619 strain 
was included as control.  
 
Multi-Locus Sequence Typing (MLST) 
Bacteria were grown overnight in Todd Hewitt medium. DNA extraction (Vela Coral et al. 
2001), MLST (Enright & Spratt 1998) and direct sequencing of PCR products with an ABI 
Prism 310 Genetic Analysis System was performed according to standard protocols. Allelic 
profiles were analysed using applications available on the MLST homepage 
(www.mlst.net). For the analysis of the relationships between closely related isolates the 
eBurst software (http://eburst.mlst.net) was used with the most stringent group definition 
(6/7 alleles identical). All allelic profiles obtained were compared to the complete listing of 
STs available in the database.  
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Results 
Meningitis cases 
Between 1998 and 2003, a total of 140 meningococcal, 117 pneumococcal and 14 Hib 
meningitis cases were confirmed by culture and/or Latex agglutination assay in the KND. 
The number of pneumococcal cases remained low during the first two years of the study, 
but increased continuously during the following years (Figure 3.1). Two subsequent 
outbreaks of serogroup A meningococci were reported during the study period. After the 
large meningococcal meningitis epidemic in Ghana 1997, 50 confirmed serogroup A cases 
occurred in 1998 (Gagneux et al. 2000). After two years of absence, from 2001 onwards 
serogroup A meningococcal cases re-emerged causing yearly outbreaks until 2004 
(Chapter 5). The number of Hib meningitis cases remained low throughout the study 
period and included mainly children below 7 years of age (Figure 3.1).  
 
The vast majority of meningococcal and of pneumococcal meningitis cases occurred 
during the dry season (Figure 3.2). The pneumococcal meningitis cases peaked one to 
two months earlier than the meningococcal cases. During the rest of the year only 
sporadic meningitis cases, mostly caused by S. pneumoniae, were observed.  
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Figure 3.3.1 Number of laboratory-confirmed (cultivation and/or latex agglutination) meningitis cases 
in the Kassena-Nankana District of northern Ghana between 1998 and 2003. 
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Figure 3.3.2 Seasonal patterns of rainfall and number of pneumococcal and meningococcal 
meningitis in the KND. (monthly rainfall data from the Meteorological Station of the KND)  
 
The populations of both meningococcal and pneumococcal meningitis patients exhibited 
a broad age range (Figure 3.3). Infants <1year had the highest incidence for both 
pneumococcal and meningococcal meningitis (43 cases/100,000 per year). For 
pneumococcal meningitis, the incidence in all other age groups was 15 - 26/100,000. For 
meningococcal meningitis the incidence was comparable for children of all age groups, 
and decreased steadily for the older age groups. As a result, the incidence of 
pneumococcal meningitis in the >60 year age group was significantly higher than for 
meningococcal meningitis (2.6/100’000 versus 23.4/100’000). The overall case fatality rate 
was 44.4% (51/117) and 4.3% (6/140) for pneumococcal and meningococcal meningitis, 
respectively. 
 
The geographic location of the homes of 74 pneumococcal and 102 meningococcal 
meningitis patients was mapped using the NDSS, but neither pneumococcal nor 
meningococcal cases were geographically clustered (data not shown). Furthermore no 
significant family clustering was observed.  
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Figure 3.3.3 Incidence (laboratory confirmed cases by latex agglutination or culture) of meningococcal 
(orange bars) and pneumococcal (blue bars) meningitis in the KND. 
 
Characterisation of pneumococcal isolates 
Between 1998 and 2003, 76 pneumococcal disease isolates were obtained from 
meningitis patients in the KND. Fifty-eight of these (76.3%) belonged to serotype 1, which 
represented the dominating serotype throughout the study (Table 3.1). The 18 non-
serotype 1 isolates from the KND belonged to nine other serotypes. Only a third (2/6) of 
the paediatric disease isolates (<5 year old) were serotype 1, the remaining belonged to 
serotype 3 and 14. In contrast, in older children (5-14 years), young adults (15-29 years) 
and grown-ups (30-59 years) the serotype 1 ratio was >80 % (24/29, 11/12 and 11/14, 
respectively). In patients >60 years the percentage of serotype 1 isolates was 56 % (5/9). 
 
Drug sensitivity testing showed that all but two of the 58 serotype 1 strains from the KND 
were completely susceptible to penicillin G, cefotaxime, chloramphenicol and ciprofloxacin. 
Minimal inhibitory concentrations (MIC) determined for the two strains (both isolated in 
2002) showing antibiotic resistances were: strain P1036: penicillin G 0.5 µg/ml 
(intermediate), cefotaxime 2µg/ml (resistant), chloramphenicol: 5 µg/ml (intermediate); 
strain P1037: penicillin G 0.5 µg/ml (intermediate), cefotaxim 1 µg/ml (intermediate), 
chloramphenicol 8 µg/ml (resistant).  
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All isolates from the KND and 15 isolates from neighbouring districts were analysed by 
MLST. The results showed that all serotype 1 isolates were clonally related (Table 3.2). 
Ten distinct STs were identified; but all shared at least six of seven alleles with one other 
ST. ST217 and its two single locus variants ST612 and ST303 dominated. In addition, 
single locus variants of the three dominating STs were sporadically found. All isolates 
obtained in 1998 and 2000 had ST217. ST303 isolates dominated from 2001 onwards 
(6/15 in 2001, 9/18 in 2002 and 14/20 in 2003).  
An eBurst analysis was done including the STs of the Ghanaian stains and all strains 
available in the MLST database (Figure 3.4). Three of the 10 STs found in the Ghanaian 
isolates (ST217, ST303 and ST612) have been previously described in altogether 34 
serotype 1 lineage B isolates (Brueggemann & Spratt 2003). 16 of these isolates came 
from Africa, the others from Israel, Europe or the United States. In addition, Brueggemann 
et al. (Brueggemann & Spratt 2003) defined three lineage B associated STs (ST613, 
ST614 and ST 618) represented by four African and one European isolate. The eBurst 
diagram (Figure 3.4) demonstrates, that all Ghanaian serotype 1 strains found in this study 
and all the lineage B isolates described by Brueggemann et al. are part of a single clonal 
complex in which all isolates share 100% genetic identity at six or seven MLST 
housekeeping loci with at least one other member of the group. 
 
Of the non-serotype 1 isolates, only the serotype 14 strains exhibited allelic profiles 
closely related to those of the serotype 1 complex (Table 2). One of the serotype 14 
strains (ST1324) was a single locus variant of ST1323 (shown in Figure 3.4), two (ST1314 
and ST1315) were double locus variants of ST1323 and the remaining isolate (ST1313) 
shared five alleles with ST1314 and four alleles with ST1323.  
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Figure 3.4 e-BURST diagram of the sequence type (ST) 217 clonal complex.  
Included are all Ghanaian serotype 1 Streptococcus pneumoniae isolates and 1 Ghanaian serotype 14 S. 
pneumoniae isolate from the present study as well as all serotype 1 lineage B S. pneumoniae isolates 
described byBrueggemann et al. (Brueggemann & Spratt 2003). Lines connect all single-locus variants with 
each other. Black circles indicate STs found in northern Ghana in the presentstudy, and the no. of isolates 
found are given. Gray circles indicate serotype 1 lineage B–associated STs not found in northern Ghana [9], 
and the countries of origin of the isolates are given. Shown is a modification of the original diagram produced 
by e-BURST, which was edited for the no. of isolates, the origin of non-Ghanaian isolates, and multiple 
single-locus variant connections. 
 
  
  
 
 
Table 3.1 Host age distribution of serotype 1 and non–serotype 1 Streptococcus pneumoniae isolates from the Kassena-Nankana District of northern 
Ghana, found between 2000 and 2003. 
 
Age group (years) <1 1-4 5-14 15-29 30-59 >60 n.s.* Total age range median 
No. of isolates serotyped 2 4 29 12 14 9 6 76 4/12 to  85 y 14y 
 Serotype 1 isolates 0 2 24 11 11 5 5 58  19/12  to 72 y 15y 
Non-serotype 1 isolates 2 2 5 1 3 4 1 18 4/12 to  85 y 13y 
Serotypes of 
non-serotype 1 strains 
14+ 3+ 
3+, 7F, 
8, 12F 
8 6A, 8, 10F 
8, 12F, 
14, 38 
2    
  
 Table 3-2 Serotype distribution and Sequence Types (STs) of S. pneumoniae strains isolates in northern Ghana, found between1998 and 2003. 
 
Allelic Profile 
Serotype ST No. of isolates 
Yr. of 
isolation aroE gdh gki recP spi xpt ddl origin (district) 
Serotype 1 217 15 1998-2003 10 18 4 1 7 19 9 KND (13), Bongo (1), Builsa (1) 
 612 8 2001-2003 10 18 4 1 7 19 31 KND (7), Bolgatanga (1) 
 303 36 2001-2003 10 5 4 1 7 19 9 KND (29), Bolgatanga (7) 
 1322 1 2001 10 5 4 1 7 19 31 KND 
 1316 1 2002 2 18 4 1 7 19 9 KND 
 1325 2 2002 10 8 4 1 7 19 9 KND 
 1331 2 2002 13 8 4 1 7 19 9 KND 
 1327 1 2003 10 18 4 1 13 19 31 KND 
 1328 1 2003 10 18 4 1 7 21 31 KND 
 1323 1 2003 10 5 4 1 7 21 9 KND 
Serotype 2 74 1 1998 2 13 4 1 6 6 14 KND 
Serotype 3 458 7 2001 2 32 9 47 6 21 17 KND (3), Bolgatanga (4) 
Serotype 4 1321 1 2002 8 8 47 18 46 122 31 Bolgatanga 
Serotype 6° 1320 1 2002 7 13 8 6 6 8 8 KND 
Serotype 7F 1326 1 2002 10 16 4 1 6 21 9 KND 
Serotype 8 1317 1 2003 7 5 15 11 83 58 70 KND 
 1318 1 2000 7 9 15 11 83 58 70 KND 
 1335 1 2003 7 9 4 60 83 28 70 KND 
 1319 1 2003 7 9 15 11 83 25 70 KND 
Serotype 10F 909 1 2003 2 42 2 1 6 19 20 KND 
Serotype 12F 989 1 2003 12 5 89 8 6 112 14 KND 
 1330 1 2003 12 5 89 8 13 112 14 KND 
Serotype 14 1324 1 2002 10 5 4 17 7 21 9 KND 
 1313 1 2003 2 5 4 12 7 21 14 KND 
 1315 1 2003 2 5 9 1 7 21 9 KND 
 1314 1 2003 2 5 4 1 7 21 14 Builsa 
Serotype 38 1329 1 2003 12 5 4 10 42 49 9 KND 
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Discussion 
N. meningitidis is regarded as uniquely capable of causing bacterial meningitis 
epidemics. Our observation of a meningitis outbreak caused by S. pneumoniae in the KND 
of northern Ghana is therefore intriguing. The outbreak exhibited epidemiological features 
characteristic of African meningococcal epidemics (Greenwood 1999), including strong 
seasonality, a broad host age range and clonal dominance. The increase in pneumococcal 
meningitis was accompanied by two successive outbreaks of meningococcal meningitis. In 
the KND the burden of disease for pneumococcal meningitis has met criteria for the alert 
status of the WHO definition of epidemic meningococcal outbreaks (threshold of 5 cases 
per 100,000 per week) and in the neighbouring Bolgatanga District even criteria for the 
epidemic status with a threshold of 10 cases were fulfilled in March 2001. Cases of both 
meningococcal and pneumococcal meningitis were concentrated in the dry season, 
suggesting that similar factors might have triggered both types of outbreak. Such factors 
may include damaged mucosal defences due to the extreme environmental conditions 
and/or co-infections of the nasopharynx (Greenwood 1999). Care was taken to avoid a 
bias associated with the well-known seasonality of meningococcal meningitis in the study 
area. Standardized guidelines for lumbar puncture were applied to avoid that lumbar 
punctures were less likely to be performed during the wet season.  
Interestingly, the pneumococcal meningitis cases peaked one to two months earlier than 
meningococcal meningitis. This may reflect either the very high invasive capacity of the 
causative clonal complex of serotype 1 pneumococci or indicate that the factors which 
trigger pneumococcal and meningococcal meningitis are not entirely the same. In this 
context, differences in climatic conditions during the early dry season (including the 
Harmattan period with cold nights and extremely dusty air) and the late dry season 
(intensive heat), may be relevant. The broad age range in both meningococcal and 
pneumococcal meningitis cases shows that age related differences in the capacity of 
natural and adaptive immune effector functions are less important for susceptibility to 
invasive disease than in other epidemiological situations. Lack of spatial clustering 
suggests that colonisation with the serotype 1 pneumococci is not focal. 
 
Clonally related bacteria from a common epidemiological source often show limited 
genotypic variation (Feil 2004). Groups of frequent genotypes plus their epidemiologically 
associated descendents have been designated clonal complexes (Feil 2004) or 
genoclouds (Zhu, van der, Falush, Brieske, Morelli, Linz, Popovic, Schuurman, Adegbola, 
Zurth, Gagneux, Platonov, Riou, Caugant, Nicolas, & Achtman 2001) on the basis of a 
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threshold level of MLST allelic identity. The pneumococcal outbreak in the KND was 
caused by a clonal complex of serotype 1 pneumococci. The three most frequently found 
STs (ST217 and its two single-locus variants ST303 and ST612) have been described 
before (Brueggemann & Spratt 2003), indicating that these genetic variants evolved prior 
to the outbreak in the KND. However, some of the infrequently isolated locus variants, 
such as ST1316, ST1322, ST1327 and ST1328 may have emerged locally. It is interesting 
to note, that ST1331 and ST1325, which were found each twice in the Ghanaian isolates 
link a ST618 isolate from The Netherlands to the clonal complex.  
 
Serotype 1 pneumococci are a common cause of invasive disease in many parts of the 
world, but are only rarely found among healthy carriers (Brueggemann & Spratt 
2003;Hausdorff, Bryant, Paradiso, & Siber 2000;Sandgren et al. 2004). Studies comparing 
the prevalence of S. pneumoniae subgroups from invasive disease and from carriage 
showed that individual serotypes may differ more than a 100 fold in their potential to cause 
invasive disease (Brueggemann, Griffiths, Meats, Peto, Crook, & Spratt 2003;Sandgren, 
Sjostrom, Olsson-Liljequist, Christensson, Samuelsson, Kronvall, & Henriques 2004). 
Individual clonal complexes belonging to the same serotype have different abilities to 
cause invasive disease (Sandgren, Sjostrom, Olsson-Liljequist, Christensson, 
Samuelsson, Kronvall, & Henriques 2004), suggesting that complex-specific virulence 
determinants might be important as well. It is not clear whether the virulence of the three 
major subgroups of serotype 1 pneumococci with distinct geographic distribution 
(Brueggemann & Spratt 2003;Gonzalez et al. 2004) is primarily determined by the 
capsular serotype and therefore uniform, or whether lineage-specific genetic differences 
modulate the potential to cause particular types of invasive disease. Our results suggest 
that the ST217 associated clonal complex might have a particular propensity to cause 
meningitis. However, further studies are needed in order to verify whether this observation 
reflects a true bacterial phenotype or merely the influence of host and/or environmental 
factors. 
 
We do not know whether the ST217 clonal complex has recently been imported into 
northern Ghana or whether it has been present for a longer time without causing more 
than sporadic disease. Clonal dissemination of S. pneumoniae is usually associated with 
antibiotic resistance (Klugman 2002), but we observed no significant resistance in the 
Ghanaian isolates. Other factors must therefore have led to the increased incidence of 
pneumococcal meningitis in the KND. Vaccination against S. pneumoniae is uncommon in 
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Ghana. However, the massive immunization campaigns with a meningococcal A+C 
carbohydrate vaccine that have been repeatedly carried out throughout the study period 
might have played a role. S. pneumoniae and N. meningitidis both colonize the human 
nasopharynx, and effective interventions against one of these bacteria is likely to promote 
competing micro-organisms. Vaccinations with conjugate vaccines have been shown to 
reduce nasopharyngeal carriage of the vaccine type bacteria and to lead to replacement 
by bacteria not included on the vaccine (Bogaert et al. 2004b;Lipsitch 1999). Even though 
polysaccharide vaccines, such as the unconjugated N. meningitidis A + C vaccine used in 
the KND, are generally thought to have no effect on the prevalence of nasopharyngeal 
carriage (Greenwood 1999), repeated immunization against N. meningitis might still modify 
the bacterial flora of the nasopharynx (Fernandez et al. 2003). Thus, it is conceivable that 
the increase in pneumococcal meningitis in the KND, as well as the recently observed 
outbreaks of non-A, non-C meningococcal meningitis (Gagneux, Hodgson, Smith, Wirth, 
Ehrhard, Morelli, Genton, Binka, Achtman, & Pluschke 2002b;Djibo, Nicolas, Alonso, 
Djibo, Couret, Riou, & Chippaux 2003;Chonghaile 2002) may have been promoted by 
mass vaccination against N. meningitis. It will be important to investigate more closely the 
interactions between these bacteria, especially in the context of vaccination (Bogaert, De 
Groot, & Hermans 2004a). 
 
Serotype 1 is not included in the currently licensed paediatric heptavalent pneumococcal 
vaccine. This vaccine contains polysaccharides from the seven serotypes (4, 6B, 9V, 14, 
18C 19F and 23F) that cause over 85% of severe pneumococcal infections in infants and 
young children in the USA and Canada (Bogaert, Hermans, Adrian, Rumke, & De Groot 
2004b;Hausdorff, Bryant, Paradiso, & Siber 2000). The vaccine covers 70% of paediatric 
disease isolates from Europe, but only 67% and 43% of those from Africa and Asia, 
respectively (Hausdorff, Bryant, Paradiso, & Siber 2000). In the KND serotypes 3, 7F, 8, 
12 and 14 accounted for the non- serotype 1 cases in patients below 15 years of age. The 
‘paedriatric’ serotypes (e.g. 6, 14, 9, 1, 5) (O'Dempsey et al. 1996) were rarely found. 
Here, the heptavalent conjugate vaccine would have covered 5.7% (2/35) of all cases and 
22% of the non-serotype 1 cases in this age group. A nonavalent conjugate vaccine 
including serotype 1 is currently being developed, but such a complex conjugate vaccine 
may be too expensive for mass immunization in the African meningitis belt. However, 
mass vaccination targeting hypervirulent serotypes with a less complex conjugate vaccine 
should be considered, since increasing trends in pneumococcal meningitis have also been 
observed in other districts of Ghana (data not shown). Predominance of serotype 1 and a 
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broad age spectrum also seem to be features of the current pneumococcal meningitis 
situation in Burkina Faso (Parent, I et al. 2005;Robbins et al. 2005). In view of the high 
case fatality rate of S. pneumoniae meningitis, there is also an urgent need for improved 
treatment options suitable for countries with limited resources. 
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Summary 
Neisseria meningitidis serogroup W135, well known for a long time as a cause of isolated 
cases of meningococcal meningitis, has recently increasingly been associated with 
disease outbreaks of considerable magnitude. Burkina Faso was hit by W135 epidemics in 
the dry seasons of 2002-2004, but only four W135 meningitis cases were recorded 
between February 2003 and March 2004 in adjoining Ghana. This reconfirms previous 
findings that bottlenecks exist in the spreading of new epidemic N. meningitidis clones 
within the meningitis belt of sub-Saharan Africa. Of the four Ghanaian W135 meningitis 
patients one died and three survived, of which one had profound neurosensory hearing 
loss and speech impairment. All four disease isolates were sensitive to penicillin G, 
chloramphenicol, ciprofloxacin and cefotaxime and had the multi-locus sequence type (ST) 
11, which is the major ST of the ET-37 clonal complex. Pulsed-field gel electrophoresis 
(PFGE) profiles of the Ghanaian disease isolates and recent epidemic isolates from 
Burkina Faso were largely identical. We conducted meningococcal colonisation surveys in 
the home communities of three of the patients and in the Kassena Nankana District 
located at the border to Burkina Faso. W135 carriage rates ranged between 0 and 17.5%. 
When three consecutive surveys were conducted in the patient community with the highest 
carrier rate, persistence of W135 colonisation over a period of one year was observed. 
Differences in PFGE profiles of carrier isolates taken at different times in the same patient 
community were indicative of rapid microevolution of the W135 bacteria, emphasising the 
need for innovative fine typing methods to reveal the relationship between W135 isolates. 
 
Introduction 
Epidemic meningococcal disease has occurred in the meningitis belt of sub-Saharan 
Africa for approximately 100 years (Greenwood 1999). Historically the epidemics have 
been primarily caused by Neisseria meningitidis serogroup A. Serogroup W135 
meningococci identified in 1968 (Evans et al. 1968) and first described in Africa in 1982 
(Denis, Rey, Amadou, Saliou, Prince-David, M'boup, Cadox, Mar, & Etienne 1982) were 
initially considered to be a rare cause of invasive disease. However, two W135 meningitis 
outbreaks coinciding with pilgrimage seasons for Hajj in 2000 and 2001 (Taha, Achtman, 
Alonso, Greenwood, Ramsay, Fox, Gray, & Kaczmarski 2000;Lingappa et al. 2003) were 
followed by a first large scale epidemic in Burkina Faso in 2002 (Taha et al. 2002;Decosas 
& Koama 2002). Since then, each year Burkina Faso has been hit by mixed meningitis 
epidemics caused by W135 and A meningococci. In Saudi Arabia W135 meningococci 
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were responsible for 13% of all meningococcal disease between 1995 and 1999 and have 
been present to a notable degree at least since 1990 (Lingappa, Al Rabeah, Hajjeh, 
Mustafa, Fatani, Al Bassam, Badukhan, Turkistani, Al Hamdan, Al Jeffri, Al Mazrou, 
Perkins, Popovic, Mayer, & Rosenstein 2003). From 2002 onwards vaccination with the 
quadrivalent meningococcal polysaccharide vaccine (A/C/Y/W135) therefore became a 
visa requirement to participate in the Hajj (Wilder-Smith et al. 2003a). Already before the 
outbreaks in 2000 the danger of W135 meningitis epidemics in Africa was recognized 
(Kwara, Adegbola, Corrah, Weber, Achtman, Morelli, Caugant, & Greenwood 1998). 
 
The Hajj outbreaks probably led to the expansion of a particular W135 clone within the  
electrophoretic type-37 (ET-37) complex (Mayer, Reeves, Al Hamdan, Sacchi, Taha, 
Ajello, Schmink, Noble, Tondella, Whitney, Al Mazrou, Al Jefri, Mishkhis, Sabban, 
Caugant, Lingappa, Rosenstein, & Popovic 2002;Popovic et al. 2000). A high acquisition 
rate of W135 meningococci (15-17%) in pilgrims has been reported (Wilder-Smith et al. 
2003b). Throughout the world these carriers have transmitted Hajj-related W135 bacteria 
after returning home (Aguilera, Perrocheau, Meffre, & Hahne 2002;Hahne et al. 
2002a;Wilder-Smith, Barkham, Ravindran, Earnest, & Paton 2003b). Related W135 strains 
also belonging to the ET-37 complex have been circulating worldwide since at least 1970 
(Mayer, Reeves, Al Hamdan, Sacchi, Taha, Ajello, Schmink, Noble, Tondella, Whitney, Al 
Mazrou, Al Jefri, Mishkhis, Sabban, Caugant, Lingappa, Rosenstein, & Popovic 2002) and 
currently both the Hajj-related epidemic strain and Hajj-unrelated local W135 strains seem 
to be responsible for sporadic W135 cases worldwide (Hahne, Handford, & Ramsay 
2002a;Taha et al. 2004). Genetic drift of the Hajj-related strain (Hahne, Handford, & 
Ramsay 2002a) complicates the analysis of the relationship between W135 isolates by 
standard typing techniques, such as pulsed-field gel electrophoresis (PFGE) and multi-
locus sequence typing (MLST) considerably. 
 
In spite of its border with Burkina Faso, no outbreak of W135 meningococcal meningitis 
has so far occurred in Ghana. Here, we describe properties of four W135 strains isolated 
between February 2003 and March 2004 from the cerebrospinal fluid (CSF) of Ghanaian 
meningitis patients and provide evidence for spreading and rapid microevolution of the 
causative W135 meningococci. 
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Materials and Methods 
Disease isolates 
In the respective hospitals, CSF samples were taken for diagnostic purpose, latex 
agglutination was performed and the causative agents were isolated by culture using 
standard microbiological techniques. Bacterial isolates of all four Ghanaian W135 cases 
were transferred for further analysis to the Navrongo Health Research Centre, where 
serological grouping was reconfirmed by PCR.  Reference isolates of W135 meningococci 
were obtained from M. Achtman, Berlin (isolated in Mecca, 2000, strains Z9230 and 
Z9232), and D. Caugant, Oslo (isolated during the outbreaks in Burkina Faso of 2001 
(BF01/01, BF24/01), 2002 (BF06/02, BF67/02) and 2003 (BF01/03)). 
 
Carrier isolates 
In three of the affected communities and two control communities throat swabs have 
been taken and analysed for colonisation with N. meningitidis and N. lactamica. 
Community K1 is a small village located in a rural setting directly on the main truck road 
between the south and the north of Ghana (Fig. 1). Nearly  the whole population of the 
village participated in the study. In December 2003 a control community located 2 km 
away from K1 was included. Communities B1 and B2 are located in Bolgatanga, the Upper 
East Region’s capital. Here throat swabs were taken from the affected and the closest 
neighbouring compounds (including the majority of the about 30 inhabitants per 
compound).  
 
After obtaining informed consent, throat swabs were taken and directly plated onto 
Thayer Martin Agar. The plates were incubated at 37ºC within eight hours after sampling 
for 24-48 hours. Two colonies with neisserial morphology were sub-cultured from each 
plate. N. meningitidis and N. lactamica colonies were identified as previously described 
(Gagneux, Hodgson, Smith, Wirth, Ehrhard, Morelli, Genton, Binka, Achtman, & Pluschke 
2002b) by standard bacteriological methods. Ethical clearance was obtained from the 
responsible institutional and national ethical approval committees. 
 
Characterisation of bacterial isolates 
Meningococcal isolates were serogrouped with serogroup-specific antisera (Difco). 
Results were reconfirmed by PCR (Taha 2000;Bennett et al. 2004;Orvelid et al. 1999). All 
W135 isolates were analysed by pulsed field gel electrophoresis (PFGE) after digestion 
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with NheI as previously described (Morelli et al. 1997). All disease isolates were tested for 
resistance to penicillin G, chloramphenicol, cefotaxime, and ciprofloxacin with E-test strips 
(Isenberg Henry D.(ed.) 1998) using the NCCLS breakpoints. Selected strains were 
analysed by multi-locus sequence typing (MLST). DNA extraction (Vela Coral, Fonseca, 
Castaneda, Di Fabio, Hollingshead, & Briles 2001), PCR (Maiden, Bygraves, Feil, Morelli, 
Russell, Urwin, Zhang, Zhou, Zurth, Caugant, Feavers, Achtman, & Spratt 1998) and 
sequencing of PCR products with an ABI Prism 310 Genetic Analysis System were 
performed according to standard protocols on the MLST homepage 
(http://pubmlst.org/neisseria/). Allelic profiles were analysed using applications available 
on the MLST homepage.  
 
Results 
Characterization of W135 disease isolates from Ghana 
Between February 2003 and March 2004, four cases of W135 meningococcal meningitis 
were reported by the regional hospitals in Tamale, Bolgatanga and the Korle Bu Teaching 
hospital (Accra), respectively. Patients came from the centre, the south or the north of the 
country (Figure 4.1) and were between 3 and 17 years of age (Table 4.1). One patient 
died, and of the three survivors one had profound sequelae. 
 
All four disease isolates were sensitive to penicillin G, chloramphenicol, ciprofloxacin and 
cefotaxime. PFGE profiles of all four Ghanaian disease isolates were compared with 
disease isolates from the Hajj outbreak in Mecca 2000 and from Burkina Faso between 
2001 and 2003. The Burkinian strains isolated  in 2001 and 2002 showed identical profiles 
(shown for strain BF67/02, Figure 4.2, lane 5, profile C), whereas the 2003 isolate 
appeared to be very closely related (Figure 4.2, lane 6, BF01/03, profile D). Profiles of the 
Ghanaian disease isolates were largely identical (Figure 4.2, lanes 7-10, profile D) and 
indistinguishable of that of the 2003 strain from Burkina Faso (Figure 4.2, lane 6). The 
reference disease isolates from the Hajj outbreak in 2000 had a distinct, but related PFGE 
profile (shown for strain N11421, Fig. 2, lane 4, profile B; both strains had an identical 
profile). All four Ghanaian disease isolates had the multi-locus sequence type (ST) 11, 
which is the major ST of the ET-37 clonal complex. 
44 Chapter 4. W135 meningococcal meningitis in Ghana  
 
Figure 4.1 Map of Ghana showing the location of home communities of W135 meningitis patients. 
The sample time points were as follows: Community K1: I) April 2003, II) December 2003 (including control 
community), III) April 2004. Community B1: December 2003, Community B2: March 2004.  The home 
community of patient A1 could not be identified and has not been sampled. 
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Table 4.1 W135 cases reported to the Ghanaian Disease Control Authorities in 2003 and 2004 
Patient ID 
Time of 
disease onset 
Village/ City  Region Age (yrs) Sex Outcome Sequelae 
K1 February 2003 Kpalkpalgbeni  Brong Ahafo 3 male survived *multiple 
A1 April 2003 Accra Greater Accra 4 male died unknown 
B1 August 2003 Bolgatanga   Upper East 17 female survived none 
B2 March 2004 Bolgatanga   Upper East 3 male survived +multiple 
* Profound neurosensory hearing loss, speech impairment, transient ataxia hyperactive left knee and challis reflexes 
+ Arthritis of the knee joints and occasional episodes of brief startling attacks during the first week after discharge but 
stopped thereafter 
 
 
 
Figure 4.2 PFGE profile of W135 carrier and disease isolates (lane: strain No.; origin)   
Indicated on the gel are the different band profiles of the W135 strains (A-G). 1: MW marker; 2, 3: N1621, 
N1622, KND 1998, carriage; 4: N1421 (Z9230), Mecca 2000, reference strains; 5: N1627 (BF67/02), Burkina 
Faso 2002, case; 6: N1628 (BF01/03), Burkina Faso 2003, case; 7: N1681 Ghana 2003, patient K1; 8: 
N1682, Ghana, 2003, patient A1 9: N1683, Ghana 2003, patient B1; 10: N1846, Ghana 2004, patient B2; 11, 
12: N1485, N1487, community K1, April 03, carriage; 13, 14, 15: N1633, N1640, N1636, community K1, Dec 
03, carriage; 16, 17: N1848, N1857, community B2, March 04, carriage; 18, 19, 20: N1951, N1953, N1959, 
community K1, April 03, carriage; 21, 22: N1888, N1903, KND, April 04, carriage; 23: MW marker 
  
Table 4.2 Carriage of different serogroups of N. meningitidis and of N. lactamica  
in home communities of three W135 meningococcal meningitis patient and in a neighbouring control community. 
 
 
 
 
 
 
 
 
 
* Non groupable (NG) strains were negative both in serological tests and in serogroup A and W135 specific PCR analyses 
 
Colonisation rate % (n) Time of 
survey 
Community  
(patient ID) 
Volunteers 
swabbed (n) N. lactamica N. meningitidis W135 A X Y NG* 
April ‘03 home (K1) 103 7.8 (8) 24.3 (25) 17.5 (18) 2 (2) 0 1 (1) 3 (3) 
Dec. ‘03 home (K1) 100 3 (3) 15 (15) 13 (13) 0 0 1 (1) 1(1) 
April ‘04 home (K1) 96 5.2 (5) 8.3  (8) 3.1 (3) 1 (1) 0 1 (1) 3 (3) 
Dec. ‘03 control (K1) 100 1 (1) 9 (9) 0 2 (2) 2 (2) 2 (2) 3 (3) 
Dec. ‘03 home (B1) 110 8.2 (9) 3.6 (4) 0 0 0 1 (1) 3 (3) 
April ‘04 home (B2) 100 4 (4) 7 (7) 2 (2) 0 2 (2) 0 2 (2) 
  
Table 4.3 Age distribution of colonisation with N. lactamica  and W135 and non-W135 N. meningitidis  in the patient home community K1  
(cumulated data from all three surveys). 
 
 
 
Frequency of colonisation 
 
 
Age group (yrs) 
<1 1-4 5-9 10-14 15-19 20-39 >40 
 
 
N. meningitidis 
serogroup W135 
1/6 (16.7%) 5/78 (6.4%) 7/44 (15.9%) 7/37 (18.9%) 6/24 (25.0%) 8/93 (8.1%) 0/17 (0%)  
 
non-W135  
N. meningitidis 
0/6 (0%) 1/78 (1.3%) 0/44 (0%) 4/37 (10.8%) 3/24 (12.5%) 5/93 (5.3%) 1/17 (5.9%)  
 
 
N. lactamica 
 
2/6 (33.3%) 
 
9/78 (11.5%) 
 
1/44 (2.3%) 
 
1/37 (2.7%) 
 
0/24 (0%) 
 
0/93 (0%) 
 
1/17 (5.9%)  
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W135 colonisation in patient communities and clonal diversity of bacteria 
Three consecutive N. meningitidis colonisation surveys were performed in community  
K1, the first six weeks after the emergence of the case,  in February 2003. In April 2003,  
17.5% of  103 inhabitants  (about 90% of the total population of the village) were colonized 
with W135 meningococci. Thereafter, the W135 colonisation rate declined to 13% in 
December 2003 and to 3 % in April 2004. In addition, a few carriers of other meningococci 
were found. N. lactamica colonisation rates were between 3 and 8%. N. meningitidis A, X 
and Y, but no W135 carriers were found in a neighbouring control community included in 
the December 2003 survey (Table 4.2).  
 
Cummulated data from all three surveys conducted in community K1 were used to 
analyse the age distribution of colonisation with W135 meningococci in comparison to 
other serogroups found and to N. lactamica (Table 4.3). Logistic regression, including 
random effects to allow for repeated assessment of the same individuals, indicated that 
the ratio of carriage prevalence of N. meningitidis to that of N. lactamica increased with 
age (Chi-square=7.6, 1 degree of freedom,  p=0.006), however there was no significant 
age trend in the ratio of W135 to other N. meningitidis (Chi-square 0.8, 1 d.f. p=0.4). 
All isolates from the 18 W135 carriers in community K1 in April 2003,  revealed identical 
PFGE profiles (shown for strains N1485 and N1487, Figure 4.2., lanes 11 and 12, profile 
D), indistinguishable from those of the Ghanaian disease isolates (Figure 4.2 lanes 7-10). 
However, some genetic diversification became apparent in the December 2003 
colonisation survey. While the isolates of nine (of thirteen) W135- carriers revealed the 
original band profile (data not shown), the isolates from the other four exhibited three new 
variant profiles (Figure 4.2, lanes 13-15, profile E, F, G). Two of the three variant PFGE 
profiles, but not the original profile, were found again in the last colonisation survey in April 
04 (Figure  2, lanes 18-20, profile E and G). 
 
In community B1 and B2 only one colonisation survey was performed, three months and 
three weeks, respectively, after the emergence of the case. While no W135 meningococci 
were found in  community  B1  in community  B2 W135 isolates of two carriers were 
obtained with the same PFGE profile as the Ghanaian disease isolates (Figure 4.2, lane 
16, profile D, Table 4.2).  In addition, from one of them a variant strain was isolated with a 
PFGE profile (Figure 4.2, lane 17, profile F) identical to a variant profile found in 
colonisation isolates from community K1.  
Chapter 4. W135 meningococcal meningitis in Ghana 49 
 
W135 colonisation in a long-term colonisation survey in northern Ghana 
Within the framework of a longitudinal N. meningitidis colonisation and disease study in 
the Kassena Nankana District (KND) of northern Ghana (Gagneux, Hodgson, Ehrhard, 
Morelli, Genton, Smith, Tanner, Binka, Achtman, & Pluschke 2000;Gagneux, Hodgson, 
Smith, Wirth, Ehrhard, Morelli, Genton, Binka, Achtman, & Pluschke 2002b), no W135 
meningococcal meningitis case was recorded between 1998 and 2004. During these 
seven years of twice yearly colonisation surveys only single carriers of W135 
meningococci have been identified in 1998 (1/300 in April and 1/299 in November 1998) 
(Gagneux, Hodgson, Ehrhard, Morelli, Genton, Smith, Tanner, Binka, Achtman, & 
Pluschke 2000). However, in April 2004 a W135 colonisation rate of 0.9% (3/350) was 
found.with isolates showing the same PFGE profile (Figure 4.2, lanes 21 and 22, profile D) 
as the Ghanaian disease isolates (Figure 4.2, lanes 7-10). Profiles of the two 1998 carrier 
isolates (Figure 4.2, lanes 2 and 3, profile A), were identical among each other but distinct 
from all other profiles observed in this study.  
 
Discussion 
In spite of the consecutive W135 epidemics in Burkina Faso in 2002 - 2004, no major 
outbreak of W135 disease has been observed so far in Ghana, demonstrating that 
bottlenecks exist for the spreading of epidemic strains within the meningitis belt, as already 
described for serogroup A meningococci (Achtman 1995a). The four isolated Ghanaian 
cases described in this paper have probably only been reported because of intensive 
national surveillance and awareness. W135 strains belonging to the ET-37 complex have 
been present in Ghana before the Mecca outbreak (Gagneux, Hodgson, Ehrhard, Morelli, 
Genton, Smith, Tanner, Binka, Achtman, & Pluschke 2000) and sporadic W135 cases may 
have easily remained undetected before the year 2000.  
 
PFGE analysis demonstrate that the four Ghanaian W135 meningitis isolates were 
closely related to recent disease isolates from Burkina Faso, indicating, that these 
meningitis cases were caused by epidemic-related strains and not by local strains of the 
ET-37 complex. At least in the north of Ghana colonisation with the Burkina Faso 
epidemic-related strain is detectable. While visitors from Burkina Faso are frequently met 
in the border communities B1 and B2, it is not possible to guess the origin of the disease 
causing W135 strain of patient A1 living close to Accra. In the case of community K1,  
located in the middle of Ghana, contact to nomads may have been the source of the W135 
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bacteria, as a part of a neighbouring community frequently moves to Burkina Faso and 
back.  
 
W135 carriage rates of healthy contacts in the three home communities of W135 
meningitis patients, were very different. W135 carriers were found in the home 
communities (K1 and B2) of the index cases aged 3 years but not in B1, the home 
community of the 17 year old patient. Age of the patients may play a role, as suggested by 
findings of a study carried out during an serogroup C outbreak in Brazil, where contact 
carriage rates were highest in households, where the index case was an infant (Cartwright 
1995). Carriage rates of outbreak strains tend to be higher in closed or partially-closed 
communities than in an open communities (Cartwright 1995). The rural community K1 has 
the features of a semi-closed community, where inhabitants lived very closely together and 
shared all living activities, while the urban communities B1 and B2 were much more open 
and loose. This may explain, why the highest (18%) carriage rate was observed in 
community K1. The age distribution of W135 colonisation, was not unusual, as the pattern 
observed in community K1 was characteristic for meningococci in general (Cartwright 
1995). 
 
Changes of the PFGE profile of colonisation isolates with time demonstrate that 
microevolution of W135 may be rapid. N. meningitidis is a naturally transformable species 
and there is evidence that microevolution is driven more frequently by recombination than 
by mutation. The observed genetic drift can make it very difficult to distinguish between 
epidemic-related and local W135 strains belonging to the same ET-37 complex and to 
prove epidemic spread of a particular clone. While available techniques are suitable to 
analyse the global population structure of other meningococcal serogroups (Lingappa, Al 
Rabeah, Hajjeh, Mustafa, Fatani, Al Bassam, Badukhan, Turkistani, Al Hamdan, Al Jeffri, 
Al Mazrou, Perkins, Popovic, Mayer, & Rosenstein 2003), new approaches are required 
for studying the molecular epidemiology of  N. meningitidis W135. 
 
An affordable vaccine against W135 meningococci (e.g., a trivalent groups A, C, and 
W135 polysaccharide vaccine) is now available and has been successfully used to contain 
outbreaks of W135 meningitis in Burkina Faso (Ahmad 2004). As Burkina Faso epidemic-
related W135 meningococci now seem to spread into Ghana, intense surveillance efforts 
at national and regional levels for timely detection of a potential W135 epidemic is an 
important issue in future years. 
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Abstract 
 
Background  The Kassena-Nankana District (KND) of northern Ghana lies in 
the African meningitis belt where epidemics of meningococcal meningitis have been re-
occurring every 8-12 years for the last 100 years. The dynamics of meningococcal 
colonisation and disease are incompletely understood.  
 
Methodology/Principle Findings Between February 1998 and November 2005, 
pharyngeal carriage of N. meningitidis in the KND was studied by twice yearly colonisation 
surveys. Meningococcal disease was monitored throughout the 8-year study period, and 
patient isolates were compared to the colonisation isolates. The overall meningococcal 
colonisation rate of the study population was 6.0%. All culture-confirmed patient isolates 
and the majority of carriage isolates were associated with three sequential waves of 
colonisation with encapsulated (A ST5, X ST751, A ST7) meningococci. Compared to 
industrialised countries, the colonising meningococcal population was less constant in 
genotype composition over time, genetically less diverse during the peaks of the 
colonization waves, and a smaller proportion of the isolates was non-serogroupable. We 
observed a broad age range in the healthy carriers, resembling that of meningitis patients 
during large disease epidemics. 
 
Conclusions  The observed lack of a temporally stable and genetically diverse 
resident pharyngeal flora of meningococci might contribute to the susceptibility to 
meningococcal disease epidemics in the African meningitis belt. Because capsular 
conjugate vaccines are known to impact meningococcal carriage, effects on herd immunity 
and potential serogroup replacement should be monitored following the introduction of 
such vaccines. 
 
Chapter 5. Clonal Waves of Neisseria meningitidis 55 
 
Introduction 
The highest burden of meningococcal meningitis occurs in the ‘meningitis belt’ of sub-
Saharan Africa; a region stretching from Senegal to Ethiopia with an estimated  population 
of 300 million (Greenwood 1999;Lapeyssonnie 1963). Within individual areas of the 
meningitis belt, major disease epidemics occur in irregular cycles every 8–12 years, with 
attack rates ranging from 100 to 1000 per 100,000 population (WHO 1998). Epidemics 
start in the early dry season, stop abruptly at the onset of the rains, but may break out 
again in the following dry season. Low humidity and high temperatures may favour the 
occurrence of meningococcal disease by damaging mucosal surfaces and the immune 
defence. In any one country, epidemics only last for two to three years (Greenwood 1999). 
The periodicity of these epidemics is not well understood, nor is it possible to predict them 
accurately. The current approach for control of meningococcal disease epidemics is based 
on early detection of the disease by the epidemic threshold of 10-15 cases per 100,000 
inhabitants per week (WHO 2000) followed by mass immunisations with polysaccharide 
vaccines (WHO 1998). However, in settings with limited resources, effective surveillance 
and timely interventions are difficult to implement. Therefore vaccination campaigns are 
often delayed (Greenwood 1999).  
 
N. meningitidis can be classified into thirteen serogroups based on the chemical 
composition of its polysaccharide capsule (Yazdankhah & Caugant 2004). Serogroup A 
accounts for most epidemics in the African meningitis belt, but C and W135 epidemics 
have also been reported (Greenwood 1999;WHO 2005). Meningococci that cause 
epidemics are genetically closely related; specific genotypes plus their epidemiologically 
associated genetic descendants constitute genoclouds (Zhu et al. 2001). The two most 
recent meningococcal disease pandemics originated in Asia and were caused  by 
serogroup A meningococci belonging to two related genoclouds (Zhu et al. 2001). These 
two genoclouds have been assigned the sequence types 5 (ST5) and ST7, respectively, 
based on Multi-Locus Sequence Typing (MLST) (Zhu et al. 2001;Maiden et al. 1998). 
Serogroup W135 meningococci used to be a rare cause of invasive disease. However, two 
recent W135 meningitis outbreaks in Mecca were followed by major epidemics in Burkina 
Faso (WHO 2005;Taha et al. 2000).  
 
N. meningitidis is a commensal of the human nasopharyngeal mucosa. It is transmitted 
by aerosol droplets or through contact with respiratory secretions. Because meningococcal 
transmission is independent of disease, characterisation of the carrier state is crucial for 
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understanding the epidemiology of meningococcal disease. Multiple colonisation studies 
have been performed in industrialized countries, but little is known about the 
meningococcal colonisation dynamics in Africa. Here, we report the findings of the (to our 
knowlede) first long-term colonisation study carried out in the African meningitis belt.  
 
Materials and Methods 
Study area 
The study was conducted in the Kassena-Nankana District (KND) of the Upper-East 
Region of Ghana. It lies within the guinea Savannah woodland and has two major 
seasons; a short wet season from June to October and a long dry season for the rest of 
the year. The district-population is about 140,000, most of them rural, except for the 
20,000 inhabitants of Navrongo town. In the KND, people live in compounds with an 
average of 10 inhabitants (http://www.indepth-network.net/dss_site_profiles/navrongo.pdf). 
Between 1997 and 2002, yearly vaccination campaigns with meningococcal serogroup 
A/C polysaccharide vaccine targeted the whole district population. Between 2003 and 
2005, smaller campaigns were carried out. In 2003, 80% of the study participants reported 
to have been vaccinated within the previous three years. Ethical clearance for this study 
was obtained from the responsible institutional review boards. 
 
Ethical Approval 
Ethical clearance for this study was obtained from the relevant institutional review boards 
and the Ghana Ministry of Health. Informed consent was obtained from all study 
participants. 
 
Colonisation isolates 
Thirty-seven residential compounds were randomly selected from a complete listing of 
the district population using the Navrongo Demographic Surveillance System (NDSS) 
(Binka F 1999). The sample size was chosen to include a total population of about 300 
individuals per survey, which means a carriage rate of 5% at any one survey 
(corresponding to a relatively frequent infection) can be distinguished at a significance 
level of 5% from those of infrequent infections carried by only 2.5% of the population.  
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Throat swabs were taken twice per year from all inhabitants of the 37 compounds 
present at the time of the visit who agreed to participate. A total of 16 surveys have been 
performed since March 1998, in each of them between 292 and 350 study participants 
have been swabbed (Table 5.1). The number of participants swabbed in single 
compounds ranged from 0 to 30 (mean 8.57, median 6), fluctuations occurred due to 
travelling activities. However, only three individuals refused to participate in the study, as a 
result one of the compounds was discontinued after the 1st visit. Another compound was 
replaced in April 2002 after being deserted by its inhabitants. The age distribution of the 
study participants was comparable with the overall age distribution in the KND (Table 5.2). 
 
At the compound visit, the throat swab was taken and directly inoculated on Thayer-
Martin agar plates (Gagneux et al. 2000). Two colonies with neisserial morphology were 
sub-cultured from each positive plate. N. meningitidis and N. lactamica colonies were 
identified by standard bacteriological methods as previously described (Gagneux et al. 
2000).  
 
Disease isolates 
Suspected meningitis patients presenting at the War Memorial Hospital (WMH), 
Navrongo, or one of the four Health Centres of the KND were recruited throughout the 
study period. A suspected meningitis patient was defined by sudden onset of fever and stiff 
neck, or fever and stiff neck and altered mental status, in accordance with WHO-guidelines 
(WHO 1998). A lumbar puncture was performed before treatment from all suspected 
meningitis patients, and the cerebrospinal fluid specimen was analyzed in the laboratory of 
the WMH as described previously (Gagneux et al. 2000). In 1998–1999, only samples 
collected during the dry season were analyzed. Thereafter, samples collected from the few 
patients with suspected meningitis who presented during the wet season were also 
included.  
 
Characterisation of bacterial isolates 
Meningococci were serogrouped with serogroup-specific antisera (Difco) according to the 
manufacturer’s instruction. In a subset of isolates, serological typing was confirmed by 
PCR (Taha 2000;Bennett, Mulhall, & Cafferkey 2004). All isolates were analysed by 
pulsed-field gel electrophoresis (PFGE) after digestion of genomic DNA with NheI (Morelli 
et al. 1997). MLST was performed as described (Maiden et al. 1998). 
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Statistical Methods 
As a measure of the invasiveness of the different genoclouds we computed the ratio of 
cases to the approximate number of carriers in the district (Table 5.3). To estimate the 
latter we assumed that each survey was representative of the six month period in which it 
was carried out, and that average duration of carriage is six months, corresponding 
approximately to the half life of Neisseria meningitidis carriage determined in a study in 
University students in the United Kingdom (Ala'Aldeen et al. 2000). The diversity (D) 
(Table 5.1) of the meningococcal carriage population was determined with respect to the 
serogroup distribution for each of the 16 surveys and for the overall study period using the 
Simpson Index (Simpson E.H 1949;Grundmann et al. 2001).  
 
The unadjusted proportion of samples carrying each bacterium provides a consistent and 
unbiased estimate of carriage prevalence, however because of the random sampling of 
the population the clustering in the sampling procedure introduced extra-binomial variation, 
which was allowed for in the estimates of standard errors (Table 5.1) by calculating robust 
(sandwich) estimates (Williams 2000) using Stata version 8.0 (Stata Corporation, TX, 
USA). 
 
Risk ratios and confidence intervals were calculated using EpiInfo v3.3.2 but these 
analyses treated the different samples as statistically independent and consequently some 
of the tests carried out are anticonservative because of the effects of repeated sampling of 
the same individuals.  We draw attention to the implications of this where it applies. 
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Results 
Clonal waves of meningococcal colonisation and disease 
We monitored the dynamics of pharyngeal carriage of N. meningitidis and bacterial 
meningitis in the KND of northern Ghana from February 1998 to November 2005; three 
major waves of clonal colonisation and disease with encapsulated meningococci were 
observed. A meningitis epidemic occured in the dry season of 1996/97 with 1396 
suspected meningitis cases in the KND, but because of lack of infrastructure no laboratory 
analysis was performed. (Hodgson A. et al. 2002) This epidemic was followed by a smaller 
outbreak with 50 laboratory-confirmed serogroup A meningitis cases in the following dry 
season. A total of 36 isolates were culture confirmed and identified as subgroup III, ST5 
bacteria (Gagneux et al. 2000), that spread throughout the meningitis belt after an 
epidemic in Mecca in 1987 (Nicolas et al. 2001). Carriage of the serogroup A ST5 
meningococci decreased steadily from 2.7% (8/301) in April 1998 to 0.3% (1/308) in 
November 1999 (Figure 5.1a). Thereafter, none of the clinical or colonisation isolates from 
the KND belonged to the serogroup A ST5 genocloud. In 2000, no serogroup A 
meningococci were isolated from either patients or carriers. However, in 2001, a new wave 
of serogroup A meningococcal colonisation and disease started.  All serogroup A carrier 
and disease strains isolated since then belonged to a new genocloud of serogroup A 
meningococci associated with ST7 that was observed for the first time in Africa in 1995 
(Zhu et al. 2001). Although colonisation was still low in April 2001 (i.e. was <0.3%), seven 
serogroup A ST7 meningitis cases were identified between February and March 2001. In 
the following three years, serogroup A ST7 colonisation rates of 1.2% to 4.3% were 
observed. In spite of yearly serogroup A/C polysaccharide mass-immunisations, this low 
level of colonisation was associated with repeated serogroup A ST7 meningitis outbreaks 
in the KND (Figure 5.1a). Laboratory-confirmed cases numbered 70 between January and 
May 2002, 56 were identified between January and May 2003, and 114 were identified 
between December 2003 and April 2004. Thereafter, the serogroup A ST7 colonisation 
rate dropped below 1% and only two serogroup A ST7 meningitis cases were recorded in 
February 2005.   
 
Between the two waves of serogroup A colonisation and disease, we documented a 
wave of colonisation with a serogroup X ST751 genocloud (Figure 5.1b) (Gagneux et al. 
2002a;Gagneux et al. 2002b). The extensive spread of this low-virulent serogroup was 
associated with a total of 15 meningitis cases between 1998 and 2003. Serogroup X 
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carriage and disease peaked in the dry seasons of 1999/2000 and 2000/01 with 
colonisation rates of 17.3 and 15.1%, respectively. While in the peak of the serogroup X 
wave the ratio of serogroup X cases to carriers was found to be between 0.1 and 
0.3:1,000, the observed ratio of serogroup A cases versus carriers during the A ST7 
outbreak was between 16.8 and 42.3:1,000 in the respective dry seasons (Table 5.3).  
 
Since November 2003, 23 non(sero)groupable (NG) ST192 carriage isolates with closely 
related PFGE-patterns were collected (Figure 5.1b). With 3.8% (12/313) their colonisation 
rate peaked in November 2004. NG ST192 strains isolates have been previously reported 
from The Gambia and Niger. (http://pubmlst.org/perl/mlstdbnet/mlstdbnet.pl?page=st-
query&file=pub-nm_isolates.xml).  
 
Investigation of Bacterial isolates 
Throughout the study period, 1145 suspected meningitis patients were recruited and their 
CSF samples were analyzed in the laboratory. Overall, 311 meningococcal meningitis 
cases were confirmed by latex agglutination.  Furthermore, a pneumococcal meningitis 
outbreak with dominance of serotype 1 occurred between 2000 and 2003 (Chapter 3), 
while overall only 17 H. influenzae meningitis cases were identified. We obtained 
meningococcal isolates in 197/311 (63%) of the confirmed cases.  Latex aggluntination 
confirmed the serogroup A capsule for all 114 cerebrospinal fluid samples that were 
negative in culture. 
 
All recovered N. meningitidis isolates belonged to the three dominating genoclouds of 
encapsulated meningococci (36 serogroup A ST5, 148 serogroup A ST7 and 15 serogroup 
X strains).  With respect to colonization, 289 (5.8%) of the pharyngeal samples contained 
N. lactamica and 302 (6.0%) N. meningitidis. Point prevalence of the different serogroups 
at the 16 individual surveys is given in Table 5.1. All serogroup A (n=55) and serogroup X 
(n=161) carriage isolates belonged to the three genoclouds causing the major sequential 
colonisation waves. In addition, 16 NG isolates shared ST and PFGE-patterns with the 
serogroup A ST5 (2 isolates), serogroup A ST7 (2 isolates) or serogroup X (12 isolates) 
isolates, respectively (Figure 5.1a). These colonisation isolates thus represented 
unencapsulated variants of the respective genoclouds. There was no evidence for an 
accumulation of the non-encapsulated variants towards the end of the colonisation waves 
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(Figure 5.1). In some cases, encapsulated and NG variants of the same genocloud were 
found simultaneously in the same compound.  
 
Bacterial carriage showed only moderate clustering by compound. Of the 39 compounds 
sampled at least once, 31 (79%) provided at least one N. lactamica and 36 (92%) at least 
one N. meningitidis positive sample. Of the 583 individual compound visits, 158 (27%) 
yielded N. lactamica and 155 (27%) N. meningitidis. To compare these numbers with 
those expected if the bacteria were randomly distributed between compounds, we selected 
289 of the samples in the database at random and found that 208 different visits including 
38 compounds were represented, while 302 samples chosen at random corresponded to 
213 visits to 37 of the compounds.  
The diversity index D (Table 5.1) varied strongly between the single-sampling time 
points. Highly homogenous carriage populations were found in the course of colonisation 
waves with peak values of D=0.855 in April 2001 for the X wave, and D=0.583 in April 
2003 for the A ST7 wave. In contrast, carriage isolates were much more divers in the 
transition phase between two clonal waves with the lowest values of D=0.194 in November 
1998 during the transition from A ST5 to X and D=0.278 in April 2002 during the transition 
from X to A ST7. Overall, the serogroup diversity in the KND (D=0.349, 95% CI 0.306-
9.393) was slightly lower than in a carriage study in Europe (D=0.282, 95% CI 0.251-
0.313) (Yazdankhah et al. 2004). 
 
Low background of meningococci unrelated to the clonal waves  
Only from 16.6% (50/302) of the meningococcal carriers, colonisation isolates were 
unrelated to the dominating serogroup A, X and NG ST192 genoclouds (Figure 5.1c). 
Although neighbouring Burkina Faso was hit by repeated W135 ST11 epidemics in the dry 
seasons of 2002-2004, in the KND, carriers of the epidemic strain were only found in April 
2004 (3/350; 0.9%) and November 2004 (2/313; 0.6%), and not a single W135 meningitis 
case was recorded between 1998 and 2005 (Chapter 4). Single carriers of W135 ST11 
meningococci were also identified in April (1/300) and in November 1998 (1/299) 
(Gagneux et al. 2002b), two years prior to a first documented W135 meningitis outbreak in 
Mecca (Taha et al. 2000). While serogroup Y meningococci (21 isolates) and serogroup Y 
ST168 related NG strains (7 isolates) were isolated in 10 out of the 16 individual surveys, 
carriage of serogroup B and serogroup 29E meningococci was rare (Table 5.1). Carriage 
of serogroup Y meningococci was strongly associated with one particular compound, 
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where during eight of the 16 surveys, 67% (14/21) of the serogroup Y strains were 
isolated. Altogether, only eight NG isolates had PFGE-patterns and STs unrelated to the 
dominating serogroup A, X, Y and NG ST192 genoclouds (Table 1). While the N. 
lactamica carriage rate remained relatively constant (4.7%– 9.3%) for six years, it declined 
after April 2004 to 0.3% in April 2005 (Figure 5.1d). We observed no significant correlation 
between the A/C meningococcal polysaccharide vaccine immunisation status and 
meningococcal carriage of all serogroups (RR=1.11; p=0.81), of serogroup A (RR=0.9; 
p=0.92), or of N. lactamica (in the >2year old RR=0.7, p=0.3). These P-values do not allow 
for the effect of clustering in the sampling.  An analysis that allowed for clustering would 
give even higher P-values, confirming the absence of effect 
 
Age distribution of carriers and patients 
Colonization with meningococci in the KND exhibited a broad age range (Figure 5.2a). It 
peaked in teenagers and young adults (median age 17.9 years; range 5 months to 84 
years). In contrast, the carriage rate of N. lactamica was highest in the <5 age group 
(Figure 5.2b). During the 1996/97 epidemic the age pattern of clinically diagnosed 
meningitis patients (median age 17.8 years; range 3 months- 80 years) resembled that of 
meningococcal carriers (Figure 5.2c), the incidence rates of males (n=628, IR=0.95%) and 
females (n=713, IR=0.98%) were comparable (RR=0.97, p=0.59). In contrast, during the 
post-epidemic A meningococcal disease outbreaks between 1998 and 2005, the incidence 
of meningitis was highest in children <10 years of age and decreased steadily with age 
(Figure 5.2c). The median age of A ST5 cases in 1998 and of A ST7 cases in 2001-2005 
was comparable (8.0 years; range 4 months- 64 years versus 10.0 years; range 2 months- 
75 years, respectively). However, between 2001 and 2005 the incidence rate of males 
(n=159, IR=0.049%) was significantly higher (RR=2.0, p<0.0001) than of females (n=89, 
IR=0.024%). The case fatality rate of A meningococcal meningitis was much higher during 
the A ST5 post-epidemic outbreak in 1998 (20%; 10/50) than during the epidemic in 
1996/97 (4.7%; 65/1396) or during the A ST7 outbreaks in 2001-2005 (4.8%; 11/238).
  
Table 5.1 Carriage rates in % during 16 carriage surveys in the Kassena Nankana District.  
Survey samples 
N. 
lactamica 
N. 
meningitidis 
serogroup 
A 
serogroup
X 
serogroup
Y 
serogroup 
W135 
serogroup 
29E 
serogroup 
B 
non 
groupable 
PFGE 
pattern of 
NG strains 
Simpson’s Index 
of Diversity * 
   % (s.e.) % (s.e.) % ( s.e.) % (s.e.) % (s.e.) %  (s.e.) %  (s.e.) % (s.e.) %  (s.e.)  D (CL) 
1 Apr 98 300 9.3 (2.7) 4.7 (1.6) 2.7 (1.1)  1.3(1.3) 0.3 (0.3)   0.3 (0.3) A 0.374 (0.173; 0.575) 
2 Nov 98 299 8.7 (2.2) 3.0 (1.3) 1.0 (0.6)  0.7(0.7) 0.3 (0.3)   1.0 (0.5) A, X, NT 0.194 (0.092; 0.296) 
3 Apr 99 292 8.2 (1.8) 5.1 (1.5) 0.7 (0.5) 3.4 (1.4) 0.7(0.7)    0.3 (0.3) NT 0.448 (0.181; 0.715) 
4 Nov 99 308 9.7 (2.0) 4.2 (1.7) 0.3 (0.3) 1.9 (1.1) 0.6(0.4)    1.3 (0.7) X, NT (3) 0.282 (0.134; 0.43) 
5 Apr 00 298 8.4 (2.4) 19.8 (3.7)  17.4 (4.0) 1.3(0.9)    1.0 (0.7) X, Y, NT 0.78   (0.642; 0.918) 
6 Nov 00 301 6.0 (2.4) 13.6 (6.0)  11.0 (4.3)     2.7 (1.9) X(7), Y 0.678 (0.527; 0.829) 
7 Apr 01 310 8.4 (2.2) 17.1 (2.9)  15.8 (2.6)     1.3 (0.7) X, Y(3) 0.855 (0.729; 0.981) 
8 Nov 01 306 6.5 (2.2) 2.0 (0.8)  1.3 (0.6)   0.3 (0.3)  0.3 (0.3) X 0.4     (0.015; 0.785) 
9 Apr 02 339 4.7 (1.4) 2.7 (1.0) 1.2 (0.7) 0.6 (0.4) 0.9(0.7)      0.278 (0.162; 0.394) 
10 Nov 02 319 5.6 (1.5) 2.8 (1.3) 1.9 (1.2) 0.6 (0.4) 0.3(0.3)      0.444 (0.139; 0.749) 
11 Apr 03 312 5.4 (1.6) 2.9 (1.1) 2.2 (1.1)  0.3(0.3)  0.3(0.3)    0.583 (0.243; 0.953) 
12 Nov 03 297 6.4 (2.1) 3.4 (1.2) 1.3 (0.8) 1.0 (0.6) 0.3(0.3)    0.7 (0.5) 192, X 0.222 (0.096; 0.349) 
13 Apr 04 350 3.7 (1.3) 8.0 (2.2) 4.3 (1.5)  0.3(0.3) 0.9 (0.8) 0.3 (0.3) 0.3(0.3) 2.0 (0.7) 192(5), A(2) 0.341 (0.194; 0.488) 
14 Nov 04 313 1.9 (0.8) 5.8 (1.9) 0.6 (0.5)   0.6 (0.6)   4.2 (1.9) 192(12), Y, NT 0.608 (0.347; 0.869) 
15 Apr 05 321 0.3 (0.3) 3.1 (1.0) 0.9 (0.5)      2.2 (0.7) 192(5), NT(2) 0.533 (0.301; 0.765) 
16 Nov 05 334 0.6 (0.4) 0.6 (0.4)       0.6 (0.4) NT(2) 1.0 (0) 
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Table 5.1. cont'd 
s.e. indicates the standard error of the % calculated with allowance for the cluster sampling. 
For NG strains the PFGE patterns are given, if more than one NG strain was isolated, the number of carriers 
are added in brackets;   
A, X, Y is the typical pattern of the respective serogroups, NT= Non-typable, PFGE-pattern is not known. 192 
is the NG ST192-pattern.  
* D and its confidence limits were determined according to Grundmann et a.[17] on the basis of serogroup 
diversity. 
 
 
 
 
 
Table 5.2 Age distribution of the overall study population during eight years colonization surveys in 
comparison with the overall population in the KND according to NDSS surveys between 1995-1999 
 Study Population Swabbed  Total population of the KND+ 
 Male %* Female %  male % female % 
<5 319 6.43 340 6.85  9780 7.07 9721 7.03 
5-10 322 6.49 501 10.10  10329 7.47 9932 7.18 
10-15 375 7.56 344 6.93  10007 7.23 9077 6.56 
15-20 266 5.36 294 5.93  7585 5.48 6520 4.71 
20-30 253 5.10 346 6.97  7587 5.48 9325 6.74 
30-40 164 3.31 328 6.61  5935 4.29 9114 6.59 
40-50 246 4.96 211 4.25  4928 3.56 7443 5.38 
>50 302 6.09 351 7.07  9092 6.57 11960 8.65 
total 2247 45.28 2715 54.72  65243 47.16 73092 52.84 
          
* % of the total population 
+
 Mean denominator of the population between 1995 and 1999 
Chapter 5. Clonal Waves of Neisseria meningitidis 65 
 
 
Table 5.3 Ratio of meningitis cases versus 1000 carriers for serogroup A and X at the different 
timepoints 
Period Serogroup A Serogroup X 
 carrier (n) cases(n) ratio* (95% CI) carrier (n) cases (n) ratio (95% CI) 
Jan-Jun98 8 43 11.7(5.4, 28.7)  1 ∞ 
Jul-Dec98 3      
Jan-Jun99 2   10 1 0.2(0, 1.5) 
Jul-Dec99 1   6   
Jan-Jun00    52 7 0.3(0.1, 0.6) 
Jul-Dec00    33   
Jan-Jun01    49 3 0.1(0, 0.4) 
Jul-Dec01  7 ∞ 4   
Jan-Jun02 4   2 1 1.2(0, 23.5) 
Jul-Dec02 6 69 42.3(15.8, 159.5) 2   
Jan-Jun03 7 1 0.4(0, 3.2)    
Jul-Dec03 4 52 16.8(7.6, 43.7) 3 1 0.7(0, 8.9) 
Jan-Jun04 15 2 1.1(0.1, 7.5)    
Jul-Dec04 2 111 18.7(10.9, 34.6)    
Jan-Jun05 3 2 1.5(0.1, 13.5)    
Jul-Dec05       
* The total population of the KND was estimated at 138’335 (INDEPTH 
 
 
 
 
next page: Figure 5.1   
Waves of colonisation and disease in the KND from April 1998 until November 2005.   
Carriage rates recorded during 16 colonisation surveys (April and November each year) and monthly 
numbers of confirmed meningitis cases of N. meningitidis.  
a) Genoclouds of serogroup A ST5 and ST7 meningococci  
b) genoclouds of serogoup X ST851 and NG ST192 meningococci.  
c) Carriage rates of other serogroups and meningococci non related to the A, X, or NG ST192 genoclouds. 
d) Carriage rates of N. lactamica 
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Figure 5.2  Age and Sex Pattern of 
Colonisation and Disease  
A) Carriage of meningococci in 
the different age groups (all 
serogroups and NG, cumulation of 
all surveys) of the male (light grey 
bars) and female (dark grey bars) 
population.   
 
B) Carriage of N. lactamica in the 
different age groups (cumulation of 
all surveys) of the male (light grey 
bars) and the female population 
(dakr grey bars).  
 
C) Age spectrum of incidence 
rates of meningococcal meningitis 
in the male (circles) and female 
(triangle) population of the KND in 
the epidemic of 1996/97 (dark grey) 
versus the interepidemic period 2001 
to 2005. Denominator is the district 
population 1995-99. On the primary 
Y-axis the epidemic incidence rates 
and on the secondary Y-axis the 
interepidemic incidence rates are 
indicated. 
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Discussion 
Here, we present the results of the first longitudinal study (to our knowleded) on 
meningococcal colonisation and disease in the meningitis belt of sub-Saharan Africa. The  
study revealed features which are in many aspects remarkably different from findings of 
colonisation studies conducted in Europe and North America (Caugant et al. 1988;Maiden 
et al. 2004;Jolley et al. 2000;Yazdankhah & Caugant 2004;Claus et al. 2005). The 
population of meningococci carried in the KND was i) less constant in the genotype 
composition, ii) less genetically diverse during the peaks of the colonization waves , iii) it 
included fewer NG strains  and iv) virulent encapsulated strains were dominant. Indeed, 
the A ST5, A ST7 and X ST751 meningococci responsible for all 197 culture-reconfirmed 
meningitis cases represented 71% (216/302) of the colonisation isolates.  
 
These results allow us to describe the major developments in meningococcal carriage 
and disease in the KND over an eight year study period that included both meningococcal 
outbreaks and  the interepidemic period.   We recorded very good compliance of the study 
participants.   However financial and organisational constraints did not allow sampling 
intervals shorter than 6 months, and this may have been too long for a robust analysis of 
acquisition rates and duration of carriage.  The relatively small number of 300 study 
members also led to a rather low sensitivity, and thus to the late detection of the serogroup 
A ST7 colonisation in the district. Meningococcal colonisation with minor clones might also 
have been undetected.  
 
In industrialised countries, approximately 10% of individuals from the general population 
are carrying meningococci at any one time (Cartwright et al. 1987). In children younger 
than four years, carriage rates are <3%. They increase to 20–40% in teenagers and young 
adults (Blackwell et al. 1990;Cartwright et al. 1987;Caugant et al. 1988;Caugant et al. 
1994) and decrease again to <10% in older age-groups. In contrast, invasive 
meningococcal disease is most common in young children and in teenagers. Current 
endemic rates of meningococcal disease in most industrialized countries range from less 
than one to five cases per 100,000 population. In industrialised settings, meningococcal 
strains collected from patients and carriers differ genetically and serologically (Caugant et 
al. 1988). Typically, the carried populations of meningococci are highly diverse, with a low 
representation of the invasive serogroups A, B, C, Y and W135 (Maiden 2004;Jolley et al. 
2000;Yazdankhah & Caugant 2004;Claus et al. 2005). The genetic composition of the 
strains carried is relatively constant over time, and up to 50% are serologically non-
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groupable (Yazdankhah & Caugant 2004;Cartwright, Stuart, Jones, & Noah 1987). 
Encapsulation is thought to reduce adherence to pharyngeal epithelial cells, and loss of 
expression of capsular polysaccharide may be an adaptation to long-term carriage 
(Cartwright 1995). Colonisation with NG strains may be beneficial to the host by eliciting 
cross-reactive immune responses to non-capsular meningococcal surface antigens 
(Cartwright 1995). 
 
The observed lack of a stable and genetically diverse resident pharyngeal flora of 
meningococci in the KND may explain why incoming new clones may spread so 
successfully in populations of the African Meningitis Belt. The instability in the resident 
flora evidently leads to clonal waves of colonisation typically lasting for about four years 
and, in the case of hypervirulent lineages, disease outbreaks or epidemics. We found that 
the case to carrier ratio was generally much higher for serogroup A than for serogroup X 
meningococci, reflecting the marked difference in virulence between these two 
serogroups. Only in the dry season of 2001 at the beginning of the A ST7 colonisation and 
disease wave did we find patient isolates that were unrepresented during the 
corresponding colonisation survey. The highest A ST7 colonisation rate (4.3% in April 
2004) was associated with the largest meningococcal meningitis outbreak observed during 
the entire study period. These data give no strong indication for a change in the case to 
carrier ratio in the course of the serogroup A ST7 outbreak. 
 
New contact of the population with genoclouds that have epidemic potential does not 
always lead to high colonisation rates. For example, we recovered isolates resembling 
those responsible for the 2002-2004 epidemics in Burkina Faso from a few carriers in KND 
in 2004, but we did not observe any wave of W135 colonisation. Importantly, fluctuations 
of the pharyngeal microflora of the population are not confined to the meningococci. For 
example, the N. lactamica colonisation rate also changed in the course of the study. In 
addition, an outbreak of pneumococcal meningitis occurred during the study period with 
features (seasonality, clonality and a broad age spectrum) characteristic of meningococcal 
epidemics (Chapter 3). Increasing herd immunity may be responsible for the 
disappearance of dominating genoclouds. However, changes in herd immunity do, not fully 
explain the complete disappearance of the A ST5 genocloud two years after the 1996/97 
epidemic nor the emergence of the closely related A ST7 genocloud after only a short time 
interval. 
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The age distribution of healthy carriers in the KND with peak carriage rates in teenagers 
and young adults was similar to many European colonisation studies (Caugant et al. 
1994;Cartwright, Stuart, Jones, & Noah 1987;Yazdankhah & Caugant 2004). The 
incidence of meningitis during the disease outbreaks in the years 1998-2005 was highest 
in children <10 years, comparable to endemic disease in industrialised countries. It is 
thought, that immune responses elicited by colonisation with meningococci and other 
antigenically cross-reactive microorganisms are responsible for the decreased disease 
susceptibility in the older age groups. This may imply that natural serum antibody-
mediated immunity against invasive disease is developing much more efficiently than 
secretory IgA-mediated protection against colonisation. 
 
However, during the epidemic in 1996/97, the age-distribution of meningitis patients 
resembled that of meningococcal colonisation, consistent with reports of most large 
meningococcal epidemics(Greenwood et al. 1979;Greenwood 1999;Lapeyssonnie 
1963;Moore 1992). During the epidemic the disease susceptibility of the whole population 
was increased and an overall incidence rate of 970/100’000 was recorded. The fact that 
also in children <10 years the epidemic incidence of meningitis was exceeding endemic 
attack rates dramatically, argues against the ‘2 hit’ hypothesis, associating susceptibility to 
disease with blocking serum IgA elicited by colonisation of the gut with cross-reactive 
microorganisms (Griffiss 1982). 
 
The factors that initiate epidemics in the meningitis belt are incompletely understood. 
Contact of a population with a hyperinvasive new genocloud that is antigenically distinct 
enough to escape natural immunity may lead to an epidemic. Loss of natural immunity in 
exposed individuals over time and new birth cohorts may make a population increasingly 
susceptible. However, epidemics are not always associated with the appearance of a new 
clone (Greenwood 1999). This suggests a role of environmental triggers, such as periods 
of hot, dry, and dusty weather, co-pathogens or social factors. In spite of intense annual 
A/C polysaccharide vaccination campaigns carried out in the KND since 1998, outbreaks 
with IR of up to 80 per 100,000 occurred between 2002 and 2004. Even though, this 
incidence was less than a tenth of the disease burden during the 1996/97 epidemic in the 
KND, it was still several times higher than in industrialized countries (Tikhomirov, 
Santamaria, & Esteves 1997). It is not clear, whether herd immunity elicited by the 
serogroup A ST5 epidemic, lack of environmental triggers or the vaccination campaigns 
have prevented a large A ST7 epidemic. 
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Meningococcal vaccines protect individuals from disease by eliciting bactericidal serum 
antibodies (Borrow et al. 2001). Recent studies following the introduction of conjugate C 
vaccines in the United Kingdom have demonstrated that capsule conjugate vaccines also 
affect carriage and transmission by inducing mucosal immune responses (Snape & Pollard 
2005;Maiden & Stuart 2002). Herd immunity may play a key role in the control of 
meningococcal infection using meningococcal conjugate vaccines (Ramsay et al. 2003). 
An affordable serogroup A conjugate vaccine may soon become available and introduced 
in the African meningitis belt (http://www.meningvax.org). Serogroup replacement and the 
emergence of escape variants (Maiden & Spratt 1999) are potential consequences of 
limited-spectrum vaccines, but these factors cannot be well understood without carriage 
studies. Our data suggest that successive waves of meningococci replace each other in 
the meningitis belt, some leaving little trace in disease surveillance statistics because of 
their low invasiveness. Once conjugate vaccines are introduced it will be critical to ensure 
that there is no replacement of vaccine serogroups with invasive alternatives. Carriage 
studies will play an important role in monitoring bacterial dynamics in order to anticipate 
any such problems and to prepare responses, such as mass vaccination with a 
supplementary carbohydrate vaccine.  
 
72   Chapter 5. Clonal Waves of Neisseria meningitidis 
Acknowledgements 
 
The study was funded by the Stanley Thomas Johnson Foundation, the Meningitis 
Research Foundation and the Meningitis Vaccine Project. The sponsors of the study had 
no role in study design, data collection, data analysis, data interpretation, or writing or the 
report. We are grateful for support and contributions of E. Arnold, F. Binka, S. Droz, I. 
Ehrhard,  B. Genton and M. Tanner. In the Navrongo Health Research Center, we 
thankfully appreciate the assistance of A. Bugri, S. Abudulai and A. Wahab in the 
laboratory, all nurses and health workers in the War Memorial Hospital, Navrongo and the 
Health Centers of the KND, C. Tindana with all fieldworkers and drivers for excellent work 
in the field, and T. Tei and M. Bugase for logistic support. We acknowledge the use of the 
NDSS database and we thank all study participants for their trust and contribution.  
This publication made use of the Neisseria Multi Locus Sequence Typing website 
(http://pubmlst.org/neisseria/) developed by Keith Jolley and Man-Suen Chan and sited at 
the University of Oxford. The development of this site has been funded by the Wellcome 
Trust and European Union. 
 
 
Chapter 6. Genetic diversification of Neisseria meningitidis 73 
 
 
 
 
Chapter 6  
Genetic diversification of Neisseria meningitidis during waves of 
colonisation and disease in the meningitis belt of sub-Saharan Africa 
 
 
 
1
 Julia Leimkugel, 2 Abudulai Forgor, 1 Jean-Pierre Dangy, 1 Valentin Pflüger, 1* 
Sebastien Gagneux, 2 Abraham Hodgson, 1 Gerd Pluschke 
 
 
 
 
1
 Swiss Tropical Institute, Basel, Switzerland 
2
 Navrongo Health Research Centre, Ministry of Health, Navrongo, Ghana 
 
*present address: Division of Infectious Diseases and Geographic Medicine, Stanford 
University Medical Centre, Stanford, USA 
 
 
 
 
 
 
This article has been submitted to  
Vaccine 
74 Chapter 6. Genetic diversification of Neisseria meningitidis 
Abstract 
 
Although Neisseria meningitidis is a highly variable organism, most invasive disease is 
caused by a minority of genotypes. Hypervirulent lineages have been identified and their 
pandemic spread has been traced. During a longitudinal meningococcal colonisation study 
in a district of northern Ghana clonal waves of carriage and disease were observed. 
Genetic diversification of genoclouds was analysed by Pulsed Field Gel Electrophoretic 
(PFGE) analysis of isolates from healthy carriers and from meningitis patients. Even during 
the limited time of persistence in the district, microevolution of the dominating genoclouds 
took place. Population genomic analyses are required to understand the genetic basis for 
the emergence of new lineages with epidemic potential, which is of crucial importance for 
the development of long-term global vaccination strategies against meningococcal 
disease. 
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Introduction 
Neisseria meningitidis is a common commensal of the upper respiratory tract of humans. 
Most invasive disease is caused by a minority of genotypes. Although genetic analyses 
have provided evidence for frequent recombination in N. meningitidis, it is possible to trace 
the pandemic spreading of certain hypervirulent genotypes (Morelli et al. 1997). However, 
constant microevolution leads to their genetic diversification. Dominating genotypes plus 
their clonally related and epidemiologically associated descendents have been designated 
genoclouds or clonal complexes. Such genoclouds persist only transiently and change 
their composition constantly through microevolution (Zhu et al.  2001).  
 
Since disease is not necessary for meningococcal transmission, characterization of the 
carrier state is crucial for understanding the epidemiology of meningococcal disease. Our 
results from the first long term meningococcal colonisation and disease study in the 
African Meningitis Belt revealed features, which were profoundly different from those 
observed in industrialized countries. All isolates from meningitis patients and the majority 
of strains from healthy carriers were associated with three sequential waves of 
colonisation with encapsulated (A ST5, X ST751 and A ST7) meningococci. Compared to 
industrialised countries, the colonising meningococcal population was less constant in 
genotype compsition over time and genetically less diverse during the peaks of the 
colonisation waves. Only smaller proportions of the isolates belonged to other serogroups 
such as W135 and Y or were non-serogroupable. The sequential waves of colonisation 
with pathogenic and apathogenic meningococcal genoclouds typically lasted for four years 
(Chapter 5).  
From this long term study, several groups of epidemiologically related isolates became 
available for genomic fingerprinting analyses: 1) sequence type 5 (ST5) isolates were 
collected from healthy carriers and meningitis patientes in 1998 and 1999. They had been 
introduced to Africa after an epidemic in Mecca during the Hajj 1987 and subsequently 
spread throughout the Meningits Belt.; 2) ST7 A meningococci emerged in the KND from 
April 2001 until April 2005. This genocloud has been recorded in Africa since 1995 
(Nicolas et al.  2001); 3) in between the two serogroup A waves, serogroup X 
meningococci caused a fulminant wave of colonisation and sporadic meningitis cases. 
Outbreaks of serogroup X meningococcal meningitis have been reported increasingly from 
Niger since the early 1990 (Etienne et al.  1990;Djibo et al. 2003;Boisier et al.  2005); 4) 
serogroup Y meningococci were isolated sporadically from carriers throughout the entire 
study period. While in most settings, serogroup Y is only infrequently attributed to invasive 
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disease, in the US recently a third of all meningococcal meningitis cases were caused by 
serogroup (Bilukha & Rosenstein 2005); 5) serogroup A135 isolates becoming available 
for genetic fingerprinting analysis included colonization strains isolated in the years 1998 
and 2004 from the KND, disease isolates from CSF of patientes from Burkina Faso and 
from other areas of Ghana, and colonisation isolates from residential compounds of W135 
index cases from different regions of Ghana (Chapter 4). Also serogroup W135 only 
occasionally caused invasive disease, until recently outbreaks during the Hajj in Mecca 
and in the African Meningitis Belt has enhanced the awareness to this serogroup and its 
epidemic potential (Taha et al. 2000;Decosas & Koama 2002;Boisier et al. 2005); 6) 
isolates from a wave of NG ST192 meningococci, that was recorded between November 
2003 and April 2005.  
 
Comparative genetic fingerprinting analysis of carriage and disease isolates by Pulsed 
Field Gel Electrophoresis (PFGE) and Multi-locus sequence typing (MLST) revealed 
genetic diversification processes during clonal expansion and allowed to study the spatio-
temporal spreading of new variants. Common and distinctive features will be presented in 
this report. 
 
 
 
Materials and Methods 
Study area 
The study was conducted in the Kassena-Nankana District (KND) of the Upper-East 
Region of Ghana. It lies within the guinea Savannah woodland and has two major 
seasons; a short wet season from June to October and a long dry season for the rest of 
the year. The district-population is about 140,000, most of them rural. People live in 
compounds with an average of 10 inhabitants.  
 
Bacterial isolates 
Carriage isolates were obtained from twice yearly colonisation surveys performed in the 
KND since April 1998 in thirty-seven residential compounds that were randomly selected 
from a complete listing of the district population (Gagneux et al. 2002b). A total of 16 
surveys have been performed since March 1998. A throat swab was taken from all 
consenting compound members present at the time of the visit and directly inoculated on 
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Thayer-Martin agar plates (Gagneux et al. 2000). Two colonies with neisserial morphology 
were sub-cultured from each positive plate. N. meningitidis colonies were identified by 
standard bacteriological methods as previously described (Gagneux et al. 2000).  
Disease isolates were obtained from all suspected meningitis patients in the KND 
through an intensive surveillance system. In the case of W135 meningococcal meningitis 
samples were received from hospitals in Tamale and Accra. A suspected meningitis 
patient was defined by sudden onset of fever and stiff neck, or fever and stiff neck and 
altered mental status, in accordance with WHO-guidelines (WHO 1998). A lumbar puncture 
was performed before treatment, and the cerebrospinal fluid specimen was analysed as 
described previously (Gagneux et al. 2000).  
 
Characterisation of bacterial isolates 
Meningococci were serogrouped with serogroup-specific antisera (Difco) according to the 
manufacturer’s instruction. In a subset of isolates, serological typing was confirmed by 
PCR (Taha 2000;Bennett, Mulhall, & Cafferkey 2004). All isolates were analysed by 
pulsed-field gel electrophoresis (PFGE) after digestion of genomic DNA with NheI (Morelli 
et al.  1997) a subset of bacteria has furthermore been typed with SpeI. MLST was 
performed as described (Maiden et al. 1998). 
 
Spatial distribution 
The spatial distribution of Serogroup A ST7 carrier- and patient compounds were 
mapped with MapInfo, using data from the Navrongo Demographic Surveillance System 
(NDSS) (Binka F 1999).  
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Results: 
 
Serogroup A  
Following a large epidemic in the dry season of 1996/97, serogroup A sequence type 5 
(ST5) isolates were isolated from meningitis patients during a post-epidemic outbreak in 
1998. Carriage of the ST5 meningococci decreased steadily from 2.7% in April 1998 to 
0.3% in November 1999 before their disappearance from the KND since the year 2000 
(Gagneux et al. 2000). The 36 disease isolates obtained in 1998 revealed three distinct 
PFGE patterns after NheI digest (I, II, and III, track 1-3, Figure 6.1), a spatial clustering of 
the distinct types could not be proven (Gagneux et al. 2000). The eight carrier strains 
isolated during the outbreak in early 1998 revealed pattern I and II (Figure 6.1., tracks 4, 9, 
11, 12, 15-17, 19), identical to disease strains. Six ST5 strains were isolated from carriers 
between Nov. 1998 and Nov. 1999. While three isolates showed three new types (IV-VI, 
Figure 6.1), pattern I persisted in the remaining three strains (Figure 6.1, tracks 7, 10, 13). 
One carrier was found positive in four subsequent surveys, showing three different PFGE 
patterns (Figure 6.1, Carrier 1, tracks 4-7). Two Non-serogroupable meningococcal strains 
from carriers revealed ST5 by MLST and pattern I by PFGE analysis (Figure 6.1, tracks 11 
and 18). 
 
The emergence of the A ST7 genocloud in the KND was confirmed by culture in three 
serogroup A cases in early 2001 before carriage of A ST7 meningococci was first detected 
one year later. Between 2002 and 2004, A ST7 colonisation rates of 1.2 to 4.3% in the 
KND were associated with repeated A ST7 meningitis outbreaks; the highest carriage rate 
(4.3% in April 2004) coincided with the largest outbreak with 114 confirmed ST7 cases in 
the dry season of 2003/04. Thereafter A ST7 carriage dropped to below 1% and only two 
more A ST7 meningitis cases were recorded in February 2005. The A ST7 PFGE pattern 
was closely related to the A ST5 pattern (Figure 6.2, tracks 1 and 2). Between 2001 and 
2005, altogether six A ST7-PFGE patterns were obtained after NheI digest of all 41 ST7- 
carrier and 147 ST7-disease isolates from the KND (Table 6.1 and Figure 6.2). In 2001, all 
three case isolates revealed PFGE type 7.1 (Table 6.1). Throughout 2002 and 2005, 
PFGE type 7.0 clearly dominated, with 85% (123/144) of the disease and 68% (28/41) of 
the carrier isolates. While the initially found pattern 7.1 persisted from 2001 to 2004, the 
remaining types (7.2-7.5) have only been isolated anecdotally from patients (Table 6.1).  
Throughout the outbreaks of 2002 until 2004, serogroup A carriage and disease was 
concentrated in the densely populated east of the district. Here, local carriage rates of up 
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to 10% have been recorded (Figure 6.3). Strains of pattern 7.0 and 7.1 have been isolated 
repeatedly from the same compound at the same visit.  
 
Serogroup X 
In between the two serogroup A outbreaks, the relatively apathogenic serogroup X 
meningococci caused a fulminating wave of colonisation in the KND, associated with 
altogether 15 meningitis cases between 1998 and 2003 (Gagneux, Hodgson, Smith, Wirth, 
Ehrhard, Morelli, Genton, Binka, Achtman, & Pluschke 2002b). According to PFGE 
analysis after NheI and SpeI digestion, virtually all strains from carriers and patients 
isolated until November 2000 belonged to three phylogenetic clusters. All three clusters 
appeared in the KND when colonisation was first detected in April 1999. Differences in the 
spatial distribution were observed, but the case to carrier ratio was comparable for all three 
clusters (Gagneux, Hodgson, Smith, Wirth, Ehrhard, Morelli, Genton, Binka, Achtman, & 
Pluschke 2002b). Carriage with X-meningococci decreased after 2001 but was detectable 
on a low level in the KND until the end of 2003. Carrier and case-isolates obtained since 
2001 in the KND had similar PFGE patterns as the isolates from 1999 and 2000 (Figure 
6.4, track 1-10). However, sporadically new variants emerged in cases and carriers (Figure 
6.4, track 11-20). 
 
Serogroup Y  
In the KND, serogroup Y meningococci were isolated on a low level with colonisation 
rates of up to 1.3% continuously between April 1998 and April 2000 and again between 
April 2002 and April 2004. During the entire study period no serogroup Y case was 
recorded in the KND. It is remarkable, that Y carriage was strongly associated with one 
particular residential compound, where altogether 14 (67%) of the 21 Y isolates came 
from. It was the only Y-positive compound between April 1998 and November 1999 and 
colonisation rates of up to 28% (4/14) were recorded. Initially, all strains isolated in the 
compound were identical according to SpeI and NheI digestion (Y1), the first variant was 
seen in April 1999 (Y2). Serogroup Y isolates that were obtained between 2002-2004 
showed distinct but closely related PFGE patterns after NheI digest (Figure 6.5, pattern 
Y3-Y7). After each period of serogroup Y carriage, sporadic NG strains have been isolated 
from healthy carriers that showed closely related PFGE patterns, in Nov. 2000/April 2001 
(Figure 6.5, track 5-7)  and No. 2004 (Figure 6.5, track 14). 
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Serogroup W135  
Four W135 meningococcal meningitis cases were recorded in Ghana between February 
2003 and March 2004 (Chapter 4). The ghanaian W135 disease isolates, all ST11 by 
MLST, revealed identical PFGE patterns after NheI digest and were closely related to 
burkinian outbreak strains from 2001 and 2002, and undistinguishable from a case isolate 
of 2003 (Chapter 4). Carriage rates in different ghanaian patient communities were found 
to be highly variable. Whereas in one of the communities not a single W135 carrier was 
found, in another patient communities 18% of the inhabitants were colonized with W135 
meningococci. Here, all carrier isolates revealed identical NheI patterns at the first visit. 
Two additional colonisation surveys showed diversification of the carriage isolates and 
finally the replacement of the original variant within one year (Chapter 4). Sporadic 
colonisation with W135 bacteria in the KND in 1998 and 2004 did not result in a major 
wave of carriage and disease. However, the 2004 carriage isolates had identical PFGE 
pattern to the 2003 case isolate from Burkina Faso (Chapter 4). 
 
Non-groupable  
Only 18.1% (55/304) of the meningococcal isolates during eight years of colonisation 
study were non serogroupable (NG). Most of the strains were related to the dominating 
encapsulated genoclouds by PFGE analysis. Between November 2003 and April 2005 we 
detected a wave of clonally related NG meningococci in the carriage population, of which 
representative isolates showed ST192 by MLST. While no case of NG 192 meningococci 
was detected throughout this period, the colonisation rate peaked in November 2004 
(3.8%). From altogether 24 strains, we saw one dominating PFGE type in 18 isolates 
(75%) throughout the whole period (Figure 6.5, pattern1). Four closely related patterns 
(see Figure 6.5, pattern 2-4, pattern 5 not shown) were found between April 2004 and April 
2005, one of them was isolated more than once (pattern 2). 
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Figure 6.1 PFGE patterns of NheI digested chromosomal DNA of serogroup A ST5 meningococci 
isolated in the KND 1998-1999. Strains were loaded in tracks 1-19 in the following order (track: strain): 
1:Z7057; 2: Z7060; 3: Z7067; 4: Z8319; 5:Z8324; 6: Z8326; 7: Z9567; 8: Z8349 (NG); 9: Z8314; 10: Z8323; 
11: Z8315; 12: Z8316;13: Z8322; 14: Z8325; 15: Z8318; 16: Z8320; 17: Z8321; 18: Z8342; 19: Z8317. 
Molecular weight markers were loaded in the flanking tracks as indicated (LM: lowrange marker; MM: 
midrange marker). CSF indicate isolates recovered from meningitis patients during the 1998 outbreak in the 
KND. All other strains were isolated from healthy carriers. A ST 5 bacteria were isolated from the same 
person (Carrier 1) during four subsequent surveys 
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Table 6.1 Distribution of PFGE pattern among the meningococcal disease and carriage isolates from the 
Neisseria meningitidis serogroup A ST7 wave in the KND 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 PFGE patterns of NheI digested chromosomal DNA of serogroup A ST7 meningococci 
isolated in the KND 2001-2005. Strains were loaded in the following order (Track:strain number): 1: N1267; 
2: N1325; 3: N1264; 4: N1479, 5: N1841;  6: N1472; 7: N1606; 8: N1362; 9: N1552; 10: N1812; 11: N2009, 
12: N1465; 13: N1604, 14: N1890; 15: N1990; 16: N2018; 17: N1359; 18: N1555; 19: N 1573; 20:1839 
Molecular weight markers were loaded in the flanking tracks as indicated (LM: lowrange marker; MM: 
midrange marker).
year 2001 2002 2003 2004 2005 
PFGE type Disease isolates (n) 
7.0  38 27 56 2 
7.1 3 1 1 14  
7.2  1    
7.3   2   
7.4   1   
7.5    1  
 
Carrier isolates (n) 
7.0  8 10 10 3 
7.1  2 1 7  
  
Figure 6.3 Spatial distribution of serogroup A ST7 carrier- and case- compounds in the KND between 2001 and 2004. 
carrier compound 7.0
carrier compound 7.0 + 7.1
case compound A7.0
case compound A7.1
case compound A7.3
case compound A7.4
case compound X
NDSS compound
carrier compound 7.0
carrier compound 7.1
case compound A7.0
case compound A7.1
NDSS compound
case compound A 7.0
case compound A 7.1
carrier compound A 7.0
carrier compound A 7.0 + 7.1
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Figure 6.4 PFGE patterns of NheI digested chromosomal DNA of serogroup X meningococci isolated 
in the KND between 2001 and 2003. Strains were loaded in the following order (Track:strain number) 2: 
N1117; 3: N1242 ; 4: N1243 ; 5: N1287; 6:N1289; 7:N1299; 8: N1311; 9:N1382; 10: N1409; 11: N1447; 12: 
N1475; 13: N1760; 14: N1764; 15: N1768; 16: N1258; 17: N1260; 18: N1261; 19: N1326; 20: N1568. 
Molecular weight markers were loaded in the flanking tracks as indicated (LM: lowrange marker; MM: 
midrange marker). 
Figure 6.5 PFGE patterns of NheI digested chromosomal DNA of serogroup Y and noun-groupable 
meningococci isolated in the KND between 1998 and 2004. Strains were loaded in the following order 
(Track:strain number) 1:N1274; 2: N2087; 3: N2089 ; 4: N1001 (NG) ; 5: N1226 (NG); 6:N1247(NG); 
7:N1383; 8: N1407; 9:N1443; 10: N1591; 11: N1756; 12: N1899; 13: N1980 (NG) Molecular weight markers 
was loaded in the flanking track as indicated (LM: lowrange marker) 
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Figure 6.6 PFGE pattern of NheI digested chromosomal DNA of non-groupable ST192 
meningococci. Strains were loaded in the following order (Track:strain number): 1: N1766, 2: N1907; 3: 
N1914, 4: N1917; 5: N1934, 6: N1970; 7: N1974; 8: N1978; 9: N1985; 10: N1992, 11: N1998, 12: N2004; 13: 
N2006; 14: N2012; 15: N2014; 16: N2015, 17:N2017; 18:N2022; 19: A ST7 reference; 20: X reference 
 
Discussion 
 
It has been suggested, that meningococcal epidemics are initiated by contact of a 
population with a particularly fit genotype which is transmitted efficiently (Zhu et al. 2001). 
After a few years the descendants of such fit strains seem to disappear from individual 
areas (Morelli et al. 1997;Achtman 1997). They may, though, cause further epidemics or 
pandemics by successful competition with other lineages for transmission to other 
geographical areas. Clonal expansion is accompanied by genetic microevolution. 
Sequential evolutionary bottlenecks have been made responsible for the apparent paradox 
between the occurrence of extensive recombination in meningococcal populations and the 
clonal uniformity observed in epidemic lineages (Achtman 2004).  
 
We have observed waves of colonization and disease by meningococcal genoclouds in 
the KND of northern Ghana (Chapter 5). While constant microevolution was detected in all 
dominating lineages, patterns of diversification were not uniform. For example,  initial 
cases of the serogroup A ST7 meningococci in the district were caused by a particular 
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PFGE variant, but a closely related type soon spread more successfully and dominated 
during the subsequent four years among case and carrier isolates. Further variants 
appeared anecdotally. In contrast, serogroup X meningococci emerged in the district in 
three phylogenetic clusters which in the following showed different patterns of 
dissemination and diversification (Gagneux et al. 2002b). Both, the X ST751 and the A 
ST7 genoclouds completely disappeared from the district after 3-4 years of extensive 
spread (Chapter 5). 
 
Contact of a population with a new virulent genotype is not always followed by extensive 
transmission and outbreaks of invasive disease. Although we detected in the KND a low 
level of colonization with W135 bacteria with PFGE patterns identical to that of the 
Burkinian epidemic clone and found a high W135 colonisation rate in a Ghanaian W135 
meningitis patient community, Ghana was not hit by a major wave of W135 colonization 
and disease. This indicates that not only bacterial factors, but also host and environmental 
factors contribute to transmission and epidemic potential of individual genoclouds. The 
same is suggested by our findings with Y meningococci. Over the years these have been 
isolated in the KND at a low frequency in 10 of the altogether 16 carriage surveys. While 
the Y genocloud was successful and persistent in one particular compound, it exhibited 
only a low transmission efficacy in the general population.  
 
It has been suggested that towards the end of epidemics the frequency of variants 
increases and that these strains represent escape variants from herd immunity (Achtman 
2004). Diversification found in our study in the PFGE patterns of A ST5, X ST751 and NG 
ST192 isolates towards the end of their spread support this assumption. Also during W135 
spread in a patient community we observed clonal diversification and replacement of the 
original variant within one year (Chapter 4). Changes in PFGE patterns are indicators of 
genomic diversification, but cannot directly be associated with structural and functional 
variation. However, in the near future high throughput DNA sequencing methods will allow 
comparing the genomes of large numbers of bacterial isolates. This will make it possible to 
assess whether herd immunity is in fact leading to the selection of escape variants that 
carry mutations in crucial antigens, such as outer membrane proteins. Identification of the 
proteins that are diversifying and thus are likely to represent targets for protective immune 
responses will have major implications for the selection of candidate antigens for 
multivalent protein-based vaccines.  
 Chapter 6. Genetic diversification of Neisseria meningitidis 87 
 
New genotypes are often lost during spread of genoclouds to other areas and may thus 
have a lower transmission efficacy in a naive host population than their parental 
genotypes. On the other hand, occasionally variants arise, which are efficiently transmitted 
and develop into the dominating genotype of new genoclouds. Differences in the 
dominating variants between countries imply that bottle necks exist in the dissemination, 
even during epidemic periods with high carriage rates. It is not understood, why 
serogroups, such as X and W135 which were for a long time considered as having a low 
pathogenicity start to cause epidemics (Taha et al. 2000;Decosas & Koama 2002;Boisier 
et al. 2007). It is expected that population genomic analyses will reveal in future how 
mutations, genetic exchange and selection shape the evolution of new N. meningitidis 
lineages. This may help to understand the genetic basis for the emergence of new 
lineages with epidemic potential (Shao et al. 2006), which is crucially important for the 
development of a successful long-term global vaccination strategy against meningococcal 
disease. 
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Abstract 
Serotype 1 pnenumococci are only rarely isolated from healthy carriers, but have been 
implicated in meningitis outbreaks. Based on Multi-Locus Sequence Typing (MLST) data 
they have been subdivided into three lineages, with each strain sharing not less than four 
of seven alleles with at least one other isolate of the same lineage. The three lineages 
(designated A, B and C) have distinct geographic distribution patterns with the majority of 
lineage B isolates originating from Africa. In our Pulsed Field Gel Electrophoresis (PFGE) 
analysis of serotype 1 isolates, strains belonging to the same lineage had closely related, 
but not identical PFGE patterns. These data reconfirmed MLST-based assignment of 
isolates to the three lineages and provided further evidence for recombinational 
diversification. Sequence analysis of the gene encoding the pneumococcal surface protein 
A revealed a surprisingly high intra-lineage conservation of this hypervariable vaccine 
candidate antigen. All 15 isolates belonging to the hypervirulent lineage B and the majority 
of lineage C isolates analysed shared a unique pspA allele, which has not been described 
in other serotypes. These findings have major implications for protein-based vaccine 
development against hypervirulent groups of pneumococci, such as the lineage B of 
serotype 1. 
 
Introduction 
Streptococcus pneumoniae is one of the most important opportunistic pathogens 
worldwide. Ranging from mild respiratory tract infections to invasive disease such as 
sepsis and meningitis it is responsible for estimated 700.000 to 1 million deaths per year 
(www.who.int). While invasive disease is usually a rare event, symptomless colonization 
with S. pneumoniae is common especially in infants with colonization rates of nearly 100% 
at 1 year of age (Crook et al. 2004). DNA-recombination within the pneumococcal 
population is frequent and the strains isolated from patients and carriers usually exhibit a 
broad genetic variability (Feil, Smith, Enright, & Spratt 2000;Jefferies, Smith, Clarke, 
Dowson, & Mitchell 2004). Over 90 different serotypes determined by the chemical 
structure of the polysaccharide capsule are known, but at any place and time only a limited 
number of serotypes are responsible for the majority of invasive infections. The 
composition of the dominating invasive serotypes varies from place to place and with time 
(Hausdorff, Bryant, Paradiso, & Siber 2000). The relevance of the capsular type in 
comparison to non-capsular factors for the virulence of pneumococcal genotypes is 
currently incompletely understood. While certain serotypes are genetically highly diverse 
and not a single genotype can be assigned responsible for the majority of invasive 
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infections (Spratt, Hanage, & Brueggemann 2004), in other serotypes only one or two 
lineages are frequently isolated from patients in different countries (Brueggemann, 
Griffiths, Meats, Peto, Crook, & Spratt 2003).  
 
Pneumococcal surface protein A (PspA) is regarded as one of the major virulence factors 
of S. pneumoniae, that is present in virtually all pneumococcal isolates (Crain et al. 1990). 
The pspA gene is highly variable (Hollingshead et al. 2000) and has a mosaic structure 
consisting of five domains, a signal peptide, an alpha-helical domain, a proline-rich region, 
a choline binding domain and a C-terminal tail. The most variable part is the N-terminal 
alpha-helical domain, which is exposed to the host immune system. Hollingshead et al. 
proposed a classification for PspA based on the sequence divergence of a stretch located 
just before the proline rich region, designated the clade-defining region (CDR). The 
classification divides PspA into three families, which can be subdivided into 6 clades 
(Hollingshead, Becker, & Briles 2000). In spite of its high sequence variability, 
considerable cross-reactivity among PspA molecules has been demonstrated. PspA is 
therefore evaluated as potential vaccine candidate for a protein based anti-pneumococcal 
vaccine (Virolainen et al. 2000;Nabors et al. 2000;Briles et al. 2000). 
 
In addition to the classical typing of bacteria with serological and biochemical techniques, 
a range of molecular typing methods have been developed to examine the population 
structure and evolution of microbial pathogens in detail. Multi-Locus Sequence Typing 
(MLST), developed in 1998 for Neisseria meningitidis has since then been extended to a 
broad variety of pathogens (http://mlst.net). It is based on the sequence variability in 
house-keeping genes that are thought to accumulate changes slowly and selectively 
neutral. Analysing the variability of seven alleles, this method gives a good resolution for 
global molecular epidemiology (Enright & Spratt 1998;Feil, Smith, Enright, & Spratt 2000). 
Pulsed Field Gel Electrophoresis (PFGE) is based on electrophoretic separation of 
fragments of genomic bacterial DNA generated by digestion with rare cutting restriction 
enzymes, yielding strain specific band patterns. PFGE usually exhibits a high 
discriminatory power and  can be used for short-term epidemiological questions such as 
the investigation of outbreaks (Porat, Trefler, & Dagan 2001;Decousser et al. 2004;Givon-
Lavi et al. 2002) . 
 
Pneumococcal serotypes vary substantially in the ratio of the frequency of isolation from 
invasive disease and from nasopharyngeal carriage (Smith et al. 1993b;Brueggemann, 
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Peto, Crook, Butler, Kristinsson, & Spratt 2004). Serotype 1 lineages have been found 
responsible for outbreaks in several communities (Porat, Trefler, & Dagan 
2001;Henriques, Kalin, Ortqvist, Akerlund, Liljequist, Hedlund, Svenson, Zhou, Spratt, 
Normark, & Kallenius 2001). In contrast, it is usually only rarely isolated from healthy 
carriers, suggesting a high virulence (Smith, Lehmann, Montgomery, Gratten, Riley, & 
Alpers 1993b;Lloyd-Evans, O'Dempsey, Baldeh, Secka, Demba, Todd, McArdle, Banya, & 
Greenwood 1996;Syrogiannopoulos et al. 2002;Brueggemann, Peto, Crook, Butler, 
Kristinsson, & Spratt 2004). However, it is not clear, whether all serotype 1 lineages exhibit 
the same degree of virulence (Musher 2006), since some reports indicate that serotype 1 
strains cause only low-level bacteraemia and are associated with a lower mortality than 
other serotypes (Sandgren et al. 2005). A global MLST analysis identified a limited number 
of serotype 1 associated sequence types (STs) and defined three genetic lineages. Within 
these, each strain shared at least four of seven MLST alleles with at least one other 
member of the lineage. Lineage B and C isolates were to a certain degree related, as most 
of them had three alleles (aroE 10, gki 4, recP 1) in common. In contrast, most lineage A 
strains did not share a single allele with lineage B strains and only one allele with lineage 
C strains, respectively (Brueggemann & Spratt 2003). The three lineages exhibited a 
distinct geographic distribution pattern. Lineage A was only isolated in Europe and 
Northern America, whereas the majority of the lineage B isolates originated from Africa 
(Brueggemann & Spratt 2003). 
 
Between 1998 and 2003 we observed a pneumococcal meningitis outbreak in Northern 
Ghana, where the majority of the cases were caused by serotype 1 pneumococci. MLST 
analysis revealed a clonal relationship of these strains, all of them belonging to  the ST217 
clonal complex belonging to lineage B (Chapter 3). Here we describe the clonal 
relationship between various serotype 1 strains based on MLST, PFGE and pspA gene 
sequence analysis. The outbreak strains of Northern Ghana were compared to 
representatives of all three serotype 1 pneumococcal lineages (Brueggemann & Spratt 
2003).  
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Materials and Methods 
Bacterial Isolates 
63 serotype 1 pneumococcal strains were isolated from CSF of meningitis patients in the 
context of a long-term study on bacterial meningitis in the Kassena Nankana District (KND) 
in Northern Ghana between 1998 and 2005. Additional strains from CSF were obtained 
from the Bolgatanga Regional Hospital in the Upper East Region (n=10) and from health 
facilities in the Bongo (n=1) and Builsa Districts (n=1). Furthermore four serotype 1 
pneumococcal isolates isolated in 2005 during a pilot study on bacterial meningitis in the 
Nouna Health District in Burkina Faso were examined. The bacteria have been identified 
and isolated from CSF of suspected meningitis patients using standard microbiological 
methods (Chapter 3). Serotyping has been performed with the Quellung Reaction using 
serotype specific antisera from the Statens Serum Institute in Kopenhagen. According to 
the lineage definition of serotype 1 pneumococcal isolates by Brueggemann et al., all 
Ghanaian and Burkinian serotype 1 isolates belonged to lineage B (Brueggemann & Spratt 
2003). Reference isolates from the other lineages A (n= 6) and C (n= 4) were obtained 
from A. Brueggemann, Oxford.  
 
Multilocus Sequence Typing (MLST) 
Bacteria were grown overnight in Todd-Hewitt medium. DNA extraction, MLST, and direct 
sequencing of polymerase chain reaction products by use of an ABI Prism 310 genetic 
analysis system was performed in accordance with standard protocols. Allelic profiles were 
analyzed by use of applications on the MLST home page (available at: 
http://spneumoniae.mlst.net/). For analysis of the relationships between closely related 
isolates, eBURST software (available at: http://eburst.mlst.net/) with the  most stringent 
group definition (6/7 alleles identical) was used. All allelic profiles obtained were compared 
with the complete listing of the sequence types (STs) available in the database. The 
diversity of STs within the lineages was assessed using the E-Burst Software with respect 
to the current state of the database. 
 
Pulsed Field Gel Electrophoresis (PFGE) 
All serotype 1 isolates have been analysed by PFGE, after modifying a protocol which 
was previously described (McEllistrem et al. 2000). Briefly, bacteria were grown overnight 
on Colombia Agar containing 5% sheep blood, in the log phase, they were harvested and 
inoculated into 5ml sterile PBS and adjusted to a density of ~5McF.The cells were 
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centrifuged for 10min, washed and centrifuged again. The pellet was suspended in 1.5% 
agarose blocs (1ml) and poured into the moulds for solidification. DNA lysis was performed 
first in 2.5ml Lysisbuffer (0.1M EDTA pH=8; 1M Nacl; 6mM Tris HCl pH8; 0.5% Brij 58, 
0.5% N-lauryl-sarcosine, 0.5% Sodiumdeoxycholate; supplemented with 50ug/ml RNAase 
and 5mg/ml Lysozyme) overnight at 37°C, after this in 2.5ml ESP Buffer (0.5M EDTA, 
pH=8, 1% N-lauryl-sarcosine, 0.1% Proteinase K) overnight at 50°C. The blocs were 
stored at 4-8°C in TE Buffer (10mM Tris HCl;1mM  EDTA). The digest was performed with 15U 
SmaI at 25°C overnight.   
 
PspA sequencing 
Selected strains from the Ghanaian serotype 1 pneumococcal meningitis outbreak and 
the pilot study in Burkina Faso were compared with the lineage A and C reference strains 
isolated worldwide (Brueggemann & Spratt 2003). 
A 1000bp long stretch of the variable region of the PspA gene was sequenced following a 
modified protocol of Hollingshead et al. (Hollingshead, Becker, & Briles 2000). Briefly, a 
1200 bp long product was obtained by PCR with the primers SKH2 5’ 
CCACATACCGTTTTCTTGTTTCCAGCC3’ and a modified LSM12 primer LSM12* 5’ 
CCAGCGTCGCTATCTTAGGGGCTGGTT3’ using standard conditions with the annealing 
temperature of 62.5°C. PCR products were purified by PEG precipitation. The 1000bp 
piece was sequenced by use of the ABI Prism 310 genetic analysis system and alignment 
of DNA and protein sequence was performed using the online available ClustalW software  
(http://www.ebi.ac.uk/clustalw/).  
 
Results:  
PFGE analysis reconfirms the MLST-based distinction between three serotype 1 lineages 
Currently serotype 1 strain data submitted to the MLST database comprise 49 STs which 
belong to 6 clonal complexes within the three lineages (Table 1). Three singletons can not 
be assigned to a lineage. Lineage B now consists of the ST217 clonal complex with 17 
STs and one singleton (ST302). Lineage C comprises three clonal complexes (ST615, 
ST1031, ST300) with each 2-3 STs. Overall within each Lineage B and C all STs share at 
least 5/7 alleles with one other ST of the respective lineage. The average distances of the 
STs within lineage B calculated by E-Burst analysis range from 1.64 to 4.0, for lineage C 
from 1.83 to 2.66. Lineage A reveals higher diversity by E-Burst analysis consisting of two 
clonal complexes (ST306 and ST305 clonal complex) and one singleton (ST1247) whith 
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only four common alleles. The average distance of STs within lineage C ranges from 2.05-
4.3 
  
Serotype 1 strains of the same lineage  exhibited closely related PFGE patterns of SmaI 
digested DNA (Figure 7.1). As expected from the sharing of multiple MLST alleles, PFGE 
patterns of lineage B (Figure 7.1, track 12-20) and lineage C (Fig. 1, track 8-11) isolates 
had more (up to 8/12) bands in common, than lineage A (Figure 7.1, track 1-7) with B or C 
isolates. Furthermore, it could be confirmed, that lineage A isolates exhibited a higher 
degree of intra-lineage diversity of PFGE patterns than lineages B and C.  In accordance 
with the E-Burst results, the six lineage A strains analysed here by PFGE could be 
assigned to the two clonal complexes. Representatives of the ST305 clonal complex  (a 
ST304 and a ST305 isolate)  differed by only two bands in PFGE (Figure 7.1, track 2, 3). 
Four representatives of the ST306 clonal complex had closely related PFGE patterns, 
which differed markedly (in up to seven bands) from those of the ST305 clonal complex.  
 
Table 7.1 MLST diversity of the serotype 1 lineages. Current available serotype 1 strain data submitted 
to the MLST database has been analysed by E-Burst, clonal complexes have been assigned and the 
average genetic distances of STs within each lineage was assesed 
MLST and E-burst Data PFGE Analysis 
Lineage 
Clonal complex 
/Singletons 
No. of ST 
average distances of STs 
(range within lineage) 
No of 
strains 
No of STs 
A ST306 15 4 4 
 ST305 5 2 2 
 ST1247 singleton 
2.05-4.3 
  
      
B ST217 17 73 11 
 ST302 singleton 
1.6-4.0 
  
      
C ST615 3 3 3 
 ST300 2 1 1 
 ST301 2 
1.83-2.66 
  
not assigned ST870 singleton    
 ST2210 singleton    
 ST150 singleton    
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Figure 7.1 PFGE profiles of serotype 1 isolates from all three different lineages. DNA was digested 
with SmaI. Indicated on top of the lanes are the lineages of the respective strains. (Lane: strain-No., ST,)  
1: MW Marker, 2: sl_4, ST304, 3:sl_30, ST305, 4: sl_2, ST227, 5: sl_11, ST228, 6: sl_3, ST306, 7: sl_38, 
ST617, 8: sl_71, ST611, 9:sl_102, ST616, 10: INV1871, ST300, 11: NCTC7465, ST615, 12: P1010, ST303, 
13: P1012, ST303, 14: P1004, ST217, 15:P1031, ST217, 16: P1026, ST612, 17: P1052, ST612, 18:  P1100, 
ST618, 19: P1032, ST303, 20: P1007, ST217 
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ST612
303(n=43)
217(n=15)
612(n=9)
618(n=2)
1331(n=2)
1325(n=2)
1316
1328
1327
1322
1323
pattern A
pattern B
pattern C
pattern D
pattern E
 
Figure 7.2 Modified E-Burst diagram and Pulsed Field-Gel Electrophoresis types of the ghanaian 
serotype 1 strains belonging to lineage B. The Pulsed Field Patterns are given by A-E, indicated in 
parenthesis is the number of strains found with the respective patterns, if more than one strain was isolated. 
 
Genetic diversity of  serotype 1 isolates belonging to lineage B 
Based on MLST analysis, all 73 Ghanaian and Burkinian isolates analysed could be 
assigned to one clonal complex (Figure 7.2) with three dominating STs (ST217, ST303 
and ST612). All remaining STs were only sporadically isolated (chapter 3). To date, the 
global collection of serotype 1, lineage B strains comprises in total 18 different allelic 
profiles (Table 7.1); eleven of these were represented in the strain collection from Northern 
Ghana and Burkina Faso. The close relationship between all lineage B isolates was also 
reflected by similarity of their PFGE patterns. Five closely related major patterns 
(designated 1A-1E) were identified (Figure 7.1). Pattern 1A (Figure 7.1, lanes 12-15) 
dominated and was found in association with seven of the 11 STs (ST217, ST303, ST612, 
ST1316, ST1323, ST1325, ST1331) in 56 of the 78 isolates included in the analysis 
(Figure 7.2). 11 strains (associated with four different STs; Figure 7.2) showed pattern 1B 
(Figure 7.1, lanes 16, 17). While no strong general association between PFGE patterns 
and STs was observed, eight of the nine ST612 strains and two strains that were single-
locus variants (ST303 and ST1327) of ST612 showed pattern B. On the other hand, the 
six isolates with PFGE pattern 1C were associated with four different STs and the groups 
of ST303 and ST217 isolates were associated each with four different PFGE patterns. 
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Intra-lineage conservation of the pspA gene sequence 
Sequence analysis of the pspA gene revealed a high degree of intra-lineage sequence 
identity. All 15 lineage B isolates analysed had an identical pspA gene sequence, 
representing an allele (designated BC) of this hypervariable protein, that has not been 
described previously (Figure2). While three of the four lineage C isolates shared this allele 
with the lineage B strains, the fourth lineage C strain, isolated in 1948, had a different 
allele (designated A), also found in five of the six lineage A isolates analysed. One lineage 
A strain had a third allele (designated A*) (Table 2). Following the clade definition of 
Hollingeshead 
 
 
1031_seqBC_      PTVVRAEEAPVASQSKAEKDYDAAKR-------DAENAKKALEEAKRAQKKYEDDQKKTE 53 
1186_seqA_       PTFVRAEEAPVASQSKAEKDYDAAVK-------KYEAAKKEYEDGKAAQKKYEDDQKKTE 53 
1188_seqA*_      PTVVRAEEAPVASQSKAEKDYDAAMKKSEAAKKDYEEAKKALEEAKAAQKKYDEDQKKTE 60 
                 **.********************* :       . * ***  *:.* *****::****** 
 
1031_seqBC_      EKAKKEKEASKEEQAANLKYQQELVKYAS---EKDSVKKAKILKEVEEAEKEHKKKRAEF 110 
1186_seqA_       EKAEEERKASEEEQAANLKYQQELVKYIR---ENDPTKKAEAKKAMDEAEKEYKKKQTEF 110 
1188_seqA*_      AKAEEEKKASEAEQAANLKYQQELVKYIEYTRGKDSTKKAKAEKAMAEAEKNYKEKQAEF 120 
                  **::*::**: ***************      :*..***:  * : ****::*:*::** 
 
1031_SeqBC_      EKVRSEVIPSAEELKKTRQKAEEAKAKEAELIKKV-------EEAEKKVTEAKQKLDAER 163 
1186_SeqA_       AEVRAKVIPSAEELKKTRQKAEEAKAKEAELTKKV-------EEAEKKVTEAKQKVDAEH 163 
1188_SeqA*_      AKVRAKVIPSAEELEETRQKAKEAKEKEPELTKKVAEAKAKLEEAEKKATEAKQKVDAE- 179 
                  :**::********::*****:*** **.** ***       ******.******:***  
 
1031_SeqBC_      AKEVALQAKIAELENEVYRLETELKGIDESDSEDYVKEGLRAPLQSELDAKRTKLSTLEE 223 
1186_SeqA_       AEEVAPQAKIAELEHEVQKLEKALKEIDESDSEDYVKEGLRAPLQFELDVKQAKLSKLEE 223 
1188_SeqA*_      --EVAPQAKIAELENQVHKLEQKLKEIDESDSEDYVKEGFRAPLQSELDAKQAKLSKLEE 237 
                   *** ********::* :**  ** *************:***** ***.*::***.*** 
 
1031_SeqBC_      LSDKIDELDAEIAKLEKNVEYFKKTDAEQTEQYLAAAEKDLADKKAELEKTEADLKKAVN 283 
1186_SeqA_       LSDKIDELDAEIAKLEKDVEDFKNSDGEQAGQYLAAAEEDLVAKKAELEKTEADLKKAVN 283 
1188_SeqA*_      LSDKIDELDAEIAKLKKDVEDFKNSNGEYSALYLEAAEKDLAAKKAELEKTEADLKKAVN 297 
                 ***************:*:** **:::.* :  ** ***:**. ***************** 
 
1031_SeqBC_      EPEKPAEETPAPAPKPEQPAEQPKPAPAPQP----------APAPKPEKTDDQQAEEDYA 333 
1186_SeqA_       EPEKPAEETPAPAPKPEQPAEQPKPAPAPQPEKPAEEPENPAPAPQPEKSADQQAEEDYA 343 
1188_SeqA*_      EPEKPAPAPETPAP--EAPAPAPKPAPAPQP-APAPKPEKPAEQPKPEKPADQQAEEDYA 354 
                 ******  . :***  * **  *********          *  *:***. ********* 
 
1031_SeqBC_      RRSEEEYNRLPQQQPPKAEKP--- 354 
1186_SeqA_       RRSEEEY-IAPNSNRQKQKNQ--- 363 
1188_SeqA*_      RRSEEEYNRLTQQQPAPAPKPEQP 378 
                 *******   .:.:     :     
____________________________ 
Figure 7.3 Clustal alignment of  the three representative protein sequences of PspA. A summary of 
the sequencing results in comparison with the other typing methods is presented in table 2. SeqBC and 
SeqA share 78% sequence identity, SeqBC and SeqA* as well as SeqA and SeqA* share 74% identity. 
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Table 7.2 Geographic origin and characteristics of strains representing three serotype 1 lineages. 
ST No of strains Lineage PFGE-type PspA allele  origin 
306 1 A  SeqA USA 2001 
617 1 A  SeqA Norway 2001 
228 1 A  SeqA Spain 2001 
227 1 A  SeqA USA 2000 
304 1 A  SeqA USA 2001 
305 1 A  SeqA* Denmark 2000 
303 6 B 1A ,1E SeqBC Ghana  
217 2 B 1A SeqBC Ghana  
612 4 B 1A ,1B SeqBC Ghana  
618 1 B 1C SeqBC Ghana 
1322 1 B 1D SeqBC Ghana 
1325 1 B 1A SeqBC Ghana 
1331 1 B 1C SeqBC Ghana 
615 1 C  SeqA USA 1948 
611 1 C  SeqBC South Africa 2001 
616 1 C  SeqBC Poland 1995 
300 1 C  SeqBC UK 2001 
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Discussion 
Using three different genetic features, the sequence diversity of seven house-keeping 
genes, sequence analysis of the hyper-variable surface protein PspA and a fingerprint of 
genomic DNA digested by a rare cutting restriction enzyme, we compared the intra- and 
inter-lineage diversity of serotype 1 pneumococcal isolates. While MLST is commonly 
used for global and long-term epidemiological analysis (Maiden, Bygraves, Feil, Morelli, 
Russell, Urwin, Zhang, Zhou, Zurth, Caugant, Feavers, Achtman, & Spratt 1998;Enright & 
Spratt 1998),  PFGE is often more useful for local or short-term epidemiological 
investigations, such as the analysis of the stability of emerging clones in the course of an 
outbreak (Porat, Trefler, & Dagan 2001). Our PFGE analysis supported MLST data-based 
sub-division of serotype 1 isolates into three major lineages and distinction of two 
subgroups of lineage A isolates. All three types of genetic analysis indicated that serotype 
1 lineages B and C are more closely related to each other than to lineage A. However, the 
finding, that a lineage C strain isolated in 1948 (Table 7.2) had the PspA allele dominating 
in the lineage A isolates, suggests a common ancestor of all three serotype 1 lineages.  
 
In an analysis of a large collection of recent lineage B isolates from Ghana and Burkina 
Faso both MLST and PFGE demonstrated substantial diversification. According to MLST, 
all isolates, covering overall 11 STs, belonged to the same clonal complex, where each 
member was sharing six of seven alleles with at least one other member of the complex. 
Five major PFGE patterns within this complex could be distinguished by PFGE analysis 
with one restriction enzyme. Individual STs were associated with a range of PFGE 
patterns and vice versa. Only PFGE pattern B was associated with a particular ST 
(ST612). Interestingly also in other African settings such as in Burkina Faso and the 
Gambia (unpublished results), closely related serotype 1 lineage B strains have been 
isolated, and the latest STs, which have been added to the ST217 clonal were found in 
Niger, Burkina Faso and Egypt (http://mlst.net), indicating that this hypervirulent clonal 
complex is widely distributed. It is not known, since when pneumococci belonging to this 
lineage circulate in Africa. Meningococcal genoclouds responsible for meningitis outbreaks 
and epidemics are known to persist only transiently and disappear completely from 
respective geographical regions after three to four years (Achtman 2004). However, it is 
not known whether the same applies for pneumococcal genoclouds with epidemic 
potential. Even though incidence rates of pneumococcal meningitis have declined after 
three years of outbreak in the KND, cases caused by serotype 1 lineage B pneumococci 
continued to occur. In this light, it will be important to further examine the virulence 
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potential and immunological properties of this pneumococcal lineage, to evaluate its 
capability to cause epidemic meningitis in African countries especially in view of the 
introduction of meningococcal conjugate vaccines and potential strain replacements. 
 
The cell wall bound protein PspA is exposed to the immune system of the host and has 
been shown to be highly immunogenic. It exhibits high sequence variability and is thought 
to be under much stronger selection pressure (Hollingshead, Becker, & Briles 2000) than 
the presumably neutral allelic variation in the house keeping genes analysed by MLST. 
Surprisingly, intra-lineage variation of PspA was much lower than allelic diversity of the 
housekeeping genes. It is assumed that a single nucleotide site in a meningococcal 
housekeeping gene is about 50-fold more likely to change as a result of recombination 
than as a result of mutation. It has been suggested that due to their very low carriage rate, 
serotype 1 pneumococci are less likely to exchange genetic material with other 
pneumococcal strains than other pneumococci (Porat, Trefler, & Dagan 2001). However, 
both MLST and PFGE results are indicative for substantial recombinational diversification 
of serotype 1 lineage B pneumococci. Therefore other factors are likely to be responsible 
for the high conservation of the PspA gene. The unexpected lack of diversification of the 
PspA protein in the clonal complex may have major implications for the design of a 
protein-based vaccine against emerging hypervirulent lineages. 
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General Discussion and Conclusions 
 
This thesis focussed on the dynamics of bacterial meningitis during a long-term study in 
the KND of Nothern Ghana. Characteristics of colonisation and disease were adressed 
and the population of the carrier- and patient-isolates were put in relationship to each 
other. Furthermore we examined the impact of emerging clones (e.g. W135) and other 
bacterial species causing acute bacterial meningitis in Northern Ghana. In addition to the 
detailed discussion in the seperate chapters of this thesis, the results of the study are 
discussed here in a broader context with respect to immunological and evolutionary 
aspects and in view of strategies for future research and an improved management of 
bacterial meningtis epidemics. 
 
Recent epidemiological trends in the African Meningitis Belt  
During the last 15-20 years a series of major epidemics and smaller outbreaks of 
meningococcal meningitis have occured within various regions of Sub-Saharan Africa. 
Numerous reports documented the emergence and spread of three major pathogenic 
meningococcal genoclouds in the African Meningitis Belt (Fekade & Zawde 1992;Salih et 
al. 1990;Haimanot et al. 1990;Guibourdenche et al. 1996;Niel et al. 1997;Riou et al. 
1996;Lengeler et al. 1995;Mohammed et al. 2000;Aplogan et al. 1997;Hodgson et al. 
2002;Gagneux et al. 2000;Nicolas et al. 2000;Jacobsson et al. 2003;Sow et al. 
2000;Mengistu et al. 2003;Nicolas et al. 2001;Nicolas et al. 2005;Fonkoua et al. 
2002;Decosas & Koama 2002;Boisier et al. 2005). The first two genoclouds were 
serogroup A subgroup III bacteria, associated with ST5 and ST7. These originated in Asia, 
invading Africa as result of pandemic spread (Zhu et al 2001). ST5 bacteria were recorded 
in Africa from 1988 until 2001, causing fulminant epidemics, peaking with more than 
150’000 cases counted throughout the Meningits Belt in 1996 (Tikhomirov et al. 1997). 
From  1995 onwards, ST7 meningococci started causing disease outbreaks, whereby in 
some countries an overlap of the ST5 and ST7 waves was recorded. (Nicolas et al. 
2001;Nicolas et al 2005). Finally, since 2001 the ST5 genocloud had completely 
disappeared, while ST5 meningococci continue to cause outbreaks. In Northern Ghana a 
major epidemic in 1996/97 caused overall more than 18’000 meningitis cases and 1’352 
cases in the KND. During a post-epidemic outbreak in the KND in 1998, 50 serogroup A 
cases were recorded, ST5 was reconfirmed by culture in all 36 isolates. No serogroup A 
ST5 cases were recorded after 1998. The ST7 wave reached Northern Ghana in 2001 and 
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caused subsequent outbreaks between 2002 and 2004 with incidence rates of  up to 
80/100’000 in the KND. 
 
With W135 ST-11 meningococci, belonging to the ET-37 complex, a third clone within a 
short period of time, caused various outbreaks in Africa. Even though isolated sporadically 
in Africa since decades, only after a first epidemic in Mecca 2000 W135 ST11 bacteria had 
a major impact on meningococcal meningitis incidence in the African Meningitis Belt. 
Between 2001 and 2004 they contributed substantially to major epidemics in Burkina Faso 
and Niger (Boisier et al. 2005;Parent et al. 2005;Taha et al. 2002), usually in mixed 
outbreaks with serogroup A ST7. Furthermore, limited outbreaks or case clusters were 
reported from Chad, Senegal, Cameroon, Benin (Nicolas et al. 2005), Sudan and Kenya, 
(http://www.who.int/csr/don/archive/year/en/). In spite of its vicinity to Burkina Faso, no 
major W135 outbreak occured in Ghana. Between March 2003 and March 2004, four 
W135 ST11 cases were reported throughout the country probably only identified as a 
result of intensive surveillance activities. The bacterial isolates were undistinguishable 
from epidemic strains from Burkina Faso by Pulsed Field Gel Electrophoresis.  
 
Serogroup X meningococci were responsible for a clonal wave of carriage up to 20% and 
altogether 15 cases of meningitis in the KND between 1998 and 2003. They have been 
responsible for substantial meningitis outbreaks in Niger between 1995 and 2000 (Djibo et 
al. 2003). Reports on further outbreaks in 2006 (M.Laforce, personal communication) may 
indicate that virulence and epidemic potential of this genocloud is also increasing. 
 
Finally, since 2003 the WHO meningococcal reference centre in Ouagadougou recorded 
that meningococcal outbreaks declined throughout the African Meningitis Belt (WHO 
2005). However, a major outbreak in Burkina Faso in 2006 is currently being investigated. 
Even though, the outbreaks of the last two decades have been analysed in detail and 
epidemiological and immunological features have been characterized, there is still a lack 
of understanding on the spread and dissappearance and on the distinct patterns of 
dispersal of the various meningococcal genoclouds within various regions of the Meningitis 
Belt. 
 
Recently, an elevated importance of pneumococcal meningitis has been recorded in non-
epidemic periods (Parent et al. 2005;Gordon et al. 2000). Little data is available on the 
serotype distribution from many regions of the Meningitis Belt. However, in selected areas 
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serotype 1 (Parent et al. 2005) or serotype 5 (Campbell et al. 2004) have been associated 
with the majority of invasive pneumococcal cases. Between 2000 and 2003 also in 
Northern Ghana an outbreak of pneumococcal meningitis occured. More than 70% of the 
isolates from KND and representative isolates from neighbouring districts belonged to 
serotype 1. The outbreak showed features characteristic of meningococcal meningitis such 
as clonality, seasonality and a broad age spectrum. It has therefore raised some concern 
about the epidemic potential of S. pneumoniae. Since 2004, the incidence of 
pneumococcal meningitis has declined in the KND. 
  
Also, Haemophilus influenzae remains an important causative agent for meningitis in 
children in countries, where the Hib conjugate vaccine has not been implemented yet. In 
Mali, yearly incidence rates of over 150/100’000, in Burkina Faso of 97/100’000  in children 
under 1 years of age have been reported recently (Sow et al. 2005;Yaro et al. 2006). 
Overall it has been estimated to be 40-60/100’000 cases in the under 5 year old children 
(WHOWHO 2003). Ghana is one of the very few African countries where the Hib conjugate 
vaccine has been implemented in the routine immunization scheme since the year 2000 
(personal communication). As a results, in the KND Hib meningitis has virtually 
dissappeared in the past years and we have only recorded isolated cases.  
 
Natural Immunity and the Dynamics of Colonisation and Disease 
Protective immunity to pneumococcal (Snapper C M et al. 2004), meningococcal 
(Goldschneider et al. 1969) or Hib meningitis (Kelly et al. 2004) depends primarily on 
bactericidal and/or opzonizing antibodies. These may be elicited by nasopharyngeal 
colonisation with these bacteria (Goldblatt et al. 2005) or due to contact with species 
sharing cross reacting antigens. In the development of natural immunity to meningococci 
related colonizers of the human nasopharynx such as N. lactamica and M. catarrhalis may 
be involved (Braun et al. 2004;Troncoso et al. 2000). Cross-reactions have also been 
observed between pneumococcal polysaccharides and polysaccharides of Klebsiella 
species and non-groupable streptococci (Lee & Koizumi 1981;Lee et al. 1984).  
 
Production of anti-pneumococcal antibodies has been shown to begin as early as 6 
months of age and increased markedly in the age between 12 and 18 months, coinciding 
with the age of highest pneumococcal carriage rates and acute otitis media (Soininen et al. 
2001). Even though meningococcal colonisation usually peaks in older children and 
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adolescents, young children are frequently colonized by N. lactamica that could lead to an 
early development of anti-meningococcal antibodies (Gold et al. 1978). Immunity is usually 
capsular group specific, but also antibodies against protein antigens may be relevant. Cell 
surface exposed proteins are currently investigated as candidate antigens for non-
serogroup/serotype specific vaccines for N. meningitidis and S. pneumoniae.  
Responses of the mucosal immune system to colonisation leading to the formulation and 
secretion of IgA may have relevance in the development of natural immunity (Simell et al. 
2002). Whereas local anticapsular IgA secretion has been reported in infants in response 
to pneumococcal colonisation and vaccination, salivary IgG has only infrequently been 
detected in this age group in contrast to older age groups (Simell, Kilpi, & Kayhty 
2002;Nieminen et al. 1999). Salivary IgG is thought mainly to be derived from serum, but it 
may also be produced locally (Zhang et al. 2002). The contribution of secretory IgA versus 
IgG in the prevention of colonisation or disease is unclear. Studies with toddlers that have 
been vaccinated with 9-valent pneumococcal conjugate vaccine showed an inverse 
correlation between acquisition of new S. pneumoniae strains and serotype -specific anti-
PS serum IgG (Dagan & Lipsitch 2004). Meningococcal PS vaccines induce mucosal IgA 
and IgG antibodies in adolescents. Whereas the titers of salivary IgA induced by pure 
group A/C- PS-vaccine and group C conjugate vaccine were comparable, salivary IgG 
titers were significantly higher after the conjugate vaccine (Zhang et al. 2000). This 
indicates, that IgA might not be the primary determinant in the protection against  
colonisation as it is seen after immunization with conjugate vaccines.  
It has been repeatedly shown, that the immunogenicity of pneumococcal serotypes 
varies. This has been seen in response to colonisation (Soininen, Pursiainen, Kilpi, & 
Kayhty 2001;Goldblatt, Hussain, Andrews, Ashton, Virta, Melegaro, Pebody, George, 
Soininen, Edmunds, Gay, Kayhty, & Miller 2005) as well as to vaccination (Korkeila et al. 
2000). Recently, this has also been reported for different meningococcal serogroups. 
Whereas low carriage prevalence of serogroup A and C have been associated with high 
anti-A and anti-C antibody titers in a non-vaccinated Nigerian population (Blakebrough et 
al. 1982), 15%  serogroup W135 colonisation failed to induce putative protective immune 
response in the majority of the population in Burkina Faso (Mueller et al. 2006).  
 
In Northern Ghana, we have observed a low diversity of the carried meningococcal  
population. Clonal waves of encapsulated meningococci followed each other and 
dominated for three or for years carrier- and patient-isolates but dissappeared thereafter. 
Background colonisation with non-groupable meningococci and isolates of other 
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serogroups was very low. The resulting low exposure to meningococcal antigens may be 
one determinant of insufficient antimeningococcal herd immunity and enhanced 
susceptibility of the population towards newly emerging meningococcal clones every few 
years. Whereas for unkown reasons there is no stable and diverse meningococcal 
colonisation in the African study population, around 10% colonisation with a diverse 
meningococcal population is typically established in human populations in Europe and the 
US (Yazdankhah & Caugant 2004;Cartwright et al. 1987). Meningococcal meningitis 
epidemics have occured until the second world war also in Europe and Northern America, 
equally dominated by serogroup A bacteria. The discontinuation and the failure of 
pandemic clones to cause significant outbreaks in these regions may indicate a change in 
the host-pathogen relationship since this time. Serogroup A meningococci of ST5 
disappeared from the KND in 1999 possibly due to sufficient herd- immunity against 
colonisation as a result of its epidemic spread. However, it is remarkable, that closely 
related bacteria of the same serogroup could establish themselves in the district only 1.5 
years later. This indicates, that also the development of non-anticapsular immune 
responses might play a role in the spread and disappearance of meningococcal 
genoclouds in the Menigitis Belt. 
 
Also the epidemiology of pneumococcal colonisation and disease reveals several 
differences between developing countries and Europe and Northern America. These are 
for example reflected in the serotype distribution and in the overall prevalence of 
colonisation  and disease. Whereas in Europe and the US commonly carried serotypes 
such as 6B, 19F, 23 also dominate in disease, in Africa the highly pathogenic serotypes 1 
and 5 are highly prevalent. Interestingly, this shift in pneumococcal serotype distribution 
seems to be a result of the last 50 to 70 years. Before, the “invasive” serotypes that are 
common in Africa also caused a higher proportion of invasive disease in the US. A meta-
analysis of 15 studies published between 1928 and 1998 in the US, reports a significant 
increase of the serogroups included in the 7-valent pneumococcal conjugate vaccine, 
while the fraction of so called “epidemic” serotypes 1,3, and 5 significantly decreased 
(Feikin & Klugman 2002). The authors suggest that the introduction of antibiotics might 
have lead to this change in serotype-distribution. Widespread use of antibiotics changed 
the selective pressure in the human nasopharynx and as a results antibiotic resistance 
might have emerged more often in the serotypes that were commonly carried than in the 
“invasive” serotypes (such as 1, 3, and 5) which are carried infrequently. The reduction of 
their proportion in the population over the last decades might thus be a consequence. 
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Differences in bacterial colonisation and disease between different human populations, 
particularly between high and low-income countries, have been attributed to differences in 
living standards and hygienic conditions. Also unkown genetic differences in human 
populations have been suggested to impact different pneumococcal colonisation rates or  
serotype distribution as seen in indigenous populations of Northern America and Australia 
(Bogaert et al. 2004a;Crook et al. 2004). The ecosystem of the human nasopharynx is 
very complex and it is almost impossible to attribute a single factor for the observed 
epidemiological differences. However, I think, that the introduction of vaccines and 
antibiotics in the second half of the 20th century has markedly influenced the immune 
system of the host and the selective forces in the bacterial ecosystem of the nasopharynx. 
Differences in vaccine-coverage and use of antibiotics might therefore also play a role in 
the regulation of the complex system of colonisation and disease of the various respiratory 
pathogens.  
 
In Northern Ghana, we have seen that not only meningococcal and N. lactamica 
colonisation but the whole system of bacterial meningitis is highly dynamic. Meningococcal 
colonisation and disease was dominated by successive clones which persisted for three to 
four years and dissappeared afterwards. N. lactamica colonisation, even though stable 
over the first few years has decreased continuously since April 2004. A pneumococcal 
serotype 1 clone caused an outbreak, with a pattern typical of N. meningitidis. And an 
epidemic clone of W135 meningococci, that has caused major epidemics in the 
neighboring country fails to induce a wave of colonisation and disease due to unknown 
reasons. 
The more we study the dynamics of meningococcal colonisation and disease, the more 
we appreciate its complexity, but the more new questions arise: What is the virulence 
potential of newly emerging clones such as the recent serogroup W135, but also 
serogroup X genocloud? Which factors do promote epidemic spread in certain regions and 
not in others? What is the significance of potential cofactors?  
It will be important to investigate the potential environmental and microbiological factors 
more indepth for a better understanding of when and how an emerging clone will cause an 
epidemic or not. The dynamics of nasopharyngeal colonisation is a very important 
determinant for the dynamics of bacterial menigitis. Implementing prospective case vs 
colonisation studies like the one presented here in a larger scale covering more regions of 
the African Meningitis Belt and investigating some of the questions raised above such as 
the continuing analysis of possible environmental and host- factors as well as genomic and 
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proteomic analysis of the differences in the pathogen will contribute to the understanding 
of epidemiological factors associated with epidemic spread of colonisation and disease. 
 
Intervention strategies against bacterial meningitis in Africa 
A) Treatment 
For the treatment of meningitis patients, apart from pharmakodynamic considerations, in 
epidemic situations the affordability of the drug is a major concern. Parenteral penicillin or 
ampicillin, given every 4-6 hours for at least 4 days, are recommended by the WHO 
guidelines as the drug of choice in the treatment of meningococcal meningitis (WHO 
1998). However, during epidemics, the application of single dose oily chloramphenicol, 
injected intramuscularly, is generally preferred and the standard treatment in most 
countries of the African Meningitis Belt. The third-generation cephalosporins, ceftriaxone 
and cefotaxime, are excellent alternatives but up to now have been considerably more 
expensive. A short course treatment with a single injection of ceftriaxone has recently 
been evaluated in a non-inferiority trial during an epidemic in Niger. The treatment failure 
as well as neurological sequelae were comparable in the patients treated with ceftriaxone 
in comparison to the ones that received the conventional chloramphenicol-treatment 
(Nathan et al. 2005). As the patent protection of ceftriaxone has recently ended, a 
significant reduction in the cost of treatment can be expected and it can be a powerful 
alternative in the managment of patients during epidemics. 
 
Chloramphenicol exhibits lower antibacterial activity against S. pneumoniae than against 
N. meningitidis. High mortality rates 50% in setting of low resources in contrast to about 
20% in industrialized countries are a major threat associated with pneumococcal 
meningitis. These have been attributed to a delayed CSF sterilisation in pneumococcal 
meningitis (Koedel et al. 2002). Also in the KND, where Chlorampenicol is the standard 
treatment for suspected meningitis patients, we have observed mortality rates of 44% of 
pneumococcal meningitis in contrast to 4.3% of meningococcal meningitis between 2000 
and 2003. It has been shown, that Ceftriaxone has a better better clinical efficacy as 
compared to oily chloramphenicol in bacterial meningitis due to S. pneumoniae (WHO 
1997). Rising incidence rates of pneumococcal meningitis in sub-saharan Africa are a 
further rationale for a careful re-evaluation of the standard treatment regimen against 
bacterial meningitis. Yet there is no indication of rising antibiotic resistance against 
Ceftriaxone in Sub-Saharan Africa. The pneumococcal isolates from Northern Ghana 
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showed good in-vitro sensitivity against Chloramphenicol, Penicillin G and Cefotaxim. Only 
isolated strains have shown reduced activity of Chloramphenicol and Cefotaxim 
respectively.  
 
B) Vaccination 
Until recently, only a bivalent A/C PS- vaccine and a tetravalent PS-vaccine against A, C, 
Y, and W135 were available wordwide against meningococcal disease. In various trials 
these vaccines were proved safe and immunogenic in older children and adults, with an 
overall calculated vaccine efficacy of 95% for the prevention of serogroup A disease in the 
first year after immunization (Patel & Lee 2005). Purified polysaccharides act as T-cell 
independent antigens due to their highly repetitive chemical structure. Thus, they do not 
induce long lasting immunological memory, the antibody titers elicited usually only last for 
a few years. Furthermore, mostly poor immune responses are measured in infants with 
immature B cell system (Jodar et al. 2002). Only serogroup A polysaccharide has been 
shown immunogenic in infants <2years but protective immunity after one dose only lasts a 
short time and even after repeated injections booster responses are poor (MacLennan et 
al. 1999;Reingold et al. 1985). Immune hyporesponsivness has been reported after 
repeated vaccination with serogroup C (Jokhdar et al. 2004). 
  
In the light of the vast meningococcal meningitis epidemics in the second half of the 
1990s, before the introduction of conjugate vaccines, heavy debates have been carried out 
on the best vaccination strategies in the African Meningitis Belt. It was repeatedly 
suggested to implement routine vaccination schemes against meningococcal disease, but 
only in a few countries, this has been adopted. In Egypt a measurable reduction in the 
serogroup A meningococcal disease after the introduction of a school based immunzation 
scheme has been reported (Nakhla et al. 2005). Also in Benin, routine immunization in two 
departments with coverage rates of 50-60% of the population, lead to the prevention of 
large meningococcal meningitis outbreaks between 1994 and 1997 (Hassan et al. 1998). 
  
In the KND, yearly vaccination campaigns between 1997 and 2002 targeted the complete 
district population. Later on smaller campaigns were carried out, especially in schools, 
creating at least for some age groups a system of routine immunization. Since 2002, up to 
80% of our carriage-study members reported to have been vaccinated within the last three 
years reflecting a high coverage rate in the district. Nevertheless, substantial serogroup A 
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ST7 meningitis outbreaks occured in the district between 2002 and 2004. Even though 
some of the patients reported to have been vaccinated, the proportion of vaccine failure is 
difficult to quantify, as vaccination is not reliably documented with vaccination cards. 
Furthermore, other unkown environmental or host-pathogen related factors might influence 
the occurence of outbreaks in the respective regions.Therefore, the data obtained so far is 
too little and incomplete to assess the population wide effect of routine immunization 
campaigns for the prevention of meningococcal outbreaks. However, for the majority of the 
sub-saharan countries of the Meningitis Belt, routine vaccination with multiple dosage in 
young children, will not be realizable due to financial and organizational contraints.  
In 2000, WHO recommendations where published that call for intense meningitis 
surveillance and stocking of vaccines at the beginning of the dry season. Alert and 
epidemic thresholds were defined with a specific plan of action to ensure early detection 
and response to meningococcal meningitis epidemics. Even though these thresholds have 
been found effective for the prediction of epidemics (Kaninda et al. 2000), lack of stocking 
and infrastructure may still lead to delayed responses by national health authorities in 
some regions of the Meningitis Belt. 
 
Against pneumococcal disease the so far available 23-valent pneumococcal 
polysaccharide vaccine covers about 90% of the serotypes associated with invasive 
disease anywhere. Being also a pure polysaccharide vaccine, it has the same limitations 
as the meningococcal PS vaccine. Currently, pneumococcal vaccination is recommended 
by WHO for individuals at increased risk of invasive pneumococcal disease, such as 
elderly, particularly those living in institutions, patients suffering from chronic organ failure 
or immunodeficiencies. For the African Meningitis Belt, so far pneumococcal vaccines 
have not been considered to be included in a standard vaccination scheme due to its 
failure in infants and the lack of immunological memory. However the large burden of 
pneumococcal disease in sub-saharan Africa due to pneumonia and meningitis 
emphasises the urgent need for intervention strategies against S. pneumoniae  in this part 
of the world. 
 
Vaccine development 
Capsular polysaccharides have been found to induce anti-capsular antibodies mediating 
complement bactericidal activity and/or opsonophagocytosis (Snapper C M, Colino J, 
Khan A Q, & Zheng Q W 2004;Goldschneider, Gotschlich, & Artenstein 1969). Thus, multi-
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serotype/-serogroup polysaccharide vaccines are in use for both S. pneumoniae and N. 
meningitidis (Lesinski & Westerink 2001). To circumvent the limitations associated with 
pure PS antigens a new generation of vaccines has been developed. The purified capsular 
polysaccharide or oligosaccharide antigens have been covalently linked to immunogenic 
carrier proteins, converting the antigen to a thymus dependant antigen and increasing its 
immunogenicity. The first conjugate vaccine for use in humans was against H. influenzae 
type B (Granoff et al. 1993). A dramatic decline of Hib disease occurred where the Hib 
conjugate vaccine was introduced. Also in Northern Ghana, since the introduction of the 
conjugate vaccine in 2000, Hib meningitis has lost its importance. Only 15 Hib meningitis 
cases have been recorded between 2000 and 2002 in the KND, and none since 2003. The 
ability of Hib conjugate vaccines to reduce nasopharyngeal colonisation by the induction of 
mucosal immunity is thought to contribute substantially to the >97% reduction in the 
incidence of HiB infections observed in Finland, the UK and the USA after the 
incorporation of the vaccine into infant vaccination schemes (Peltola et al. 1992;Booy et al. 
1997;Adams et al. 1993). Following the overwhelming success of Hib conjugate vaccines, 
conjugate vaccines for meningococcal and pneumococcal disease have been developed 
and in part already introduced.  
 
The first meningococcal conjugate vaccine against serogroup C was introduced into 
routine immunization in the UK in Novemver 1999 (Jodar et al. 2002). The immediate 
consequence was an overall decrease in serogroup C invasive disease by over 85% 
between 1999 and 2001 in the targeted age groups (Balmer et al. 2002). Later on it was 
shown, that in contrast to pure polysaccharide vaccines, this capsule conjugate vaccines 
also affect carriage and transmission by inducing mucosal immunity (Maiden & Stuart 
2002;Ennes et al. 1992) and might therefore contribute to the development of herd 
immunity in the non-vaccinated population. On the other hand, strain replacement, the 
emergence of escape variants or capsule switching are major concerns associated with 
the introduction of conjugate vaccines (Maiden & Spratt 1999). Even though no direct 
indication for capsule switch has been obtained a significant increase in genetic diversity 
of meningococcal isolates as been recorded in the first years after the introduction (Diggle 
& Clarke 2005). Also in the KND we do not have indications for frequent capsule switch in 
the colonisation isolates analysed. 
  
Another concern connected with the introduction of conjugate vaccines is the duration of 
protection induced. Data collected since the introduction of the conjugated HiB vaccine in 
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the early 199s indicate that vaccine effectiveness and duration of protection depend on the 
schedule of immunisation and significant waning of antibody titers occurs in children that 
have been vaccinated during infancy (Kelly, Moxon, & Pollard 2004). Comparable results 
have been obtained after the introduction of meningococcal serogroup C conjugate 
vaccine. Even though good long-term vaccine efficacy was observed in older children and 
adults, waning antibody titers and reduced vaccine efficacy was measured after one year 
following infant immunization (Trotter et al. 2004;Borrow et al. 2002). However 
immunological memory was demonstrated in children aged 4 years by rapid increase of 
SBA titers after the administration of a booster dose (Borrow et al. 2002). Therefore 
modified immunization schedules with late booster doses have been suggested.  A 
quadrivalent conjugate vaccine (A,C,Y, W135) has been licensed in the US in January 
2005 (Vu et al. 2006), but this vaccine is too expensive for routine use in the Meningitis 
Belt. 
 
To date, no meningococcal conjugate vaccine has been licensed for the the African 
Meningitis Belt. A serogroup A conjugate vaccine for the use in all age groups and a 
serogroup A/C formulation for the implementation into the current EPI vaccine using a 
heptavalent formulation for infants in Africa, are currently tested in clincal trials (Soriano-
Gabarro et al. 2004). Effective immunization schedules need to be developed carefully, as 
waning antibody titers in older children and adolescents might have large implications in 
the prevention of meningococcal disease, as peak incidence rates are reported in these 
age groups. School based immunzation of older children might therefore have a greater 
long-term impact than infant immunization with several booster doses where lack of 
compliance might reduce the herd effect of this vaccine. During the last 20 years we have 
seen a strong dominance of serogroup A meningococcal meningitis in the Meningitis Belt. 
On the other hand we have recorded a potential of other serogroups for epidemic spread. 
Yet, we cannot predict the upcoming epidemiological trends and we can not be sure of the 
consequences of the introduction of a serogroup A conjugate vaccine and whether it will 
be as successful as the introduction of the Hib vaccine. Therefore, continuous surveillance 
needs to monitor the emergence of new clones, possibly of non-vaccine serogroups of 
Neisseria meningitidis and other species with an epidemic potential such as S. 
pneumoniae. 
 
Pneumococcal conjugate vaccines with up to 11 serotypes linked to a protein carriers 
have been designed, all of them showed to be safe and immunogenic in infants and 
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toddlers (Obaro et al. 2000;Ahman et al. 1996;Shinefield et al. 1999;Esposito et al. 2005). 
As too much carrier antigen coupled to protein carrier may impair the antibody response to 
the polysaccharides (Bogaert et al. 2004b), conjugate vaccines are limited in their 
maximum number of serotypes included. A heptavalent conjugate vaccine has been 
licensed in the US in 2000 and shortly after in Europe. Formulated according to the most 
prevalent serotypes in the US and Canada, it has a potential coverage of over 85% of 
pneumococcal isolates in the US, but only 60-70% for Europe and around 55% for Asia. In 
Africa this rate might be even lower, between 33% of all strains from adults and up to 67% 
of pneumococcal isolates from young children could be covered by the 7V-conjugate 
vaccine (Hausdorff et al 2000). During the pneumococcal outbreak in Northern Ghana, this 
vaccine would have covered less than 10% of all serotyped pneumococcal cases. The 
nona-valent formulation which is currently undergoing clinical trials reveals a better 
coverage rate as it comprises in addition to the 7V-vaccine formulation the serotypes 1 
and 5. These serotypes are prominent in Africa and Asia causing localized outbreaks such 
as in Northern Ghana. A randomised vaccine trial of the 9V conjugate vaccine in children 
in the Gambia has shown a high efficacy against radiological pneumonia, a substantial 
reduction of all-cause hospital admission and improved child survival (Cutts et al. 2005).  
 
The consequences of the introduction of pneumococcal polysaccharide conjugate 
vaccine has been closely monitored in various studies. It has been described that carriage 
of vaccine serotypes declined significantly, whereas non-vaccine-serotypes increased and 
the total carriage rate stayed constant. Furthermore a shift of drug resistance towards the 
non-vaccine serotypes was observed (Frazao et al. 2005). The pathogenic potential of 
non-vaccine serotypes is not known, however an increase in episodes of acute otitis media 
has been observed in vaccinated children (Eskola et al. 2001). Capsule switch has been 
reported in several multi drug resistant clones and seems to be a frequent phenomenon in 
pneumococcal populations. Also during the pneumococcal outbreak in Ghana we have 
seen indications for a capsule switch from serotype 1 to 14, as the serotype 14 isolates 
were closely related to the ST217 clonal complex. The introduction of conjugate vaccines 
comprises a great potential to fight the disease burden caused by this pathogen. On the 
other hand, it will be unavoidable to closely monitor the changing pneumococcal 
epidemiology in response to this intervention. 
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Table 8.1 Serotypes included in current (un-)conjugated pneumococcal PS vaccine formulations 
Vaccine-formulation Serotypes included Status 
PS-Protein : 7-valent 4, 6B, 9V, 14, 18C, 19F, 23F licensed 
PS-Protein :9-valent 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 5 in development 
PS-Protein :11-valent 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 5, 3, 7F in development 
PS : 23-valent 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 5, 3, 7F, 
2, 8, 9N, 10A, 12F, 15B, 17F,19A,  20, 22F, 33F 
licensed 
 
Certain proteins of the pneumococcal cell wall may also be accessible for antibodies and 
represent target structure for protein-based vaccines. Animal studies have also shown a 
protective effect of immunoglobulins directed against selected pneumococcal cell surface-
associated proteins, including pneumococcal surface protein A (pspA), pneumococcal 
surface adhesin A (psaA), and pneumolysin (Paton et al. 1993). These proteins are 
currently leading candidates for protein based pneumococcal vaccines (Briles at al. 2000). 
Although PspA shows considerable heterogenicity in clinical isolates, Nabors and 
colleagues found broadly cross-reactive antibodies to heterologues PspA molecules after 
immunization with a single recombinant PspA preparation (Briles et al. 1998;Nabors et al. 
2000). Surprisingly the pspA gene in ghanaian serogroup1 isolates turned out to be highly 
conserved, suggesting further investigation of its potential as a vaccine candidate. 
 
The impact and afforability of anti-pneumococcal vaccination with conjugate vaccines in 
infants and high-risk groups in developing countries with the greatest burden of 
pneumococcal disease, especially in infants is still under evaluation. Considering, that a 
full vaccination regimen with conjugate vaccines might be unaffordable in many countries, 
as an additional cost-effective measure for the protection of newborns during the first three 
months of life single immunization of pregnant women with the 23valent-polysaccharide 
vaccine has been suggested after the transfer of maternal antibodies has been shown via 
the placenta and the breast milk of immunized mothers (Shahid et al. 1995;Obaro et al. 
2004). The development of protein based antipneumococcal vaccines or less complex 
conjugate vaccines focussed on the serotypes prevalent in Africa, might be an alternative 
in fighting the high burden of pneumococcal disease in this region. 
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Outlook 
During the course of the long term meningococcal colonisation and disease study 
performed so far, we have observed the close association between colonisation and 
disease and found that bacterial meningitis in the African Meningitis Belt is highly dynamic. 
Even though, through improvement of surveillance activities, outbreaks can now be 
detected earlier, still emergency vaccination campaigns are often initiated too late to have 
a major impact on the course of epidemics. This implies the need for further improvement 
in the implementation of already existing intervention strategies and efficient support of 
countries suffering from epidemics. 
  
Recently newly emerging meningococcal clones have been detected, in Africa and Asia. 
Serogroup W135 ST2881 meningococci have been isolated since 2003 from meningitis 
patients in Niger, Benin and Nigeria. ST2881only shares one MLST locus with ST11, is 
therefore not closely related (Nicolas et al. 2005) and its pathogenic potential not well 
characterized. In the Anhui province in China, a new serogroup C clone has been 
responsible for several outbreaks between 2003 and 2005. By MLST and PFGE analysis it 
was shown, that these bacteria did not belong to the previously known major clonal 
complexes responsible for the major disease burden in the 20th century, but constituted a 
new clonal complex, ST4821 (Shao et al. 2006). Further spread of these bacteria within 
China and to other countries needs to be monitored carefully to evaluate the potential risk 
of causing a future wave of meningococcal meningitis in the African Meningitis Belt and to 
ensure the preparation of health authorities to answer possible epidemics timely.  
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During the long-term study on bacterial meningitis in the Kassena Nankana District 
(KND) of Northern Ghana, meningitis patients were recruited in the War Memorial Hospital 
of Navrongo and four health centers between February 1998 and November 2005. CSF 
was taken from all suspected meningitis cases for diagnostic purposes and Hib diagnosis 
was based on gram stain and Latex Agglutination. Furthermore, laboratory-data was 
obtained from the Regional Hospital in Bolgatanga for the period of 2000 until 2002.  
 
Both datasets indicate a low significance of Hib meningitis in Northern Ghana. In the 
KND, between 1998 and 2002, altother only 17 cases of Haemophilus meningitis have 
been diagnosed. After 2002 until 2005 no single Hib meningitis case was recorded in the 
KND. While from four patients the outcome of the disease is not known, five of these 
patients died. Of two patients the age was not known, however, 11/15 patients were up to 
five years old (median age: 5 years, age range: 6 months to 55 years). 
These data are in accordance with laboratory results from the Bolgatanga Hospital 
between 2000 and 2002. While in total 580 suspected meningitis patients were recruited 
and 65 meningococcal meningitis and 191 pneumococcal meningitis cases were seen, 
only 9 Hib meningitis cases were recorded in this time period.  
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Figure 1 Hib meningitis cases in the KND between 1998 and 2005, reported in the laboratory of the War 
Memorial Hospital, Navrongo. Diagnosis was performed with Latex agglutination. 
 
The incidence of Hib meningitis seen in these two settings of Northern Ghana is lower 
than in many other regions of sub-saharan Africa. This is most probably due to the 
introduction of the Hib conjugate vaccine into the routine immuninzation scheme of infants 
in the year 2000 in Ghana as one of the first African countries (personal communication). 
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Wherever the vaccine is not yet implemented, Haemophilus influenzae remains an 
important causative agent for meningitis in children. In Mali, yearly incidence rates of over 
150/100’000, in Burkina Faso of 97/100’000  in children under 1 years of age have been 
reported recently (Sow et al. 2005;Yaro et al. 2006). Overall it has been estimated to be 
40-60/100’000 cases in the under 5 year old children (WHO 2003). Even though we do not 
have solid pre-vaccination data from the district, the low significance of Hib meningitis 
between 1998 and 2002 and its dissapearence in 2003 until 2005 indicate the positive 
effect of Hib immunization.  
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